completeness_percent,weighted_completeness_percent,error_percent,quality_rating,weighted_quality_rating,id,weighted_quality_score,title,pid,publisher,quality_score,weighted_error_percent,schema_version
4.76,4.76,46.51,Not Rated,Not Rated,0056a5c8-4f98-4e9e-b74a-bd498be71c0d,29.36,KPIC,11dee486-22d2-4cf4-a955-512249e61645,,29.12,46.03,1.1.7
50.0,46.03,27.91,Not Rated,Not Rated,00ffee70-43d6-4a81-8568-32b0b6d9e39c,59.52,National Paediatric Diabetes Audit - Parent and Patient Recorded Experience measures,b0979e07-3331-408f-853b-5eeba80ce8f9,ALLIANCE > HQIP,61.05,26.98,1.1.7
69.05,60.32,18.6,Bronze,Bronze,0121c132-5be6-414e-853b-885ff301854f,71.43,PTCL Biobank,19fa25a7-c15d-441c-b635-ad49043e7a96,ALLIANCE > TISSUE DIRECTORY,75.22,17.46,1.1.7
69.05,60.32,16.28,Silver,Bronze,01470238-7a17-47a5-a131-17178ba26a0a,72.22,Human Developmental Biology Resource (HDBR),399a6d67-7577-4476-a3b6-4bbceb5a8ff7,ALLIANCE > TISSUE DIRECTORY,76.38,15.87,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,019aaff2-4b37-474e-b7c1-4223b224b788,38.88,Substance Misuse Dataset (SMDS),291c0dd4-0988-42d2-8e0b-878a892add57,,32.78,55.56,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,025706a9-538b-4773-aa8d-4004b1351c1a,41.27,Careers Wales Dataset (CARW),e4004e0e-6adb-4b11-82c2-af0caf61d751,,33.95,50.79,1.1.7
28.57,23.81,32.56,Not Rated,Not Rated,02a6e7b7-ccf8-4446-b899-74065c8b3dd9,45.24,National Diabetes Audit - Core Clinical Audit Dataset,f4c8900b-5db5-4426-95e9-2f1617c92a76,ALLIANCE > HQIP,48.0,33.33,1.1.7
69.05,60.32,16.28,Silver,Bronze,0315886c-f34a-4f1d-8f76-2dfa80a6e949,72.22,Cam-UroOnc Biorepository,21044030-1cd5-46b1-b072-c9959fd330b4,ALLIANCE > TISSUE DIRECTORY,76.38,15.87,1.1.7
28.57,23.81,32.56,Not Rated,Not Rated,039c0b29-63f6-4ce9-8d89-87012a52e44f,45.24,The Leicester City and County Chronic Kidney Disease Cohort,4dfec37d-dd24-465f-85ea-30209aff3a26,ALLIANCE > UNIVERSITY HOSPITALS OF LEICESTER,48.0,33.33,1.1.7
61.9,53.97,20.93,Bronze,Bronze,03abf37c-41b2-4ff3-9c09-2cfea438526a,66.67,"4 Country ChrOnic: estimating respiratory disease burden in adults, South India",2f1244b8-7cbf-4fa3-8534-433efd769d48,HUB > BREATHE,70.48,20.63,1.1.7
59.52,68.25,30.23,Not Rated,Not Rated,03fb3b18-4419-44f7-a035-9ddfecfcadfc,65.87,COVIDsortium,529f126b-660c-4c31-aeb2-765dac1d9df0,OTHER > UNIVERSITY COLLEGE LONDON,64.64,36.51,1.1.7
16.67,14.29,37.21,Not Rated,Not Rated,0477b06f-cbed-4949-982e-ce248a47ed1a,38.89,SOLUS,e653b264-3e44-4ed1-a376-86df45db7f72,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,39.73,36.51,1.1.7
92.86,96.83,18.6,Gold,Gold,04f22c93-53df-440a-a71a-50d6827450bc,87.31,North West London COVID-19 Patient Level Situation Report (NWL COVID19 SITREP),ed08c844-343e-44fa-a02d-3ad5ecf25184,HUB > DISCOVER NOW,87.13,22.22,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,04f28919-aa6c-4beb-b186-0ad0043c1c6c,38.88,NIHR IBD BioResource: Sample holding,f2af20f9-af84-40ce-8a07-7d095948653e,,32.78,55.56,1.1.7
26.19,22.22,37.21,Not Rated,Not Rated,04fb4aac-415b-4493-986b-65bbef5214d3,42.86,National Asthma and COPD Audit Programme (NACAP):COPD and adult asthma secondary care organisational dataset,1982d9ef-890a-41ff-a86a-de61d65aaa09,ALLIANCE > HQIP,44.49,36.51,1.1.7
95.24,100.0,13.95,Gold,Gold,05716e41-9842-4c07-8ddd-af9f9231e056,92.06,Bowel Screening Wales,9f29d47e-4e9a-41b8-b7bc-5ef3570294ef,ALLIANCE > SAIL,90.64,15.87,1.1.7
95.24,100.0,16.28,Gold,Gold,05a0baf4-72ea-4e02-b4fb-64c37bb1eb0e,89.69,COVID-19 Shielded People list,dc22db56-8791-4e96-9ce6-6b6a58b1241f,ALLIANCE > SAIL,89.48,20.63,1.1.7
59.52,50.79,18.6,Bronze,Not Rated,05eadf79-02a7-4c1f-b1be-93694172a9b3,65.87,IBD Registry,a406d06b-350e-4392-ab4e-b1012e422a34,HUB > GUT REACTION,70.46,19.05,1.1.7
69.05,60.32,16.28,Silver,Bronze,0664f988-276e-4268-af43-1986a3101f38,72.22,INCA Trial,edd55990-a616-4a9c-a4a2-38af136a349b,ALLIANCE > TISSUE DIRECTORY,76.38,15.87,1.1.7
69.05,60.32,16.28,Silver,Bronze,069c213c-eb04-463e-a300-7614c03cf623,72.22,HCV Research UK,01492322-9b33-41cc-9f51-484024e45878,ALLIANCE > TISSUE DIRECTORY,76.38,15.87,1.1.7
92.86,98.41,18.6,Gold,Gold,06dee089-8c10-4a8b-aa94-7cb699dc3c80,89.68,"OMOP dataset: Hospital COVID patients: severity, acuity, therapies, outcomes",0eb789bb-0047-46ac-83ff-631f31e98da0,HUB > PIONEER,87.13,19.05,1.1.7
16.67,14.29,37.21,Not Rated,Not Rated,0711cc7e-80d5-4781-a1ab-2637ea176ceb,38.89,Millennium Clinical Events,5f45bcd1-970b-44ba-8ae2-0fb49b85ffa9,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,39.73,36.51,1.1.7
80.95,71.43,11.63,Silver,Silver,0715a950-3999-46d8-a646-6496866638a1,79.37,Prospective Observation of Fibrosis in the Lung Clinical Endpoints,bb8de9d2-cc38-4c40-b104-ffd167f64f76,HUB > BREATHE,84.66,12.7,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,074e00d5-05c1-48c6-a6c3-d5228fa515bb,38.88,COVID-19 Shielded People List (CVSP),dc22db56-8791-4e96-9ce6-6b6a58b1241f,,32.78,55.56,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,077a21b9-5c5a-4c68-a9f0-b4fa3384aead,41.27,COVID-19 Sequence Data,602cbc9b-0113-4712-8c4a-0efe8d86b77c,,33.95,50.79,1.1.7
33.33,31.75,27.91,Not Rated,Not Rated,07b82dd5-adc3-42c5-8a60-914042b5bc40,52.38,Exome sequencing,2ddf0659-f05a-4f1c-b558-63a96e5b49f7,UK Biobank,52.71,26.98,1.1.7
76.19,84.13,25.58,Bronze,Silver,07e3ac82-a38d-45f3-9933-07439f6a761d,79.36,The impact of COVID on hospitalised patients with COPD; a dataset in OMOP,323dc330-aad9-472a-b579-ab66f5f75906,HUB > PIONEER,75.31,25.4,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,084ab1d8-78f6-4c04-b829-6891c6463ca9,41.27,Breast Test Wales (SBTW),8b9efd45-f56d-4aa3-b2b8-c66ff3813a2b,,33.95,50.79,1.1.7
80.95,88.89,20.93,Silver,Silver,08846261-45f0-4bcf-9801-fe785dcef1c9,83.34,Careers Wales dataset,e4004e0e-6adb-4b11-82c2-af0caf61d751,ALLIANCE > SAIL,80.01,22.22,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,0910383a-44d6-4652-98da-550df7204416,38.88,NHS Tayside and Fife Accident & Emergency Dataset (ISD/National),750063ea-6bfd-4492-9748-2a18080cf6ea,,32.78,55.56,1.1.7
73.81,82.54,25.58,Bronze,Silver,0942304f-8b91-4258-af9c-3a1801c7e79f,78.57,The acute presentation of pregnant women to non-maternity Emergency departments,86632207-1e57-4272-b178-ea069a13cae1,HUB > PIONEER,74.12,25.4,1.1.7
69.05,60.32,16.28,Silver,Bronze,097cc6bd-ce98-47ec-a73d-5d2c250f2697,72.22,ICON9 Trial,1fdf266c-d5d8-418d-a423-81265da540a2,ALLIANCE > TISSUE DIRECTORY,76.38,15.87,1.1.7
4.76,4.76,46.51,Not Rated,Not Rated,09f04291-670d-4db0-a3e4-7e0d84555231,29.36,Development of ELISA and Rapid Testing Kits for COVID-19,6b2aca2c-b03a-44ba-80a1-883b744421b6,,29.12,46.03,1.1.7
95.24,100.0,16.28,Gold,Gold,0abfceb7-5a56-4559-b0d4-88326e0331a3,89.69,Pathology Data from WRRS,48ef8f54-9606-4e6f-9256-3cc07ffd10b8,ALLIANCE > SAIL,89.48,20.63,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,0ac16d3d-5ca8-4e25-ad46-ce8e03a04e17,38.88,Pathology Data from WRRS (PATH) - Legacy,48ef8f54-9606-4e6f-9256-3cc07ffd10b8,,32.78,55.56,1.1.7
78.57,85.71,25.58,Silver,Silver,0ac9438e-da8d-4488-bdc6-8285d1401b1d,78.57,Census 2011 E&W - Household structure for COVID-19 models,2f66bcf9-e626-4e8d-bc6e-2d3958e709d8,NCS > OFFICE FOR NATIONAL STATISTICS,76.5,28.57,1.1.7
69.05,60.32,18.6,Bronze,Bronze,0b7ea326-fc05-4aca-a962-3f93128b91d1,70.64,HPB Biobank,ebe6c9dd-fb95-4301-a929-c21b8077753a,ALLIANCE > TISSUE DIRECTORY,75.22,19.05,1.1.7
66.67,57.14,18.6,Bronze,Bronze,0c219a61-a1d6-4c5b-bec2-3537454e4137,69.05,Teleconsultation in remote rural India: management of COPD and Asthma,de496590-26b3-4e74-bc5e-1ff5c83f5b43,HUB > BREATHE,74.03,19.05,1.1.7
69.05,60.32,18.6,Bronze,Bronze,0c50801d-1079-4879-b608-5e8f112b313f,70.64,Tissue Access for Patient Benefit (TAPb),35985f8e-f01a-41cc-a9e2-30299d3d6eed,ALLIANCE > TISSUE DIRECTORY,75.22,19.05,1.1.7
71.43,58.73,16.28,Silver,Bronze,0c78d1cf-4ba6-44f4-adcf-16c15142d8fb,69.84,Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II),25bc9862-5b6c-4dda-80b2-46642d9e518a,HUB > BREATHE,77.58,19.05,1.1.7
47.62,46.03,32.56,Not Rated,Not Rated,0c98200b-48b5-418a-b8d0-a7708abc1f39,57.94,Mental Health Services Data Set - Community,f3bb6a68-2c32-40a7-9a79-61a718068893,ALLIANCE > NHS DIGITAL,57.53,30.16,1.1.7
4.76,4.76,46.51,Not Rated,Not Rated,0d65fabc-6cb0-4a77-a01d-cb341b0b053c,29.36,NIHR IBD BioResource: NHS Trust data,ae1898da-7fe5-4fe0-b10d-9f06cdec1735,,29.12,46.03,1.1.7
71.43,63.49,16.28,Silver,Bronze,0d6ab9af-c43b-490d-b39c-2d72de46a661,73.81,The Cleft Collective,12288034-00a4-47a8-a779-1cf7a55270e4,ALLIANCE > TISSUE DIRECTORY,77.58,15.87,1.1.7
69.05,60.32,16.28,Silver,Bronze,0d70b5c8-da5d-49c5-8ff5-0bdc7b5f6306,72.22,MRC Brain Banks Network,6f1b9a4e-2367-47f1-a985-3ed9bf3a7211,ALLIANCE > TISSUE DIRECTORY,76.38,15.87,1.1.7
69.05,60.32,16.28,Silver,Bronze,0d79e0d8-9b3d-4450-9c34-0539673dc9a5,72.22,Leeds NIHR Biomarker Research Tissue Bank,8648d251-6186-4383-82fc-c036a87c3842,ALLIANCE > TISSUE DIRECTORY,76.38,15.87,1.1.7
73.81,79.37,32.56,Bronze,Bronze,0ddcb454-2372-4180-9ba0-a7e1896d4fe2,73.02,Real Time Data Network (RTDN),616c4488-65a5-4608-a187-0c6bc78b359a,HUB > DATA-CAN,70.62,33.33,1.1.7
71.43,79.37,27.91,Bronze,Bronze,0e07413c-892c-4f06-bd22-2a917eb5c905,74.61,Cancer Registration Data,2ed7bbbc-80db-46c2-a45b-632dda40794b,ALLIANCE > NHS DIGITAL,71.76,30.16,1.1.7
64.29,77.78,44.19,Not Rated,Not Rated,0e6e6ed5-ab81-4d7f-b06a-768bf33357ca,64.28,Mental Health Minimum Dataset v4 (Sensitive) Episodes,29c61f09-c4a1-425f-9bbc-888c23d99516,ALLIANCE > NHS DIGITAL,60.05,49.21,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,0e71fb49-9d05-4bc6-8737-2f2b1ff591b5,41.27,Healthcare Workers Risk Assessment (HWRA),ed131fee-0635-4613-a453-a383d5dd7cec,,33.95,50.79,1.1.7
69.05,60.32,16.28,Silver,Bronze,0ecedaa2-e8f5-4eb2-ad3f-fc2ce433fc36,72.22,Cardamon Clinical Trial Samples,c0dcceca-c8cf-4269-a0e0-0c18b6ba2de1,ALLIANCE > TISSUE DIRECTORY,76.38,15.87,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,0efcd6ce-4e7a-4f8e-8903-1a987ec76b1c,41.27,Better Rx BRIT2 Patient GP Dataset,656b2c22-9e57-4f15-9b3c-1969da6495ca,,33.95,50.79,1.1.7
69.05,60.32,16.28,Silver,Bronze,0faa4c3e-edf5-4ae8-9b26-c59c98e26b57,72.22,UKALL14 Trial,b5533cb5-0c59-495b-9b11-3c401daeb958,ALLIANCE > TISSUE DIRECTORY,76.38,15.87,1.1.7
64.29,77.78,44.19,Not Rated,Not Rated,0fc61ace-397d-4489-9e62-77f88082e775,64.28,Mental Health & Learning Disabilities Dataset v 1 (Non-Sensitive) Events,9c8bd383-b117-4167-a25c-9e15fa5ec1c6,ALLIANCE > NHS DIGITAL,60.05,49.21,1.1.7
19.05,15.87,41.86,Not Rated,Not Rated,1092c90a-d3d5-4904-97ba-1861cfaddb65,38.09,CDE Clinical Events,e3b36044-e1fb-418b-946a-b83626bf2e3f,ALLIANCE > BARTS HEALTH,38.59,39.68,1.1.7
21.43,17.46,37.21,Not Rated,Not Rated,10b10bc5-ce28-4cc0-b006-2a0e6d03a72d,40.48,CDE Patient Demographics,209d7fae-0521-4d07-8a4d-e0843a46a107,ALLIANCE > BARTS HEALTH,42.11,36.51,1.1.7
4.76,4.76,46.51,Not Rated,Not Rated,112db000-f69f-47a4-8dd7-db7b6d839e68,29.36,Bangladesh Asthma Hajj Study,27e1ffc7-5804-40e2-83e2-93f570906127,,29.12,46.03,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,115109e7-9a35-420f-831e-0707bc96375c,38.88,UK SARS-CoV-2 viral sequencing data (COG-UK) - Lineage/Variant Data - NI,3d2d9c5e-6111-4583-a6db-07affd628f1e,,32.78,55.56,1.1.7
28.57,23.81,32.56,Not Rated,Not Rated,1199f5b5-99f0-4aae-9769-ab754f05dcdb,45.24,National Maternity and Perinatal Audit Organisational Survey 2019,01ad25ed-8cde-43d7-bc77-d8cc3d165df4,ALLIANCE > HQIP,48.0,33.33,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,125202ff-1d00-4f8e-96e1-1d5a310ab326,41.27,2019 UK Parkinson's Audit - Occupational therapy,9890eee9-44d4-49f7-8674-16c05a5f82e0,,33.95,50.79,1.1.7
4.76,4.76,46.51,Not Rated,Not Rated,12d62b02-2167-407d-acdb-6ddb9d251d36,29.36,NIHR IBD BioResource: SNP imputation data,7dee2bd6-733a-4b2e-a942-7f9eaf8ebbc2,,29.12,46.03,1.1.7
69.05,60.32,18.6,Bronze,Bronze,12dba445-dfa9-46af-abc0-5bd3701061a7,71.43,UK primary Sjogren's syndrome Registry,38fe1a10-ebf9-4dc1-8c35-2e7b33b1f6b5,ALLIANCE > TISSUE DIRECTORY,75.22,17.46,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,135f2650-ea0c-4cad-80ac-c86449a176a8,38.88,Tayside Radiology,af10ec29-1866-4726-b33f-3948afe182f2,,32.78,55.56,1.1.7
69.05,60.32,18.6,Bronze,Bronze,1406c52a-e5d6-4c57-883d-62e405eb604a,71.43,Manchester Eye Tissue Repository,47fc8f03-eba1-4efa-ae3e-148a76b56517,ALLIANCE > TISSUE DIRECTORY,75.22,17.46,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,140ce7b6-8a58-4d0f-a24b-81b0f4289a68,38.88,Referral to Treatment Times (RTTD),0bf54842-c1db-4bdb-9f55-c5be490bf758,,32.78,55.56,1.1.7
83.33,90.48,23.26,Silver,Silver,142f3390-95eb-49be-bc8c-1a752a7d308e,82.54,Scotland Accident and Emergency,05e6752e-3a0b-4809-aa14-207b4761ef60,ALLIANCE > PUBLIC HEALTH SCOTLAND,80.03,25.4,1.1.7
61.9,50.79,20.93,Bronze,Not Rated,1450ff1a-4526-4a6e-b9e9-25969878449d,64.28,COPDMAP Consortium,bcbc41cb-99f7-482e-ba3d-561164abbd4e,HUB > BREATHE,70.48,22.22,1.1.7
54.76,46.03,16.28,Bronze,Not Rated,145916c8-d3ca-4465-a719-93dd0770a6e4,64.28,Optimum Patient Care Research Database,e3ca35c1-b2e2-4479-adf1-6a78b1c8c088,HUB > BREATHE,69.24,17.46,1.1.7
95.24,100.0,20.93,Gold,Silver,148ebbaa-28f4-42e0-a27f-8587e516c3bf,84.92,Cystic Fibrosis Patient Sweat Tests,34f0c2bd-d42e-4441-a89b-e0e384f12afa,ALLIANCE > CYSTIC FIBROSIS TRUST,87.16,30.16,1.1.7
95.24,100.0,16.28,Gold,Gold,15805559-2115-4822-b91f-635de36fb289,89.69,Active Adult Survey,1eb67fd5-33f6-49dd-a43d-854fff9f25f5,ALLIANCE > SAIL,89.48,20.63,1.1.7
80.95,88.89,25.58,Silver,Silver,1584af1e-9683-4727-8c9b-9bea8beaa68d,80.16,UHB 2020 Winter Society of Acute Medicine Benchmarking Audit,5bf9bf39-3cd7-4a54-994b-9914405f945e,HUB > PIONEER,77.69,28.57,1.1.7
95.24,100.0,18.6,Gold,Gold,15efea36-d022-495c-a5b6-90f51631a643,90.47,GENOMICS ENGLAND 100K QUICK VIEW,4cc5ed33-3190-4f80-953b-cabd5a2b1c7c,GENOMICS ENGLAND,88.32,19.05,1.1.7
28.57,23.81,34.88,Not Rated,Not Rated,1603b4e2-6465-4636-b7d7-1f8c6abbc717,44.45,National Bowel Cancer Audit -  Organisational Survey dataset,4e232aa8-ad56-4d82-adcc-cd06715a5c45,ALLIANCE > HQIP,46.84,34.92,1.1.7
83.33,88.89,20.93,Silver,Silver,1638cce2-12f5-410b-9624-86d2f407c502,80.95,COVID-19 Clinical Information Network (CO-CIN),84336be3-23bd-466e-b29b-df48db897665,ALLIANCE > ISARIC 4C,81.2,26.98,1.1.7
71.43,63.49,16.28,Silver,Bronze,16445ebd-bd45-4ded-a7ae-05f33f676598,73.81,MFT Biobank,d17efe5d-325f-4fcf-b25e-87d1f6269bea,ALLIANCE > TISSUE DIRECTORY,77.58,15.87,1.1.7
69.05,60.32,16.28,Silver,Bronze,167cc04b-23b8-4a9e-9ff9-6c8e07d6a561,72.22,Cambridge Blood and Stem Cell Biobank,c51ab59a-33ce-4145-a642-7f3f96bca545,ALLIANCE > TISSUE DIRECTORY,76.38,15.87,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,16d40748-66f1-4fc3-bdb3-7c8103cadeb7,41.27,2019 UK Parkinson's Audit - Physiotherapy,27690c58-a5da-4359-909a-8e19ff6ca463,,33.95,50.79,1.1.7
19.05,33.33,55.81,Not Rated,Not Rated,16f11980-e2e7-4f79-8e33-39ba4dc3547f,36.5,Suspected Cancer Pathway Daily (SPCD),9ea2f685-d6c2-49fe-a0e2-735910584d67,,31.62,60.32,1.1.7
16.67,14.29,37.21,Not Rated,Not Rated,172242ce-a1c5-4915-9c71-686f6e7d5789,38.89,ARIA Medonc,88eb839c-bc51-45f0-b15e-ea89bba9ffca,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,39.73,36.51,1.1.7
80.95,88.89,25.58,Silver,Silver,1785cc1a-ace0-4980-8352-5977b2b72969,80.16,UHB 2019 Summer Society of Acute Medicine Benchmarking Audit,5acfadf9-21a7-4517-a1b2-620d20469611,HUB > PIONEER,77.69,28.57,1.1.7
69.05,60.32,18.6,Bronze,Bronze,17cd75a2-e2b5-440c-89b1-22c9f3b03a03,71.43,IoN Trial,e10a660d-b84c-475f-abd4-024dd1af7a5d,ALLIANCE > TISSUE DIRECTORY,75.22,17.46,1.1.7
52.38,44.44,23.26,Not Rated,Not Rated,17ff9515-8296-435b-a50e-014168714689,60.31,Generation Scotland: Scottish Family Health Study,f4f0ef1a-46cf-4734-8516-3adb0b62ae6d,ALLIANCE > GENERATION SCOTLAND,64.56,23.81,1.1.7
95.24,100.0,16.28,Gold,Gold,1900af1a-bd21-4157-ac48-203eec682073,89.69,GENOMICS ENGLAND 100K BIOINFORMATICS DATA,98999c67-0133-4f11-be95-b84ee5727c84,ALLIANCE > GENOMICS ENGLAND,89.48,20.63,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,19525c5f-92ee-41b6-bb79-673624b27bdd,38.88,Improving Access to Psychological Therapies Data Set,bcf6e5ce-986d-4b84-9c9c-69de966e8bbd,,32.78,55.56,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,196dc924-9289-4f31-900d-d9310dc34361,41.27,Patient Episode Dataset for Wales (PEDW),4c33a5d2-164c-41d7-9797-dc2b008cc852,,33.95,50.79,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,199b8c9f-baf2-4eb8-a8fe-783f58eceb2e,38.88,COVID-19 Consolidated Deaths (CDDS),70e37f44-5c3e-4c83-a42a-89b3476d1d45,,32.78,55.56,1.1.7
71.43,63.49,16.28,Silver,Bronze,1a412ff0-6275-4cab-a485-bb76befc7afe,73.81,UK real-world lymphoid tissue bank,c9f82f86-79e1-4067-932f-5e6dc939006d,ALLIANCE > TISSUE DIRECTORY,77.58,15.87,1.1.7
95.24,100.0,20.93,Gold,Silver,1a4b65e9-5241-4081-9cbb-43a8c8c6ea3b,84.92,Cystic Fibrosis Patient CFQ-R,9cf5dbd3-a109-4e8d-b1bb-7e4126bd887f,ALLIANCE > CYSTIC FIBROSIS TRUST,87.16,30.16,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,1afb9620-da7d-4098-85fc-185334b5a369,38.88,Prescribing,6d044471-62d2-4190-b315-503f77d33ef2,,32.78,55.56,1.1.7
28.57,23.81,32.56,Not Rated,Not Rated,1b85497d-af3c-4a4d-8240-ff680411a0a4,45.24,National Joint Registry - Revision Knee Replacement dataset,6664317b-39b9-4133-b6c7-ec4bddf78c76,ALLIANCE > HQIP,48.0,33.33,1.1.7
28.57,23.81,34.88,Not Rated,Not Rated,1bbcb128-dd3e-4f56-81d5-17df2dab3c52,44.45,National Audit of Psychosis - Audit on Early Intervention in Psychosis services - contextual data,4559a14f-563d-4fd2-93ae-27c6c0fd891e,ALLIANCE > HQIP,46.84,34.92,1.1.7
80.95,90.48,30.23,Bronze,Silver,1bc9ccd6-44d0-43db-843a-f9fa293c4090,79.37,Mother-Baby Link for CPRD GOLD,b734a1b5-37d3-4859-85d4-bf011df2a951,ALLIANCE > CPRD,75.36,31.75,1.1.7
78.57,85.71,23.26,Silver,Silver,1c3f55ec-d6fc-477e-a1b7-4b8dd43323c6,80.95,NIHR BioResource: Health and Lifestyle Questionnaire,321e3ad6-96b9-4f19-bbc4-d06dfe2a59d5,ALLIANCE > NIHR BIORESOURCE,77.66,23.81,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,1c524f7c-ee22-4bdc-877b-8dddc03e3aa2,38.88,Deaths General Registrar Office – National Records Scotland,5362cfea-d554-43ba-916a-4460da39cc0c,,32.78,55.56,1.1.7
85.71,92.06,30.23,Silver,Silver,1c942123-845d-4c31-9f04-8e044be00e58,80.16,HES Admitted Patient Care data for CPRD Aurum,ed2de8fe-a204-4a4e-bcfa-9e3ad85e2fee,ALLIANCE > CPRD,77.74,31.75,1.1.7
4.76,4.76,46.51,Not Rated,Not Rated,1ca52b96-27d9-491a-b5f0-5787852d39d2,29.36,Sero-surveillance to monitor the trend of SARS-CoV-2 infection in rural India,185e9c5c-e686-4174-bcba-5e2f584b5cbb,,29.12,46.03,1.1.7
54.76,46.03,23.26,Not Rated,Not Rated,1cb397d5-a86d-4354-b1f7-565b7ef5054b,61.11,Asthma self-management behaviour in Bangladesh and Pakistan,3b378225-48e1-45fa-b62d-fc4ed4b39bec,HUB > BREATHE,65.75,23.81,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,1d2acc70-0e2d-4601-bbbb-569a49bfaa5b,38.88,Tayside Microbiology: Tests,826be5be-9977-49f9-b6d1-83ed9de08ebe,,32.78,55.56,1.1.7
95.24,100.0,16.28,Gold,Gold,1d46f920-e253-4e7d-a72a-843d068d3c69,89.69,Critical Care Dataset,1789286a-deaf-49df-88cd-660e92934af6,ALLIANCE > SAIL,89.48,20.63,1.1.7
47.62,46.03,32.56,Not Rated,Not Rated,1d5e3b05-8ce3-4f80-ae3a-f6031ad8cf69,57.94,Mental Health Services Data Set - Service Users,f48ad0a1-f90c-4a81-8c04-b23f2d8baf7a,ALLIANCE > NHS DIGITAL,57.53,30.16,1.1.7
21.43,17.46,37.21,Not Rated,Not Rated,1db7ce43-0dc3-4fa9-8bc8-14db16aba508,40.48,Patient SIMD Postcode,798567eb-d790-466e-880b-75a1e94ffdf2,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,42.11,36.51,1.1.7
19.05,15.87,39.53,Not Rated,Not Rated,1e465797-5e54-4667-9120-d373e75be64f,38.88,Somerset Cancer Registry,3ec5f1c4-95c0-4b1d-899b-399cec32ad49,ALLIANCE > BARTS HEALTH,39.76,38.1,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,1e875c15-4a99-4c3e-9621-e4ebf594469f,38.88,UK Renal Registry - CKD and AKI on Dialysis Dataset,b7152f21-0f2c-4ed9-a013-51e725242f94,,32.78,55.56,1.1.7
66.67,58.73,18.6,Bronze,Bronze,1fcbb814-10e0-43b7-b383-b5c818090ac8,69.84,NIHR BioResource: SNP imputation data,39d7ad29-be30-4e12-a7c8-d8757141de85,ALLIANCE > NIHR BIORESOURCE,74.03,19.05,1.1.7
28.57,23.81,32.56,Not Rated,Not Rated,203cc8b4-7711-4d1f-9213-af982d6cff28,45.24,Sentinel Stroke National Audit Programme Clinical Dataset,059a6495-a7d5-435b-8e2b-806c6ccccf2e,ALLIANCE > HQIP,48.0,33.33,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,207c4fd9-9ef9-492e-bf64-4c268289824b,38.88,Annual District Death Extract (ADDE),15cf4241-abad-4dcc-95b0-8cd7c02be999,,32.78,55.56,1.1.7
92.86,96.83,20.93,Silver,Gold,208f79dc-2294-4370-8f16-0d0f7bec9d10,86.51,Moorfields Eye Image Dataset Release 001,6bfe44ef-9532-4986-b8a2-9c2cda4a89cc,HUB > INSIGHT,85.97,23.81,1.1.7
28.57,23.81,34.88,Not Rated,Not Rated,21676706-0165-4469-bffe-fbe5c6cb0f18,44.45,National Clinical Audit of Anxiety and Depression - spotlight audit on psychological therapies (clinical),6c81b082-bdc5-4dcc-838a-e6e52e1be1cb,ALLIANCE > HQIP,46.84,34.92,1.1.7
80.95,71.43,32.56,Bronze,Bronze,21cd4b8e-f4f5-44a6-83eb-b7799e98ba55,69.84,South London and Maudsley NHS Foundation Trust (SLaM) Clinical Record Interactive Search (CRIS) platform,a25a9892-9141-4e78-8415-945ba73da11e,ALLIANCE > SLaM,74.19,31.75,1.1.7
28.57,23.81,32.56,Not Rated,Not Rated,21d2acc3-f943-4469-98a4-1d9a5045bed6,45.24,National Joint Registry - Revision Hip Replacement dataset,4b8286e2-c4e4-4db4-8fd9-5f1c8b4e56de,ALLIANCE > HQIP,48.0,33.33,1.1.7
78.57,85.71,25.58,Silver,Silver,22173802-db99-475e-b95e-d69798734077,77.78,NHS 111 Dataset,3d6b69dc-cb3c-4b9a-bdea-a798e7d5b5cf,ALLIANCE > SAIL,76.5,30.16,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,224f725d-9180-496a-8bae-3dab0099688f,38.88,Death Registration Data - Provisional Monthly Extracts,487222b7-5c13-4a92-8b41-044796048720,,32.78,55.56,1.1.7
71.43,63.49,16.28,Silver,Bronze,22739526-317f-4b0e-a23b-ece0c859958f,73.81,QTL Programme at MRC HGU,351cc017-caff-4303-8a48-1aa1b90fce2b,ALLIANCE > TISSUE DIRECTORY,77.58,15.87,1.1.7
69.05,60.32,16.28,Silver,Bronze,227fe0ea-d76e-4c14-a33e-ca255380937d,72.22,Children's Cancer and Leukaemia Group (CCLG) Tissue Bank,c232fa07-5d28-4bdc-b540-1ad8d933c5f9,ALLIANCE > TISSUE DIRECTORY,76.38,15.87,1.1.7
69.05,60.32,16.28,Silver,Bronze,22974866-44c7-4176-9c51-6b57a1dda39d,72.22,University of Liverpool - GCP Laboratory Facility,029b7f0f-911e-46ce-837f-031959f067da,ALLIANCE > TISSUE DIRECTORY,76.38,15.87,1.1.7
21.43,19.05,39.53,Not Rated,Not Rated,22aecb42-9ea3-4d60-b392-d3cdd0a806f8,40.48,CDE Encounters,3598723f-62fb-4377-9a8b-b264ced1aabd,ALLIANCE > BARTS HEALTH,40.95,38.1,1.1.7
95.24,100.0,23.26,Silver,Silver,239e8253-a997-4676-8940-16b74a004365,85.72,GENOMICS ENGLAND 100K RARE DISEASE & COMMON,3f2b37f1-e8f7-42e5-83c4-fc9e1c58725d,GENOMICS ENGLAND,85.99,28.57,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,24562202-5f76-4ada-9495-2260e3e7c42f,38.88,Emergency Department Dataset Daily (EDDD),fa257aa8-51fc-4eb7-a448-e473fa54686d,,32.78,55.56,1.1.7
69.05,60.32,18.6,Bronze,Bronze,24f2374a-e804-434e-a805-e29b332b0693,71.43,SWIFT-RTB,d387ed7c-14fa-49e2-8ced-df0f9372eb88,ALLIANCE > TISSUE DIRECTORY,75.22,17.46,1.1.7
83.33,90.48,23.26,Silver,Silver,2550f814-0849-4d19-b83e-edef46b157fb,81.75,Intensive Care National Audit and Research Centre - Covid19,add6226b-0f21-439a-84a6-51dc26cdc425,ALLIANCE > SAIL,80.03,26.98,1.1.7
78.57,87.3,27.91,Bronze,Silver,262c28eb-151e-4ab2-a813-81841f5292eb,80.16,Patient postcode linked deprivation measures for CPRD Aurum,bd85a09c-fe4a-41b8-81d2-77feadcd1a0a,ALLIANCE > CPRD,75.33,26.98,1.1.7
64.29,77.78,44.19,Not Rated,Not Rated,263ad0a8-ae90-4c1d-85d6-c3d2470eb2b7,64.28,Mental Health Minimum Dataset v4 (Non-Sensitive) Episodes,2964d1b0-2630-468a-82c1-00f5ac901b3d,ALLIANCE > NHS DIGITAL,60.05,49.21,1.1.7
64.29,77.78,44.19,Not Rated,Not Rated,263f28a4-9835-4856-b1c3-0a0d4085f207,64.28,Mental Health Minimum Dataset v2.6 (Sensitive),dc37fcd6-1e68-46e5-b73d-4896e069746a,ALLIANCE > NHS DIGITAL,60.05,49.21,1.1.7
73.81,65.08,16.28,Silver,Bronze,263f4ce3-7ccf-45c3-9d41-c1f5ed14cc81,74.6,Arden Tissue Bank,62fdfd1c-f195-49cc-b3a1-7d9fd2cc8e1b,ALLIANCE > TISSUE DIRECTORY,78.77,15.87,1.1.7
76.19,82.54,18.6,Silver,Silver,26b03931-18ce-4a83-99de-1fca258518f3,81.75,Child Health Systems Programme - 27-30Months Review,d2d57b7f-95d8-425f-b2fd-cc9aff05e659,ALLIANCE > PUBLIC HEALTH SCOTLAND,78.8,19.05,1.1.7
76.19,66.67,18.6,Silver,Bronze,270b55a8-a9ee-44ee-8db6-eb214e721eea,74.6,Scottish Human Papillomavirus Archive,4883530f-1c8d-49aa-886e-ea3b958772ea,ALLIANCE > TISSUE DIRECTORY,78.8,17.46,1.1.7
78.57,85.71,25.58,Silver,Silver,273e091c-d0b3-4529-9cd2-4bc1a1b6195a,80.16,"Deeply phenotyped sepsis patients within hospital: onset, treatments & outcomes",38ff49e2-dffa-4103-87a8-386f9f424d22,HUB > PIONEER,76.5,25.4,1.1.7
35.71,30.16,27.91,Not Rated,Not Rated,274238a8-ec06-4ee4-83ae-a419a925d43b,50.8,Unified Cohorts Research Network,cffcf30d-cedb-421b-a5dc-6726633cb99a,HUB > BREATHE,53.9,28.57,1.1.7
19.05,33.33,55.81,Not Rated,Not Rated,27a97f1b-e7ac-4723-87db-0a4d9e3ed4b6,36.5,NIHR IBD BioResource: SNP chip data,3c749cfc-4008-4916-b64f-969d6a754c0f,,31.62,60.32,1.1.7
28.57,23.81,32.56,Not Rated,Not Rated,27f4b803-145d-4622-815a-3cc9ce71aab3,45.24,National Audit of Dementia Round 4 - organisational checklist,0a305b29-cf23-4261-9299-5251e41ee9f0,ALLIANCE > HQIP,48.0,33.33,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,28486729-6a76-4a03-8c28-3ea971071583,41.27,Looked After Children Wales (LACW),cfdafacb-48f0-4ad8-9f20-193a5eec2da4,,33.95,50.79,1.1.7
71.43,79.37,25.58,Bronze,Bronze,28bb6308-013f-47d3-8c4b-74720ad3901d,75.4,Labour Force Survey (Longitudinal),4ac15572-fe9a-46d3-860d-a46b616181f7,NCS > OFFICE FOR NATIONAL STATISTICS,72.93,28.57,1.1.7
80.95,88.89,30.23,Bronze,Silver,2918676c-74b0-4a4e-8814-697e9aa6a81c,80.16,National Radiotherapy Dataset (RTDS) for CPRD GOLD,56a66de8-3470-4a36-ac71-4d5471e72654,ALLIANCE > CPRD,75.36,28.57,1.1.7
19.05,15.87,41.86,Not Rated,Not Rated,29de7178-dcf3-4859-bd96-ca6d944db5f8,38.09,DENDRITE Dataset,31920b14-d114-410f-8255-522e6451c44e,ALLIANCE > BARTS HEALTH,38.59,39.68,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,29e5de14-f1d8-49fc-8766-21c2fc488d47,41.27,COVID-19 Symptom Tracker Dataset (CVST),594cfe55-96e3-45ff-874c-2c0006eeb881,,33.95,50.79,1.1.7
4.76,4.76,46.51,Not Rated,Not Rated,2a17a802-a2da-4bfc-8571-b2015350eed4,29.36,Treatment of Bangladeshi children with severe pneumonia,2f4c56b3-ca6a-4b30-a7f0-d83e68192c5b,,29.12,46.03,1.1.7
28.57,23.81,32.56,Not Rated,Not Rated,2a4d55ba-3ea7-495e-9ffe-ab1b919c149d,45.24,National Diabetes Audit - National Diabetes Foot Care Audit clinical dataset,dabf34b3-7368-4097-94c5-5b4f4be68fc6,ALLIANCE > HQIP,48.0,33.33,1.1.7
64.29,77.78,44.19,Not Rated,Not Rated,2a725f9d-c4a9-4c89-aa37-b3c25cc83389,64.28,Mental Health & Learning Disabilities Dataset v 1 (Sensitive) Records,7c2b435c-5442-4a05-9b8d-08024ec57c30,ALLIANCE > NHS DIGITAL,60.05,49.21,1.1.7
92.86,98.41,18.6,Gold,Gold,2b09ea87-5b22-4049-b7dd-de0889699115,88.09,Millennium Cohort Study,a380bd6b-009f-4b78-b638-ba9ee62be2eb,ALLIANCE > SAIL,87.13,22.22,1.1.7
78.57,85.71,27.91,Bronze,Silver,2b40a784-79ea-4403-a4bd-0950a7a36a6c,79.36,Leeds-IQVIA Collaboration,00b897c7-d50d-486a-af1b-bd94821b58f7,HUB > DATA-CAN,75.33,26.98,1.1.7
71.43,63.49,20.93,Bronze,Bronze,2bd45ffb-b22f-4f02-968b-f5ab8f9d6342,71.43,UCL Infection DNA Bank,3e5fb54a-84ec-4888-9a72-4093c6e90dbc,ALLIANCE > TISSUE DIRECTORY,75.25,20.63,1.1.7
69.05,60.32,16.28,Silver,Bronze,2c3e75c3-141a-4d29-b7f0-0dbe14fb18fd,72.22,MDSBio,13c71637-144e-4742-8aea-aefb778a360e,ALLIANCE > TISSUE DIRECTORY,76.38,15.87,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,2ca2a23d-64c3-4691-9289-197436dddfa3,38.88,Millennium Cohort Study Dataset (MCSD),a380bd6b-009f-4b78-b638-ba9ee62be2eb,,32.78,55.56,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,2cb07157-1c99-48dc-9926-0ad968a09166,38.88,Higher Education Statistics Agency (HESA) Student Data,68b04d3b-17b4-4a04-a8a3-e2a93ed231df,,32.78,55.56,1.1.7
80.95,88.89,32.56,Bronze,Silver,2d25b733-d95a-485b-9499-907a48b51919,76.19,Mental Health Dataset (MHDS) for CPRD GOLD,d5c0cc93-3347-46f0-b8dd-f44e82718e38,ALLIANCE > CPRD,74.19,36.51,1.1.7
95.24,100.0,20.93,Gold,Gold,2d4b933d-1c8b-4fde-860e-c324454d28f9,88.09,GENOMICS ENGLAND 100K NHSD LINKED DATA,14c31b39-f189-4417-bd38-635268495593,GENOMICS ENGLAND,87.16,23.81,1.1.7
19.05,33.33,55.81,Not Rated,Not Rated,2d4d0d89-edfb-448a-b95b-a3c0401ebe75,36.5,COVID-19 Vaccination Adverse Reaction,080a90e4-4bc6-4153-a4c6-c120eef5ba94,,31.62,60.32,1.1.7
57.14,47.62,20.93,Bronze,Not Rated,2d6e8e68-2fc9-4b9c-a517-c5c5677af225,62.7,IBD NIHR BioResource: NHS Trust data,ae1898da-7fe5-4fe0-b10d-9f06cdec1735,HUB > GUT REACTION,68.1,22.22,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,2d7a047c-a90f-48e4-82ee-9a8a082a696e,41.27,Welsh Cancer Intelligence and Surveillance Unit (WCISU),368ad790-3ad8-4f93-9a7c-0bfb64dc6015,,33.95,50.79,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,2e51fba7-c119-4892-9e4e-89748bcb96eb,38.88,Emergency Department Dataset (EDDS),75c4dcb8-33bf-43f4-b2bb-db51b6621b2c,,32.78,55.56,1.1.7
95.24,100.0,16.28,Gold,Gold,2ef8bfd7-3edb-49e0-a1eb-edc181c03e1d,91.27,Patient Episode Dataset for Wales,4c33a5d2-164c-41d7-9797-dc2b008cc852,ALLIANCE > SAIL,89.48,17.46,1.1.7
4.76,4.76,46.51,Not Rated,Not Rated,2f9c0340-2116-41f5-bdbd-921561476061,29.36,Community perception on public health measures for COVID-19 prevention/control,6464fb4f-2838-495b-9963-4001204ed166,,29.12,46.03,1.1.7
66.67,60.32,20.93,Bronze,Bronze,2fee4aae-94c4-40b2-9e35-4f9558a5b223,69.84,Cancer Patient Experience Survey (CPES) for CPRD Aurum,fded6e24-8fef-47a4-a65e-9455bed043d3,ALLIANCE > CPRD,72.87,20.63,1.1.7
69.05,60.32,16.28,Silver,Bronze,30a0ee0e-d9f9-4341-b00c-2fab8f122b5f,72.22,Watch and Wait Trial,e46dccbf-484d-45d2-a42a-4d308b87c113,ALLIANCE > TISSUE DIRECTORY,76.38,15.87,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,30ca0f33-0644-4c92-afc3-357aad57b6ec,38.88,Diagnostic and Therapy Services Waiting Times (DATW),97896866-ab5e-408a-ac5a-072802db9faf,,32.78,55.56,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,30e1343e-0628-47aa-b4f6-756cdb6e54c6,41.27,COVID-19 Sequence Data (CVSD),602cbc9b-0113-4712-8c4a-0efe8d86b77c,,33.95,50.79,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,31c026ce-fd30-4825-b6b9-e530a4dff9fc,41.27,Daily Situation Report Data (DSRD),c74a9b9e-1fea-4aac-99fd-54e30668e085,,33.95,50.79,1.1.7
4.76,4.76,46.51,Not Rated,Not Rated,320d4c1e-df08-4eaa-ab9f-bd342d1799a0,29.36,Webex Cohort,9254f941-db57-4a97-922e-880b84855a21,,29.12,46.03,1.1.7
76.19,85.71,30.23,Bronze,Silver,32bff357-1c24-43d5-8741-261f5a764802,78.57,Practice postcode linked deprivation measures for CPRD Aurum,9f689ef4-26c6-4f85-80ff-5116974f315a,ALLIANCE > CPRD,72.98,28.57,1.1.7
95.24,100.0,18.6,Gold,Gold,333d92ca-3a32-41bd-8b16-96aee2dc85b1,88.89,Wales Asthma Observatory,8604bcdc-235a-4c70-b29b-1617396815e6,HUB > BREATHE,88.32,22.22,1.1.7
69.05,60.32,18.6,Bronze,Bronze,33e4b8c6-23cc-4c5f-a7a5-8380035b6601,71.43,TRICON8B,ff875c08-58e6-4e33-8ffe-6f51c8364333,ALLIANCE > TISSUE DIRECTORY,75.22,17.46,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,349f5326-67b5-4ff8-a9b8-8e6c4e42a9f2,38.88,Emergency Department (eEMS),2ba72371-1527-4d8d-94e2-f795e45b9f77,,32.78,55.56,1.1.7
78.57,85.71,27.91,Bronze,Silver,34d2310f-c5f2-42c4-be1a-31c1ad579013,78.57,Hospital Episode Statistics Critical Care,80564a6b-1458-41de-a131-772eb93c0509,ALLIANCE > NHS DIGITAL,75.33,28.57,1.1.7
78.57,85.71,27.91,Bronze,Silver,34f9be53-2445-439b-8ca4-f151359d7e46,79.36,National Cancer TRE,b5439bc5-8141-4a13-a024-a6db2003b40e,HUB > DATA-CAN,75.33,26.98,1.1.7
28.57,23.81,32.56,Not Rated,Not Rated,355e388e-5e1e-48af-8146-7671f6478167,45.24,National Neonatal Audit Programme - clinical audit,382e897a-77cf-46ca-8d44-d79449ab61df,ALLIANCE > HQIP,48.0,33.33,1.1.7
71.43,63.49,16.28,Silver,Bronze,359006d7-1c6c-43c2-8905-09b016398ae1,73.81,BRAIN UK,1c455ad3-af51-4b93-aff4-c5d3dacfa9f4,ALLIANCE > TISSUE DIRECTORY,77.58,15.87,1.1.7
4.76,4.76,46.51,Not Rated,Not Rated,35fde6f6-ff7d-44f0-92fc-1d28b488cbc1,29.36,The Malaysian Asthma Hajj Study,8187f77f-65e3-435e-ad7e-d7f22e2fcf80,,29.12,46.03,1.1.7
64.29,77.78,44.19,Not Rated,Not Rated,36047c5f-7d57-4d25-a114-2bcc6c11708f,64.28,Mental Health Minimum Dataset v3_3.5 (Sensitive),c123f74c-0731-428e-b31b-eee2723df54d,ALLIANCE > NHS DIGITAL,60.05,49.21,1.1.7
76.19,85.71,30.23,Bronze,Silver,36d3480e-38ae-470c-ab6f-b704ee2645ec,78.57,Practice postcode linked deprivation measures for CPRD GOLD,3326d554-ca11-4dc6-aff0-c5b314442d27,ALLIANCE > CPRD,72.98,28.57,1.1.7
54.76,47.62,20.93,Bronze,Not Rated,36e6b617-ecd5-4ae2-87d6-4a00bb2c653a,63.5,Exploring the provision of supportive care for patients with COPD in Malaysia,af8cdc87-789e-4bea-9d8b-927aa689d211,HUB > BREATHE,66.91,20.63,1.1.7
80.95,88.89,30.23,Bronze,Silver,372083bc-3243-4fce-989d-914e677a12cd,80.16,National Radiotherapy Dataset (RTDS) for CPRD Aurum,9c535c8d-ebac-4212-b602-fc2489df2c92,ALLIANCE > CPRD,75.36,28.57,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,375dae92-2015-478b-b1bc-5de90b6d53a9,41.27,Glaucoma dataset at University Hospitals Birmingham,48c44534-0184-471e-93b8-1385f92c6631,,33.95,50.79,1.1.7
71.43,63.49,16.28,Silver,Bronze,37687806-bab2-4de8-87a7-844a0061e7f8,73.81,Bristol Dental School Saliva Bank,8d77f0ad-f376-4d61-a97d-5e996c2bbe72,ALLIANCE > TISSUE DIRECTORY,77.58,15.87,1.1.7
71.43,63.49,16.28,Silver,Bronze,381413fe-8808-47f8-b8df-e65baa543ae4,73.81,UK MND Collections,89e2d798-c488-4eaf-a50f-a93616093304,ALLIANCE > TISSUE DIRECTORY,77.58,15.87,1.1.7
28.57,23.81,32.56,Not Rated,Not Rated,3814fc7e-02af-41ff-af00-4076ca325d5e,45.24,Epilepsy 12 - clinical audit,1fcaf429-8762-454c-b999-c5fdd757b880,ALLIANCE > HQIP,48.0,33.33,1.1.7
92.86,96.83,20.93,Silver,Silver,38194ca7-57f5-40ff-b463-900e306cd40f,84.92,North West London Pathology (NWL PATH),2c5f3ef6-53f8-42e6-a077-8718261df026,HUB > DISCOVER NOW,85.97,26.98,1.1.7
69.05,60.32,18.6,Bronze,Bronze,38254214-35f1-4564-b7bb-aab331732dab,70.64,NIHR Nottingham Digestive Diseases Collection,f20bf814-ee80-4e67-ab00-afff884ddbb4,ALLIANCE > TISSUE DIRECTORY,75.22,19.05,1.1.7
95.24,100.0,13.95,Gold,Gold,38468759-3351-4722-9eeb-4c6dc9fa44ce,92.06,Congenital Anomaly Register and Information Service,6fe7e004-eb51-4c7b-9905-1ec9a4827dca,ALLIANCE > SAIL,90.64,15.87,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,387c62e0-2cb3-4804-9c3e-c0c5864cd33c,38.88,Emergency Care Data Set (ECDS),7749d90e-dd7a-4697-8a9c-666491c64a0c,,32.78,55.56,1.1.7
78.57,85.71,25.58,Silver,Silver,391ab58c-3412-4fa0-96f6-fdd5ae380b86,80.16,Clinical response thresholds (acuity) in acutely unwell patients: onset-outcome,a9018475-452b-4864-bbc3-80eda2067820,HUB > PIONEER,76.5,25.4,1.1.7
64.29,77.78,39.53,Not Rated,Bronze,3935e2fd-0c30-4f56-8388-45a02e0499b4,67.46,Bridge file: Hospital Episode Statistics to Diagnostic Imaging Dataset,2f73575d-23c8-4bb8-87db-115cde076127,ALLIANCE > NHS DIGITAL,62.38,42.86,1.1.7
4.76,4.76,46.51,Not Rated,Not Rated,3a0a0acd-c549-41f4-8188-14235decf473,29.36,"BRIAN App - Patient data; treatments, PROMs, multi-modal data and demographics",37c82bb7-eaae-4f16-97b6-045373b7ba18,,29.12,46.03,1.1.7
42.86,38.1,25.58,Not Rated,Not Rated,3a56c317-bf1b-448d-89ab-3421eae3aa18,57.14,Death register,722056a5-5fc6-4ad2-8efe-62a80dd6389b,UK Biobank,58.64,23.81,1.1.7
4.76,4.76,46.51,Not Rated,Not Rated,3a986158-0593-43e9-bd8c-359e701dd0f2,29.36,National Emergency Laparotomy Audit - Patient Audit Dataset,25b93812-191f-49bb-bbd0-782fb85b2bd2,,29.12,46.03,1.1.7
95.24,100.0,16.28,Gold,Gold,3ab70331-aa54-4f0d-aa95-ea2b95bed9d5,89.69,Annual District Birth Extract,12a77014-4a77-4eb1-8b26-f49689352d1b,ALLIANCE > SAIL,89.48,20.63,1.1.7
95.24,100.0,16.28,Gold,Gold,3abe6b38-e479-4eb3-87d6-ef4803ff88f9,89.69,Emergency Department Data Set,75c4dcb8-33bf-43f4-b2bb-db51b6621b2c,ALLIANCE > SAIL,89.48,20.63,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,3ad98a4d-9018-4af0-9b7f-e9edcf9ac329,38.88,NHS 111 Dataset (NHSO),3d6b69dc-cb3c-4b9a-bdea-a798e7d5b5cf,,32.78,55.56,1.1.7
88.1,92.06,18.6,Silver,Silver,3b0a3b33-dbd5-4cb0-b863-0e1fd80c9a1e,84.92,IBD NIHR BioResource: Consent records,44ca2cf8-679e-447c-a9eb-55b32159679a,HUB > GUT REACTION,84.75,22.22,1.1.7
28.57,23.81,34.88,Not Rated,Not Rated,3b6d2dbe-0241-4c38-9038-2d6ce1e280de,44.45,National Audit of Psychosis - Audit on Early Intervention in Psychosis services - case note audit,24b88d1a-4363-4619-870e-9ba9fc5d09e1,ALLIANCE > HQIP,46.84,34.92,1.1.7
19.05,15.87,39.53,Not Rated,Not Rated,3b752633-8274-4418-b15b-4502bab03935,38.88,CDE Surginet Documentation,4c4bc482-16f5-462f-8daf-51ec6492074d,ALLIANCE > BARTS HEALTH,39.76,38.1,1.1.7
28.57,23.81,32.56,Not Rated,Not Rated,3b7778c9-a8f5-4682-bb0a-b875dcc36cda,45.24,National Cardiac Audit Programme - National Adult Cardiac Surgery Audit (NACSA),5f37e3c2-b5ac-43eb-8eba-ac94dbbff103,ALLIANCE > HQIP,48.0,33.33,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,3b8357ac-bf06-44c4-9a43-8e772bec709c,38.88,IBD NIHR BioResource: Demographic,b4121feb-f91b-4e20-a19b-fa49c7a5c1c1,,32.78,55.56,1.1.7
64.29,57.14,18.6,Bronze,Bronze,3bb25cba-b4dc-47f1-ab5e-b63f89500612,69.05,IBD NIHR BioResource: SNP imputation data,7dee2bd6-733a-4b2e-a942-7f9eaf8ebbc2,HUB > GUT REACTION,72.84,19.05,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,3c14d319-4ff5-42ff-b440-400f099f9b13,38.88,Active Adult Survey Dataset (AASD),1eb67fd5-33f6-49dd-a43d-854fff9f25f5,,32.78,55.56,1.1.7
71.43,61.9,18.6,Silver,Bronze,3c23941a-42a7-4940-b32f-aea743c0dc2a,72.22,Tissue Solutions Ltd,bbcdc352-e0f7-4672-93a7-134bcf5001b1,ALLIANCE > TISSUE DIRECTORY,76.42,17.46,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,3c54d5c1-fbf0-4f1e-979f-3b2251f9a26a,38.88,Cancer Network Information System (CNIS / CANISC),da91f0eb-1761-485b-8b7f-9121b6a1d004,,32.78,55.56,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,3c87fdb6-c58a-4827-93c1-d50cfb708761,38.88,Intensive Care National Audit and Research Centre (ICCD),fa8bf269-4769-491b-b398-fa63137d14ab,,32.78,55.56,1.1.7
80.95,87.3,16.28,Silver,Silver,3cc60b9a-8654-417d-bc1a-b72a7462a980,84.92,Child Health Systems Programme - First Visit,dec04153-f595-41ce-9d7e-5ef0c3fe8289,ALLIANCE > PUBLIC HEALTH SCOTLAND,82.34,17.46,1.1.7
71.43,63.49,16.28,Silver,Bronze,3ce4870c-5062-4d01-8801-2cf505b979b7,73.81,TwinsUK,19b4cd38-3828-4bb1-a980-4f7420658965,ALLIANCE > TISSUE DIRECTORY,77.58,15.87,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,3cefb3f4-a463-4762-909b-3e4f3cef8e93,38.88,COG-UK Viral Genome Sequences,1fe02b65-7b77-43bf-93c8-4f0743fee672,,32.78,55.56,1.1.7
92.86,96.83,18.6,Gold,Gold,3d51dc99-c44f-44ff-bdab-da205c5e394e,87.31,North West London Outpatient Care Data (NWL OP),9f1df859-f1d0-4f1e-959e-affd05138a25,HUB > DISCOVER NOW,87.13,22.22,1.1.7
4.76,4.76,46.51,Not Rated,Not Rated,3d889aa6-aa28-4f3f-b220-e8bb40b38a6f,29.36,Assessment of ASHA’s workload and its determinants,1a02bc11-a378-4f9e-82f9-c52674b388bd,,29.12,46.03,1.1.7
69.05,60.32,16.28,Silver,Bronze,3db58c78-fc8b-49b2-a847-b43fd0184500,72.22,Ethical Tissue - University of Bradford,fdf9ac68-fc89-4adf-9a73-3a94a9974aef,ALLIANCE > TISSUE DIRECTORY,76.38,15.87,1.1.7
28.57,23.81,32.56,Not Rated,Not Rated,3de5a3fe-a1bf-4075-883f-f076a460ae26,45.24,National Joint Registry - Primary Ankle Replacement dataset,b8d009d0-0163-4aaf-8bd6-ad363c859862,ALLIANCE > HQIP,48.0,33.33,1.1.7
28.57,23.81,32.56,Not Rated,Not Rated,3e203d75-2b38-4e2f-bfca-793c710fbbd2,45.24,National Joint Registry - Primary Elbow Replacement dataset,b06415af-9151-4ccc-83a1-ab859943fb2b,ALLIANCE > HQIP,48.0,33.33,1.1.7
19.05,33.33,55.81,Not Rated,Not Rated,3e4d27e2-baa8-4bb5-a711-d0b36f1f278c,36.5,Diagnostic Imaging Dataset,86f46be3-bc29-4820-8363-de6530a94c6f,,31.62,60.32,1.1.7
4.76,4.76,46.51,Not Rated,Not Rated,3ed8d3fe-92a3-43bc-9fba-274fb34847af,29.36,Higher Education Statistics Agency (HESA),36f54a48-6f0a-4827-a86b-fd677a22a88f,,29.12,46.03,1.1.7
4.76,4.76,46.51,Not Rated,Not Rated,3ee4c2af-ff04-4dcf-830e-420e0a21a6d2,29.36,mHealth for pneumonia prevention,fc66381e-cc46-4bca-85fc-fc2ee09cc5dd,,29.12,46.03,1.1.7
69.05,60.32,16.28,Silver,Bronze,3f00330d-1f45-4cab-86c2-e91b7c1a59e9,72.22,Multiple Sclerosis and Parkinson's Tissue Bank,4684d391-a6a7-44f7-bf4b-62b6b693f9fa,ALLIANCE > TISSUE DIRECTORY,76.38,15.87,1.1.7
59.52,49.21,20.93,Bronze,Not Rated,3f1d93ae-792e-4f0c-8cb7-40413b81e132,63.5,NIHR BioResource: NHS Trust data,3731006a-ee7c-4d15-bc07-4eeb29a3d031,ALLIANCE > NIHR BIORESOURCE,69.3,22.22,1.1.7
19.05,33.33,55.81,Not Rated,Not Rated,3f4b5de2-6434-4ec2-8175-d9450668da4a,36.5,Suspected Cancer Pathway Daily (SCPD),9ea2f685-d6c2-49fe-a0e2-735910584d67,,31.62,60.32,1.1.7
78.57,85.71,27.91,Bronze,Silver,3fbef1ac-fa6d-4c72-836d-3a8d8a0f7b08,79.36,Barts Health NHS Trust COVID-19 EHR Extracted Dataset,d6e8163f-2ab8-4880-bbb6-a174b4a95632,ALLIANCE > BARTS HEALTH,75.33,26.98,1.1.7
78.57,85.71,27.91,Bronze,Silver,3fc555e1-3e36-46dc-bef1-2d94d560bcb2,77.78,The impact of ethnicity and multi-morbidity on C19 hospitalised outcomes,cfa1ef13-8ae0-4827-8a0f-9d2df5244725,HUB > PIONEER,75.33,30.16,1.1.7
95.24,100.0,13.95,Gold,Gold,3fceb952-0b21-40f4-bd69-fa5cd7ad7df9,92.06,Cafcass Wales,29a714e1-5289-4362-be24-2848c954344e,ALLIANCE > SAIL,90.64,15.87,1.1.7
4.76,4.76,46.51,Not Rated,Not Rated,3fd2760d-ab12-48ee-8b32-b229aead60a4,29.36,Estimating Chronic Respiratory Disease burden in adults in Asian LMICs,56130df6-1880-4600-a7a4-afa9a4bcc895,,29.12,46.03,1.1.7
16.67,14.29,37.21,Not Rated,Not Rated,40573895-497b-4d47-90e1-6aafe70b93f6,38.89,Endobase,e830b2a5-14d6-4643-a206-619bf5372dc8,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,39.73,36.51,1.1.7
71.43,77.78,25.58,Bronze,Bronze,41a667eb-1c84-4665-b0d4-d26405d277c5,75.4,Domiciliary Social Care Worker [DSCW],0e38bbf4-c788-4a1a-9af8-a24821250154,ALLIANCE > SAIL,72.93,26.98,1.1.7
64.29,55.56,16.28,Bronze,Bronze,41ac5dfd-7b23-4f1b-a91e-03e8186e4ab8,69.05,Care-seeking practices for childhood pneumonia in non/tribal areas of Pune India,4346676d-6108-47de-b579-6cef74c6acef,HUB > BREATHE,74.0,17.46,1.1.7
80.95,88.89,27.91,Silver,Silver,41ce265a-c252-45c4-9b80-d764b0737f38,79.37,Quality of Life of Colorectal Cancer Survivors: Patient Reported Outcomes (Aurum,bfb90d2b-746d-44a6-a896-4979d73d9276,ALLIANCE > CPRD,76.52,30.16,1.1.7
78.57,85.71,27.91,Bronze,Silver,41f84b0f-0621-4e21-937b-cc05c183166b,78.57,Hospital Episode Statistics Outpatients,d4362d41-0838-4f41-bba3-c3268312c444,ALLIANCE > NHS DIGITAL,75.33,28.57,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,4232439b-610b-48ec-abe3-f8c8fe818817,41.27,Welsh Dispensing Dataset (WDDS),50ef6443-ed4b-40f9-97fb-1cfd53be6579,,33.95,50.79,1.1.7
61.9,74.6,39.53,Not Rated,Bronze,4262e057-6978-4e4c-a05d-c4f328422090,67.46,Mental Health and Learning Disabilities Data Set,e9b43936-e700-40c9-8b32-57ed44583f3d,ALLIANCE > NHS DIGITAL,61.19,39.68,1.1.7
95.24,100.0,20.93,Gold,Silver,42ac7c27-a37b-4081-8a33-51ac077e6a4e,84.92,Cystic Fibrosis Patient Microbiology Cultures,9c1727f6-2032-413f-bf60-470769b2616e,ALLIANCE > CYSTIC FIBROSIS TRUST,87.16,30.16,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,42e4299f-1e06-4e24-ab40-b71949f5cba3,38.88,Pathology - PATH,48ef8f54-9606-4e6f-9256-3cc07ffd10b8,,32.78,55.56,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,4330b6ee-f333-4cd8-90b9-0f43f7cb0b67,38.88,Covid-19 Infection Survey linked with VOA and EPC data,2193ad56-6671-4ecc-9ecf-6da84e23e9fd,,32.78,55.56,1.1.7
83.33,90.48,32.56,Bronze,Silver,4353b5fa-b3aa-4786-9e7f-4fb2273f5d3e,78.58,Systemic Anti-Cancer Treatment (SACT) data for CPRD Aurum,f8af632e-442d-4931-a370-b7fa2fa4b896,ALLIANCE > CPRD,75.38,33.33,1.1.7
92.86,98.41,13.95,Gold,Gold,45499ef9-daca-4a88-8493-c3c1a92960d0,91.27,Welsh Ambulance Services NHS Trust,d415a5c5-8432-4a81-937f-12135ade6de7,ALLIANCE > SAIL,89.45,15.87,1.1.7
69.05,58.73,16.28,Silver,Bronze,458d7f2d-9ba8-4593-862c-14160692d494,70.63,Asthma and COPD: practices and perceptions of GPs in rural India,c15bc3ad-c053-496b-863f-1d54075d5bd4,HUB > BREATHE,76.38,17.46,1.1.7
64.29,77.78,44.19,Not Rated,Not Rated,46493a09-b3bb-4c0e-b944-82665ee21508,64.28,Mental Health Minimum Dataset v4 (Sensitive) Events,9c31a2bd-ff3a-4379-a4b8-0b90527a4c38,ALLIANCE > NHS DIGITAL,60.05,49.21,1.1.7
28.57,23.81,34.88,Not Rated,Not Rated,46762bdc-42f9-4c92-92fe-9c757083ad33,44.45,National Paediatric Diabetes Audit - Spotlight survey of workforce in Paediatric Diabetes Units,fe8f8e2c-2f77-464d-9d45-a601cb2f8bf9,ALLIANCE > HQIP,46.84,34.92,1.1.7
95.24,100.0,13.95,Gold,Gold,46e30817-b19e-40f2-9b06-9611b2985148,92.06,Maternity Indicators Dataset,a0c27454-8cbe-418f-bdae-a85d5e92e9d4,ALLIANCE > SAIL,90.64,15.87,1.1.7
4.76,4.76,46.51,Not Rated,Not Rated,46f6e0d3-412e-4799-8683-1ca649b99eec,29.36,Developing and Evaluating Interventions to Improve Asthma Care,d57d7956-d13e-49c4-bb31-889b8e560596,,29.12,46.03,1.1.7
28.57,23.81,32.56,Not Rated,Not Rated,4710222c-9830-4ae4-8be6-b25c723812e1,45.24,Sentinel Stroke National Audit Programme Acute Organisational survey dataset,fe6a4c83-f46f-4f61-8460-e120fdf8d864,ALLIANCE > HQIP,48.0,33.33,1.1.7
69.05,60.32,16.28,Silver,Bronze,47d22aea-cbe9-47d4-8f65-45861d9c5f6f,72.22,Tayside Biorepository,6ac9b356-00f1-49da-825a-6eb04d18e49d,ALLIANCE > TISSUE DIRECTORY,76.38,15.87,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,47e26b2b-8be1-4595-a327-a9f00e0d4712,38.88,NIHR IBD BioResource: Consent records,44ca2cf8-679e-447c-a9eb-55b32159679a,,32.78,55.56,1.1.7
71.43,63.49,20.93,Bronze,Bronze,47f57de8-aa71-4df1-af4a-a81e37d4ae8c,72.22,"St Thomas' Hospitals Plasma, serum & DNA Bio bank from patients with antiphospholipid antibodies",425f4534-51c4-4f75-8ca0-d7c731dbd903,ALLIANCE > TISSUE DIRECTORY,75.25,19.05,1.1.7
38.1,34.92,25.58,Not Rated,Not Rated,480ccd8a-309e-417a-ac23-5b2d9cd281b1,54.76,Genotype,93a7352f-fce4-42c9-9a8c-efc7fe23eda0,UK Biobank,56.26,25.4,1.1.7
92.86,96.83,18.6,Gold,Gold,48182af6-2ccd-44b2-92d5-69cc140e7d67,87.31,North West London Primary Care Prescriptions Data (NWL PCP),0fb33df6-ab36-4170-9fad-1eaf35a3a812,HUB > DISCOVER NOW,87.13,22.22,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,483f49ea-07b3-4efb-8bad-0d9af5ed5f0f,38.88,National Vascular Registry - Organisational Audit dataset,3c661240-e4d2-456c-a809-133c23f9c469,,32.78,55.56,1.1.7
83.33,90.48,32.56,Bronze,Silver,484bff65-c47e-47ce-9eb5-5d381f961160,78.58,Cancer registration data for CPRD Aurum,3f3df3be-05a8-42b2-89d9-f731deb7ea66,ALLIANCE > CPRD,75.38,33.33,1.1.7
28.57,23.81,34.88,Not Rated,Not Rated,489cb34a-f20d-4fe0-849a-db85f00141f5,44.45,Falls and Fragility Fracture Audit Programme National Audit of Inpatient Falls clinical dataset,3c19e2c9-96d5-45f3-9c55-fc3cec762cd7,ALLIANCE > HQIP,46.84,34.92,1.1.7
28.57,23.81,34.88,Not Rated,Not Rated,491cc634-05e8-48fe-9018-ffb9e7eed84e,44.45,"National Audit of Dementia - spotlight audit on the prescription of psychotropic medication, 2019",949d9d7a-a3f1-480a-8563-3fb024300561,ALLIANCE > HQIP,46.84,34.92,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,4a860548-406b-4a05-991e-0bc840e67974,41.27,Health & Attainment of Pupils in a Primary Education Network (HAPN),464d8653-4e69-406b-93fd-d68c29d5dfdc,,33.95,50.79,1.1.7
28.57,23.81,34.88,Not Rated,Not Rated,4b2fbd88-71c7-4572-99ea-5987a72a0c1a,44.45,Epilepsy 12 - National organisational audit (service descriptor questionnaire) and Trust profile,2c737d63-69f4-4a02-8df9-54c1e65e845f,ALLIANCE > HQIP,46.84,34.92,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,4b59ff6f-2830-4f2b-b35a-623ef4520eb8,41.27,Systemic Anti-Cancer Therapy Dataset (SACT),6c4ed998-0f05-415c-a3e4-42430bb62d24,,33.95,50.79,1.1.7
92.86,98.41,13.95,Gold,Gold,4b6d3344-e73a-4f46-8e9d-fabb85827772,91.27,Daily Situation Report Data,c74a9b9e-1fea-4aac-99fd-54e30668e085,ALLIANCE > SAIL,89.45,15.87,1.1.7
64.29,55.56,18.6,Bronze,Bronze,4cb9082f-619d-4be2-8d09-641f2c573d38,68.25,"Prevention, detection, treatment: adult lung disease/cancer in rural Tamil Nadu",2581994d-5be2-4465-bb62-60c4c97e8e2b,HUB > BREATHE,72.84,19.05,1.1.7
69.05,60.32,16.28,Silver,Bronze,4cde083a-bf5a-4f57-97c6-38632e10050d,72.22,Obesity Research Biobank Syndicate (ORBiS),264a1987-a8cb-4a83-81e0-70b4c3893b7d,ALLIANCE > TISSUE DIRECTORY,76.38,15.87,1.1.7
28.57,23.81,32.56,Not Rated,Not Rated,4d0c3779-9251-4a4a-9eff-41a47869157f,45.24,National Oesophago-Gastric Cancer Audit - clinical dataset,306274ee-a098-43cc-b113-2df8116a8703,ALLIANCE > HQIP,48.0,33.33,1.1.7
28.57,23.81,32.56,Not Rated,Not Rated,4d1271dd-b256-454b-9b13-be38bef73f15,45.24,Paediatric Intensive Care Audit Network - core dataset (admission),4ca76471-6970-4ad4-87c7-fae77a98cbf5,ALLIANCE > HQIP,48.0,33.33,1.1.7
69.05,60.32,16.28,Silver,Bronze,4dd3f23c-44be-4126-aac5-ba655d07855c,72.22,POUT-T,c6e0e70e-7f23-4a44-a2cf-1d7d87be7808,ALLIANCE > TISSUE DIRECTORY,76.38,15.87,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,4ddf1fe9-537e-4342-848d-8ec273979cba,38.88,Annual District Death Daily (ADDD),584bf8c8-d58f-44c6-9b65-e1611144fd54,,32.78,55.56,1.1.7
19.05,33.33,55.81,Not Rated,Not Rated,4f78dee8-8f16-41a9-8249-2c72d77be2e4,36.5,Suspected Cancer Pathway Monthly (SCPM),fcf5a844-f48d-428e-aa06-abe64e66185e,,31.62,60.32,1.1.7
28.57,23.81,34.88,Not Rated,Not Rated,501b0226-1cbf-4717-8dee-adf189dd0088,44.45,"Maternal, Newborn and Infant Clinical Outcome Review Programme - perinatal surveillance dataset",11deee42-5876-4ebe-acca-e996702e1343,ALLIANCE > HQIP,46.84,34.92,1.1.7
28.57,23.81,34.88,Not Rated,Not Rated,50609a73-30a0-46ca-847d-4a9c1bfec5fc,44.45,National Cardiac Audit Programme - Myocardial Ischaemia National Audit Project (MINAP),3558f8a1-6d52-4b59-b513-51c068095bc2,ALLIANCE > HQIP,46.84,34.92,1.1.7
83.33,88.89,30.23,Silver,Silver,50925199-a35d-4327-87cd-7761d713a72b,78.57,HES Outpatient data for CPRD Aurum,8d3f3e58-be79-4450-b2e3-f5ab8a25fb0e,ALLIANCE > CPRD,76.55,31.75,1.1.7
19.05,15.87,39.53,Not Rated,Not Rated,5271131b-ba5b-452d-b230-077094a031c2,38.88,ARIA Dataset,621dd611-adcf-4434-b538-eecdbe5f72cf,ALLIANCE > BARTS HEALTH,39.76,38.1,1.1.7
78.57,85.71,27.91,Bronze,Silver,52a467b0-5401-4818-9c16-2e41d68704c1,76.19,NIHR BioResource: SNP chip data,c388676c-a5e5-419c-967c-239c1f0c3c5c,ALLIANCE > NIHR BIORESOURCE,75.33,33.33,1.1.7
80.95,88.89,32.56,Bronze,Silver,52c784f6-99c6-4407-b660-abaa1682c955,76.19,Mental Health Dataset (MHDS) for CPRD Aurum,48627b2d-f247-4921-9ee1-6c37adfff10d,ALLIANCE > CPRD,74.19,36.51,1.1.7
92.86,96.83,20.93,Silver,Silver,535a0983-6618-4211-a939-ae2edfe26f9a,84.92,North West London Adult Social Care Data (NWL ASC),de9cf0f5-b26a-4363-9df8-3628a4aa6b6e,HUB > DISCOVER NOW,85.97,26.98,1.1.7
73.81,82.54,25.58,Bronze,Silver,53b7c446-667b-409e-920e-67cb516de3ae,78.57,Ventilatory strategies and outcomes for patients with COVID: a dataset in OMOP,cacba424-6c2c-4b57-8f5b-64e92a78370a,HUB > PIONEER,74.12,25.4,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,53dbbca0-b57d-4f93-8f05-37f626f9a7bc,38.88,Scottish Medical Imaging (SMI) Research Dataset,1c49a822-6432-468b-8ba5-6aab534654b9,,32.78,55.56,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,542bf16f-baea-4fca-be51-fcef9732494a,41.27,Cervical Screening Wales (SCSW),b32325d7-7f00-4d20-9935-dd02e1bc6932,,33.95,50.79,1.1.7
69.05,60.32,16.28,Silver,Bronze,54a7dd45-d6c7-4b4d-801d-2becd2b694f1,72.22,Epilepsy Society Brain and Tissue Bank,f13258c3-f85a-4772-b42e-da8a84c5064a,ALLIANCE > TISSUE DIRECTORY,76.38,15.87,1.1.7
28.57,23.81,32.56,Not Rated,Not Rated,558ee6da-6bfc-49b0-8815-f4f1670adcd8,45.24,National Audit of Care at the End of Life - organisational level audit,a290592c-a6f5-4874-b283-1d33e923c487,ALLIANCE > HQIP,48.0,33.33,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,561ce879-88cc-415d-822e-10aaab966981,41.27,Welsh Ambulance Services NHS Trust (WASD),d415a5c5-8432-4a81-937f-12135ade6de7,,33.95,50.79,1.1.7
69.05,60.32,16.28,Silver,Bronze,567b23fe-abf2-4e2e-88f7-505dfeaa3cde,72.22,LBIH Biobank,c0318a31-a32c-4d3a-9591-dfe9352bf2b9,ALLIANCE > TISSUE DIRECTORY,76.38,15.87,1.1.7
4.76,4.76,46.51,Not Rated,Not Rated,567b5d24-07df-4430-8466-4444ecbe86c8,29.36,Assessing the feasibility and effectiveness of introducing pulse oximetry,2f36b7b3-e50f-459f-a691-f62dde65e2bd,,29.12,46.03,1.1.7
73.81,80.95,23.26,Bronze,Silver,56c3aabb-cb99-4da9-a6ed-3212c02e6f20,78.57,"Diabetic Eye Screening: the Birmingham, Solihull and Black Country Data Set",36886b21-12ff-45e7-82bc-fb5308c12450,HUB > INSIGHT,75.28,23.81,1.1.7
69.05,60.32,18.6,Bronze,Bronze,56f3e791-a204-4f67-a4d0-52803148d71a,71.43,TNT: Triple Negative breast cancer Trial,5f4c825d-d6c3-453e-9667-8cdf2329b6e1,ALLIANCE > TISSUE DIRECTORY,75.22,17.46,1.1.7
4.76,4.76,46.51,Not Rated,Not Rated,5727d014-0c5c-4dcb-89c9-ff33e1b680bb,29.36,Wellcome Sanger Institute: Whole Exome Sequencing,cd20517c-2f75-40e9-9ee8-563d32624b55,,29.12,46.03,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,57458394-945e-4e6a-abc7-91df0f44cb60,38.88,NIHR IBD BioResource: Health and Lifestyle Questionnaire,18bfe765-5733-41f3-8114-0a1ec2524b5b,,32.78,55.56,1.1.7
78.57,84.13,25.58,Silver,Silver,575514e3-6e8f-4218-bd75-ff32742abc52,76.19,Coronavirus and the social impacts on Great Britain,e253257c-48c2-491b-b3b9-205161a16a7e,NCS > OFFICE FOR NATIONAL STATISTICS,76.5,31.75,1.1.7
95.24,100.0,16.28,Gold,Gold,57726e95-afe2-4d62-ab1e-81d90eb0ec1d,91.27,COVID-19 Test results,f5f6d882-163d-4ef1-a53e-000fba409480,ALLIANCE > SAIL,89.48,17.46,1.1.7
4.76,4.76,46.51,Not Rated,Not Rated,590e7bb7-a6e3-4f87-af2f-e46943f98ce9,29.36,Exploration of Pneumonia Related Policy Formation and Implementation in Pakistan,e0d00cb7-62e1-4a38-8df6-cf537b59228d,,29.12,46.03,1.1.7
4.76,4.76,46.51,Not Rated,Not Rated,598ab9d9-04a3-4628-be64-d8f026d266ac,29.36,Computational Framework to Interpret Chest X-rays and Diagnose Pneumonia,cf9bc775-1db7-44e4-9a16-317d5bb063a2,,29.12,46.03,1.1.7
85.71,92.06,23.26,Silver,Silver,5b5deab2-2a83-4eef-83a8-13853beee94c,81.75,National Records of Scotland (NRS) - Stillbirth Data,dca0c95b-ae7d-4163-8c3b-a881f779df02,ALLIANCE > PUBLIC HEALTH SCOTLAND,81.22,28.57,1.1.7
92.86,96.83,20.93,Silver,Silver,5b9b7964-615b-438a-b151-d2f884a24aee,84.92,North West London Accident and Emergency Data (NWL A&E),721db252-8069-433d-bb6d-4b44b243d364,HUB > DISCOVER NOW,85.97,26.98,1.1.7
69.05,60.32,16.28,Silver,Bronze,5bb40472-fc5d-4b16-a0a6-d1d42fd1d3e8,72.22,VinCaP,e57dd7a2-3c5c-4285-8001-8e2589c395e9,ALLIANCE > TISSUE DIRECTORY,76.38,15.87,1.1.7
52.38,42.86,30.23,Not Rated,Not Rated,5c7ae78d-53e6-427d-a3a9-52538f8342dc,55.55,International Severe Asthma Registry,9711e6cc-426c-4cef-afb3-64382f8d7ed4,HUB > BREATHE,61.08,31.75,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,5ce6905a-8b54-4d6c-9da6-e2d57ce45419,38.88,National Waiting List Diagnostics,e508951d-e118-4217-84a4-722e50fdd400,,32.78,55.56,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,5cf49b5c-bb8d-4ab2-90ce-74d801f7c090,38.88,Renal Register – ISD National dataset,32edd77d-533c-423f-b045-937507f8505d,,32.78,55.56,1.1.7
19.05,33.33,55.81,Not Rated,Not Rated,5de4bedb-32a9-4a66-9c92-5987453794f1,36.5,Public Health Research Database (PHRD),a325f33e-bac8-49af-896f-1e025941dae8,,31.62,60.32,1.1.7
16.67,14.29,37.21,Not Rated,Not Rated,5e022f8f-4d07-44bb-a87c-43e31200fe1e,38.89,ARIA Radonc,59d72237-6969-4f59-9e87-48138978abe8,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,39.73,36.51,1.1.7
92.86,96.83,18.6,Gold,Silver,5e19a471-64e3-4aa4-ac56-6901d5e39e28,85.72,North West London Mental Health Data (NWL MH),2d3ec99a-a087-4355-8539-5a22cef58910,HUB > DISCOVER NOW,87.13,25.4,1.1.7
95.24,100.0,16.28,Gold,Gold,5e2a7277-dc64-499a-b16d-51850d9ad00b,89.69,Emergency Department Dataset Daily,fa257aa8-51fc-4eb7-a448-e473fa54686d,ALLIANCE > SAIL,89.48,20.63,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,5e442584-9acd-4e8d-9448-5f8f2b937d56,38.88,NHS Tayside and Fife Biochemistry (Lab Data Restructured),10ffac16-d0c2-4d53-ab6a-69a38e283223,,32.78,55.56,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,5e9d4a4b-544c-4739-b079-62f353086fde,41.27,Moorfields AMD Dataset Release 002,bf392537-82b4-4d71-ace0-e7bea3b167fb,,33.95,50.79,1.1.7
80.95,87.3,27.91,Silver,Silver,5e9d9633-c4f4-47cc-96d9-350191e18539,78.57,HES Diagnostic Imaging Dataset for CPRD Aurum,617f9f54-3fb6-40c3-b391-fe51d1fc7c49,ALLIANCE > CPRD,76.52,30.16,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,5e9fba37-017b-4481-bc69-75ef1e005c2f,41.27,National Community Child Health Database (NCCHD),20fe153c-a5e5-4991-900e-8fa9988e771a,,33.95,50.79,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,5ef3573a-274a-41e1-8f64-9330109d59d1,38.88,National Cancer Registration and Analysis Service,0a852454-ee67-443b-a091-d13499a71b41,,32.78,55.56,1.1.7
95.24,100.0,20.93,Gold,Gold,601f1504-2706-405b-94cb-8cd14231f434,86.51,North West London population data (NWL POP),1032850f-7631-4d9e-a760-b0532bffd21a,HUB > DISCOVER NOW,87.16,26.98,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,607daf12-816c-4dba-8aa2-cf71dd69d66c,38.88,Tayside Microbiology: Isolations,eaa4bab0-0501-4511-aa2d-4e4fee0f0bf3,,32.78,55.56,1.1.7
69.05,60.32,16.28,Silver,Bronze,60b148f7-b48c-49c4-9286-b83691cfc7b2,72.22,STAMPEDE,71eb0192-1124-4b27-86e4-1139e0047a02,ALLIANCE > TISSUE DIRECTORY,76.38,15.87,1.1.7
95.24,100.0,20.93,Gold,Gold,62c01293-83a5-4d4d-9d36-9d7aa2bf120f,88.09,GENOMICS ENGLAND 100K PHE LINKED DATA,ea748742-568a-46e2-b603-2fada49024e1,GENOMICS ENGLAND,87.16,23.81,1.1.7
35.71,30.16,27.91,Not Rated,Not Rated,62fef8d2-c397-43c3-b14a-69cf89423887,50.8,Vitamin D supplementation meta-analyses,2454a964-be58-4d1f-8f9a-ffae9db9129c,HUB > BREATHE,53.9,28.57,1.1.7
19.05,33.33,55.81,Not Rated,Not Rated,645168a0-21b1-4e13-85d8-266ad9040af8,36.5,Suspected Cancer Pathway Monthly (SPCM),fcf5a844-f48d-428e-aa06-abe64e66185e,,31.62,60.32,1.1.7
4.76,4.76,46.51,Not Rated,Not Rated,646d65df-fc4c-4680-b949-79ec8f40b406,29.36,"Trusted Research Environments for CVD-COVID-UK in England, Scotland, and Wales",7e5f0247-f033-4f98-aed3-3d7422b9dc6d,,29.12,46.03,1.1.7
19.05,33.33,58.14,Not Rated,Not Rated,649261ce-833f-459e-908c-2ef93c5fed41,34.12,Civil Registration - Deaths,050163dc-1728-4ac5-a7d9-4dd3ca0ca12a,,30.45,65.08,1.1.7
83.33,90.48,30.23,Silver,Silver,65481fcf-cc98-44f0-bcfe-c21bcb8db0f5,79.37,HES Accident and Emergency data for CPRD Aurum,c43501ec-08b4-4d33-a7dd-d19fca821925,ALLIANCE > CPRD,76.55,31.75,1.1.7
73.81,82.54,27.91,Bronze,Bronze,65c641db-3271-4f96-8cb4-94cf9e6379b4,74.61,SICSAG Episodes (Scottish Intensive Care Audit Group),6f8182d2-2993-400d-829d-b52cdb324bf3,ALLIANCE > PUBLIC HEALTH SCOTLAND,72.95,33.33,1.1.7
92.86,98.41,16.28,Gold,Gold,65c8a30c-de2c-47bf-87e4-18c86e75e54a,88.89,Diagnostic and Therapy Services Waiting Times,97896866-ab5e-408a-ac5a-072802db9faf,ALLIANCE > SAIL,88.29,20.63,1.1.7
28.57,23.81,32.56,Not Rated,Not Rated,660d7cbd-3fcf-4139-9ef5-9b4bd03c4bee,45.24,National Cardiac Audit Programme - Cardiac Rhythm Management (CRM),3cc81e6c-0c17-4ccd-8202-a9aceb82c989,ALLIANCE > HQIP,48.0,33.33,1.1.7
64.29,55.56,18.6,Bronze,Bronze,661b27db-38d4-4a9c-ac40-e3146ef12350,68.25,Theory of Planned Behaviour Intervention: respiratory disease in South India,7d23e729-72b0-4dd1-820d-07697b49acd0,HUB > BREATHE,72.84,19.05,1.1.7
69.05,60.32,16.28,Silver,Bronze,6620b221-6909-4106-a49e-f1b5820be2f3,72.22,interNational Anaplastic Thyroid Cancer Tissue Bank (iNATT),5ef75d71-73ce-4451-9d7a-a39dd82b712f,ALLIANCE > TISSUE DIRECTORY,76.38,15.87,1.1.7
92.86,96.83,25.58,Silver,Silver,664513d6-d766-461d-a69e-206a928cd14f,83.34,The Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) primary care sentinel network and database,d5049af5-e351-4b22-8f75-6f3dfc96419b,ALLIANCE > ROYAL COLLEGE OF GENERAL PRACTITIONERS,83.64,30.16,1.1.7
28.57,23.81,34.88,Not Rated,Not Rated,668eefeb-fb5c-46d8-a052-12fa8da4931b,44.45,National Asthma and COPD Audit Programme (NACAP): Adult Asthma secondary care clinical dataset,becd2624-9a01-4f01-bcf8-56e94545a49a,ALLIANCE > HQIP,46.84,34.92,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,67ab8a56-99d7-4951-aacb-5dca0b8ffa35,38.88,National Waiting List Clock Stops,3f073707-50b4-48cf-93b6-76843519a5c0,,32.78,55.56,1.1.7
80.95,71.43,11.63,Silver,Silver,67cd0c2b-3944-4bc4-a03a-4081ee67847f,79.37,Genetics of Asthma Severity & Phenotypes,6277abc6-c039-4886-8489-d4a2cdb8190c,HUB > BREATHE,84.66,12.7,1.1.7
76.19,82.54,27.91,Bronze,Bronze,67fa61c8-7973-4eb4-999c-fbed084d4445,74.61,Covid-19 Infection Survey,628e9ad9-28c5-4d58-9ec5-04a63be9b4cf,NCS > OFFICE FOR NATIONAL STATISTICS,74.14,33.33,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,682b4d85-732a-4440-922d-07191a604143,38.88,UK Renal Registry - AKI Lab Alerts Dataset,c38541a7-cf43-4bfd-928d-75613abc8e3f,,32.78,55.56,1.1.7
28.57,23.81,32.56,Not Rated,Not Rated,69547543-ca00-455c-872d-a176191d5ada,45.24,National Joint Registry - Revision Ankle Replacement dataset,b4f076d2-c9a3-49ba-84f4-94148dc8511a,ALLIANCE > HQIP,48.0,33.33,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,69833273-2b81-4657-8d80-5bafb2c0834d,38.88,"Deaths – CHI, Community Health Index",faf2fc49-d09f-4ea2-a2cb-b1d30fffa406,,32.78,55.56,1.1.7
28.57,23.81,34.88,Not Rated,Not Rated,6a11bc97-b57a-458f-8a3e-98c71221cb5c,44.45,National Asthma and COPD Audit Programme (NACAP): primary care workstream resources,8a3ec96a-0600-4c6d-8761-9d277f07b9da,ALLIANCE > HQIP,46.84,34.92,1.1.7
92.86,96.83,16.28,Gold,Gold,6a390359-1e26-470f-a4e5-bfb31a5ed643,88.1,North West London Patient Index (NWL PI),1fe1e7bb-ef6e-4d89-9824-bb560afc81f0,HUB > DISCOVER NOW,88.29,20.63,1.1.7
73.81,80.95,32.56,Bronze,Bronze,6a63513f-92cb-43ce-b0dd-fdb1113150c9,72.22,Mental Health Services Data Set,fa2ec63d-f76d-4555-8fc1-f4bd66e3c60d,ALLIANCE > NHS DIGITAL,70.62,36.51,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,6a9a3c4c-95d4-45da-9520-c3b9aceb6d13,41.27,UHB Linked Diabetic Eye Disease from National Screening to Hospital Eye Care,7c087b3c-cc04-4d3d-894b-7ea5419fa714,,33.95,50.79,1.1.7
66.67,74.6,25.58,Bronze,Bronze,6ae22437-38d7-4c47-b529-e100e15c81ab,73.81,Synthetic Dataset: Patients at risk of sudden death: hypertrophic cardiomyopathy,7b1c1f1a-4fb2-452d-9a3c-7748992b1fa4,HUB > PIONEER,70.55,26.98,1.1.7
71.43,63.49,16.28,Silver,Bronze,6aebcd6d-10c6-44cd-80d6-b5a90791db4f,73.81,York Tissue Bank,71e898d1-db8c-4887-a605-dd6336b92a34,ALLIANCE > TISSUE DIRECTORY,77.58,15.87,1.1.7
76.19,66.67,20.93,Silver,Bronze,6bc36f07-d55a-4a97-afab-29d93dc65bde,73.81,Sheffield Brain Tissue Bank (SBTB),bdda7221-7c02-4ced-b7a8-3806a073d981,ALLIANCE > TISSUE DIRECTORY,77.63,19.05,1.1.7
69.05,61.9,16.28,Silver,Bronze,6bca5d27-5b98-45e7-b834-6980ba5db5c9,73.02,Leicester Respiratory Research Database,01c3d08c-6948-4059-a027-3437e4f5d53b,HUB > BREATHE,76.38,15.87,1.1.7
69.05,60.32,16.28,Silver,Bronze,6bde3902-5d69-4c24-9d10-f84a63efdb22,72.22,Leeds Breast Research Tissue Bank,2dc1218d-df5f-4025-826c-cf5ca7d67882,ALLIANCE > TISSUE DIRECTORY,76.38,15.87,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,6c12c555-c011-4f43-b98f-df0bfaad6b05,38.88,Moorfields Eye Image BioResource 001,6bfe44ef-9532-4986-b8a2-9c2cda4a89cc,,32.78,55.56,1.1.7
83.33,90.48,20.93,Silver,Silver,6c5c67d5-b7f6-4126-ac5c-be2bf45eb1cc,84.93,General Acute Inpatient and Day Case - Scottish Morbidity Record (SMR01),98cda353-0011-45b2-80ca-4ed24cd084bf,ALLIANCE > PUBLIC HEALTH SCOTLAND,81.2,20.63,1.1.7
4.76,4.76,46.51,Not Rated,Not Rated,6cae7a61-568d-40b1-984a-1dd9365f9c71,29.36,Effects of second-hand smoke on pregnant women: a phenomenological study,4a5c610f-019d-450a-90c5-0fe315027f56,,29.12,46.03,1.1.7
28.57,23.81,32.56,Not Rated,Not Rated,6cd16bca-395b-4dbc-a817-15fd55a1a8e8,45.24,National Vascular Registry Audit Carotid Lower Limb Amputation clinical dataset,03e77b9d-57b8-44d5-8d64-9b1325958b22,ALLIANCE > HQIP,48.0,33.33,1.1.7
71.43,63.49,20.93,Bronze,Bronze,6ceec25d-2c8e-4dd7-8f99-2e56ec63c298,71.43,DARWIN1 Trial,7f9672fa-dad5-479d-a929-52719e8cc2fa,ALLIANCE > TISSUE DIRECTORY,75.25,20.63,1.1.7
35.71,31.75,34.88,Not Rated,Not Rated,6d41700e-6dac-47c1-ba31-eb2f23539efe,49.21,Emergency Care Dataset (ECDS),57fa56f2-78d1-49af-ab8d-e8146d711868,ALLIANCE > BARTS HEALTH,50.42,33.33,1.1.7
4.76,4.76,46.51,Not Rated,Not Rated,6dd170f2-c9fe-4496-9499-26783d84e3c2,29.36,Exploring Personal Preparedness and Self-Protective Measures during COVID-19,680a7d41-0fd1-4b32-a2cd-190e338f8ac7,,29.12,46.03,1.1.7
61.9,53.97,20.93,Bronze,Bronze,6dd62b6b-d832-4c65-a101-20fe9edd75fc,66.67,"Introducing pulse oximetry in IMNCI, primary health facilities in Pune India",dae5b81c-db28-414b-9328-5596632a8732,HUB > BREATHE,70.48,20.63,1.1.7
69.05,60.32,16.28,Silver,Bronze,6dd6c679-7c5f-4d8e-b1e4-8f1447425e96,72.22,Wales Cancer Bank,37886fb5-d0ae-400f-89eb-78664897bcf2,ALLIANCE > TISSUE DIRECTORY,76.38,15.87,1.1.7
19.05,33.33,55.81,Not Rated,Not Rated,6e47173e-651a-404e-a0b2-1fa1cbd887b1,36.5,Covid-19 Second Generation Surveillance System,fede31c6-a9c5-4cfb-9866-9b58b2199cff,,31.62,60.32,1.1.7
40.48,36.51,25.58,Not Rated,Not Rated,6e5916d4-017c-4542-bc71-edf6d4c5a055,56.35,Biological samples,41ac38b0-31cd-4865-a357-80ce557b2312,UK Biobank,57.45,23.81,1.1.7
28.57,23.81,34.88,Not Rated,Not Rated,6e70b32a-dfbc-46d3-9784-479f3f09527e,44.45,National Asthma and COPD Audit Programme (NACAP): Pulmonary rehabilitation - organisational audit,4b33fc6d-3cac-4404-adac-d693328456fa,ALLIANCE > HQIP,46.84,34.92,1.1.7
83.33,90.48,23.26,Silver,Silver,6f348bdc-21e4-459b-b658-dc839a1e2133,81.75,Intensive Care National Audit and Research Centre,fa8bf269-4769-491b-b398-fa63137d14ab,ALLIANCE > SAIL,80.03,26.98,1.1.7
28.57,23.81,32.56,Not Rated,Not Rated,6f8a0bd2-8bc6-4ebd-8464-7f63c56668b4,45.24,National Early Inflammatory Arthritis Audit - clinical dataset,b0797c05-352f-455f-8d27-150b6f6354cc,ALLIANCE > HQIP,48.0,33.33,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,6fbdc930-be40-4492-ba79-82d06d49b539,38.88,"NHS Tayside A&E, Diagnosis dataset during A&E visit",14a39e96-8ac3-4df3-b42b-07718121c585,,32.78,55.56,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,6fd8abda-7e49-436c-9131-a1f607569c14,38.88,Covid-19 UK Non-hospital Antibody Testing Results,a77e52cc-d404-45d6-835f-32e2dc46778a,,32.78,55.56,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,7017aede-b38a-4b70-b7b2-aade001d0cc0,38.88,School Workforce Annual Census (SWAC),5692eade-5738-48ed-8527-39be9caaa7b5,,32.78,55.56,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,708839a0-d003-4917-bbd9-92741f54ab75,38.88,National Waiting List Clock Starts,2b847fd2-0f65-43b7-84e1-10cec99d699e,,32.78,55.56,1.1.7
69.05,60.32,18.6,Bronze,Bronze,70b4d407-288a-4945-a4d5-506d60715110,71.43,CASPS: A Phase II trial of Cediranib in ASPS patients,7dcd5c0a-1922-4fe2-9b7e-090e4c39861b,ALLIANCE > TISSUE DIRECTORY,75.22,17.46,1.1.7
4.76,4.76,46.51,Not Rated,Not Rated,70c318c4-b388-4102-924e-5419d44c1679,29.36,CuT-AsthMa: Culturally tailored school-based intervention for asthma in Malaysia,009bcb87-05f3-46e6-8866-7e4df698cb19,,29.12,46.03,1.1.7
73.81,65.08,16.28,Silver,Bronze,71b8569c-b582-499c-85aa-909b825f6ea6,74.6,Avon Longitudinal Study of Parents and Children,255d70c6-9a50-4b62-adc0-44216606a216,ALLIANCE > AVON LONGITUDINAL STUDY OF PARENTS AND CHILDREN,78.77,15.87,1.1.7
16.67,14.29,37.21,Not Rated,Not Rated,72fe91de-b0c0-423a-ad68-bd7067b20ad8,38.89,Infoflex Cancer Registry,5505e91d-9e0a-4969-87d5-00f256d91306,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,39.73,36.51,1.1.7
78.57,85.71,23.26,Silver,Silver,730b3e54-1f59-4c07-b5d6-e6b63e4dda35,80.95,"Deeply-phenotyped hospital COVID patients: severity, acuity, therapies, outcomes",16a09f1b-3654-4ec3-9913-fb70cb1e2364,HUB > PIONEER,77.66,23.81,1.1.7
78.57,69.84,9.3,Silver,Silver,73462506-32c5-43a0-963e-06d67e967b97,79.37,UK BiLEVE Consortium Dataset,b8bcda0b-3c90-4382-aeb7-b01fc27e58fa,HUB > BREATHE,84.63,11.11,1.1.7
28.57,23.81,32.56,Not Rated,Not Rated,73bcc43a-e9ef-462a-9c32-be108d9020a0,45.24,National Early Inflammatory Arthritis Audit - organisational survey dataset,a9ac99fe-32be-40ef-9509-03e6b2713ddf,ALLIANCE > HQIP,48.0,33.33,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,73edba9a-3799-47e4-9a6e-a52321c21367,38.88,Postponed Admitted Procedures (CAPD),bff94600-a254-4111-82f7-6167084d81ca,,32.78,55.56,1.1.7
95.24,100.0,34.88,Silver,Silver,73f54071-62bf-48f5-8be1-569208b18ab8,80.16,HIC Hepatitis v2,66be725a-b950-4bf8-9a35-7e33ce765a25,NIHR Health Informatics Collaborative Viral Hepatitis Theme,80.18,39.68,1.1.7
69.05,60.32,16.28,Silver,Bronze,74241b17-23b7-4233-b7b9-1a484aa053b0,72.22,Myeloma XII clinical trial samples,576fbcf8-ff25-4230-ae69-e72ca02b95f1,ALLIANCE > TISSUE DIRECTORY,76.38,15.87,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,747d57aa-a02b-411c-9403-2e3ec9d3e5b5,38.88,NIHR IBD BioResource: Contact detail,02ddc5c9-03d4-40e4-9934-e60817ec8f3e,,32.78,55.56,1.1.7
42.86,38.1,27.91,Not Rated,Not Rated,75614b69-bc18-416b-9d27-fd8ca9fc4521,56.35,Cancer register,a4751434-54ea-4d22-a66a-a5d32bd80c40,UK Biobank,57.48,25.4,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,75b8e10e-cc35-41be-aad7-990afc13b08e,38.88,Children Receiving Care and Support Census (CRCS),fb3fac03-a428-4b3f-8058-5622e1fd57d8,,32.78,55.56,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,76535d6e-ce0c-407c-ba22-1b2420a1e654,41.27,National Exercise Referral Scheme,131784c0-769d-4f7b-b7d0-b5f4b89886d4,,33.95,50.79,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,77422eb1-7bdb-4205-b3d0-57d1add35317,41.27,Moorfields DMO Dataset Release 001,120106fb-49b4-4bc0-b30c-50a59c5c6253,,33.95,50.79,1.1.7
95.24,100.0,13.95,Gold,Gold,77824298-ef3b-40f7-a0a4-b6dedb2e7a02,92.06,The National COVID-19 Chest Imaging Database,31f0148b-f965-4136-ab39-6c5bbbf8c2d9,NHSX,90.64,15.87,1.1.7
71.43,63.49,16.28,Silver,Bronze,7793f54e-73be-4c97-a941-ba105b1b0480,73.81,Leeds Multidisciplinary Research Tissue Bank,7e60a651-b3d6-40ef-93dc-1f87dabee7be,ALLIANCE > TISSUE DIRECTORY,77.58,15.87,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,77b48222-3a00-4dcc-b0ef-3f99dfae697e,38.88,Lifelong Learning Wales Record (LLWR),cba62a8d-5917-4912-ad4d-340472f7b904,,32.78,55.56,1.1.7
19.05,33.33,55.81,Not Rated,Not Rated,77dc7118-443c-4c85-a18c-e7bbe01e9e7a,36.5,1958 National Child Development Study - Pain data,33092502-12ef-4bc0-8400-5f63915cbf33,,31.62,60.32,1.1.7
35.71,46.03,46.51,Not Rated,Not Rated,7858978f-30e8-42e7-abe4-d9af5447c278,47.62,NHS Tayside and Fife Haematology Biochemistry (Lab Data Restructured),10ffac16-d0c2-4d53-ab6a-69a38e283223,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,44.6,50.79,1.1.7
71.43,63.49,16.28,Silver,Bronze,7862c1c2-d4d6-4b3c-aea1-1f15a5b3b5ea,73.81,UCL / UCLH Biobank for Studying Health and Disease,ce533c67-5565-4010-bedf-dca3863a9084,ALLIANCE > TISSUE DIRECTORY,77.58,15.87,1.1.7
95.24,100.0,13.95,Gold,Gold,78ce070c-84db-4676-81c5-0c672f4e12e3,92.06,COVID-19 Symptom Tracker Dataset,594cfe55-96e3-45ff-874c-2c0006eeb881,ALLIANCE > SAIL,90.64,15.87,1.1.7
64.29,77.78,44.19,Not Rated,Not Rated,78fe2e13-7f40-406f-a584-04909d0ce060,64.28,Mental Health Minimum Dataset v4.1 (Sensitive) Episodes,efecbe58-4822-4f17-bf5c-92113d143db9,ALLIANCE > NHS DIGITAL,60.05,49.21,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,796d97b4-6f3d-4ee8-8966-9238efdcac2d,40.47,Synthetic Dataset - Patients at risk of sudden death: hypertrophic cardiomyopathy,7b1c1f1a-4fb2-452d-9a3c-7748992b1fa4,,32.78,52.38,1.1.7
71.43,63.49,18.6,Silver,Bronze,79b02690-798b-462d-9ced-f53c9e39d624,73.02,Central England Haemato-oncology and oncology Research Biobank (CEHRB),314953f6-58e7-49c0-adfd-c60e623eba74,ALLIANCE > TISSUE DIRECTORY,76.42,17.46,1.1.7
64.29,77.78,44.19,Not Rated,Not Rated,7aa02796-787a-42c2-b97e-d008fa77e4b8,64.28,Mental Health & Learning Disabilities Dataset v 1 (Non-Sensitive) Records,1a8fc23c-b67b-4171-b5e1-1b650fce1ef4,ALLIANCE > NHS DIGITAL,60.05,49.21,1.1.7
19.05,33.33,55.81,Not Rated,Not Rated,7aa38c5c-771c-4157-a008-32051a5aed4b,36.5,Education Wales (EDUW),204fa806-071d-4410-9c2c-143017d32d24,,31.62,60.32,1.1.7
28.57,23.81,32.56,Not Rated,Not Rated,7c1f02ee-a72e-4aca-9205-0013f0796db6,45.24,National Joint Registry - Revision Shoulder Replacement dataset,9623e62b-3c50-44aa-8923-0bbb94e7ad61,ALLIANCE > HQIP,48.0,33.33,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,7d313fa6-941f-48ca-93e1-05d912d183ac,41.27,GPES Data for Pandemic Planning and Research (COVID-19),696cfc9f-090d-4328-94ac-140760a77c73,,33.95,50.79,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,7daacbe5-082d-4c12-b801-0fb08932dada,41.27,COVID-19 Vaccination,b0049073-3335-433d-bdb9-de22547698f8,,33.95,50.79,1.1.7
47.62,41.27,25.58,Not Rated,Not Rated,7df79ee6-e67d-4ad9-89f3-23bee6cb0ec5,57.94,Effect of personal air pollution exposure on asthma control in children,57efab41-65fc-4069-8b9d-e5ced13cb4d3,HUB > BREATHE,61.02,25.4,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,7e71ee33-f029-40a1-8db0-e13467aaf2ac,38.88,Covid-19 UK Non-hospital Antigen Testing Results,f06ec631-77d0-4b12-a21f-f11e7af49ba5,,32.78,55.56,1.1.7
45.24,39.68,27.91,Not Rated,Not Rated,7e780260-e8d3-4541-b51e-213233dfc349,56.35,At-Risk Registers Integrated into primary care to Stop Asthma crises in the UK,36a5da45-772c-4c67-8ec3-84c9e67332d3,HUB > BREATHE,58.67,26.98,1.1.7
19.05,33.33,58.14,Not Rated,Not Rated,7f49d025-11d9-4d04-9b77-19a2f5acf8e6,34.12,Covid Lateral Flow Test (CVLF),ce60d677-6263-4d41-9d45-d3c7ebb3ee36,,30.45,65.08,1.1.7
88.1,95.24,23.26,Silver,Silver,7f4fb30c-2a09-4d75-bed2-114751e06723,84.92,UHB Eye Image Dataset Release 001,21fb56d1-726f-40e3-a998-e4b34ba3e46f,HUB > INSIGHT,82.42,25.4,1.1.7
95.24,100.0,25.58,Silver,Silver,7fdb684d-bb7a-4d0b-8666-9f10510f071f,84.92,GENOMICS ENGLAND 100K CANCER & COMMON,702f0198-bdfe-401e-97f2-35f5d26357ad,GENOMICS ENGLAND,84.83,30.16,1.1.7
76.19,82.54,23.26,Silver,Silver,80a7208f-c174-42bd-9127-e8f006de7c95,77.78,COVID-19 Test Trace and Protect [CTTP],c0fc84af-aeab-4c7e-aa0b-8264baff55d9,ALLIANCE > SAIL,76.47,26.98,1.1.7
95.24,100.0,13.95,Gold,Gold,80e9c439-4909-4534-8bfe-6f01fdec7de7,92.06,Cervical Screening Wales,b32325d7-7f00-4d20-9935-dd02e1bc6932,ALLIANCE > SAIL,90.64,15.87,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,8160dc2b-860a-47e1-a5d2-38473d1d31a0,38.88,Critical Care Dataset (CCDS),1789286a-deaf-49df-88cd-660e92934af6,,32.78,55.56,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,8193e951-2ed8-4ccf-9fe5-5c2e6f933d60,41.27,Outpatient Dataset,d331159b-b286-4ab9-8b36-db39123ec229,,33.95,50.79,1.1.7
83.33,90.48,32.56,Bronze,Silver,81a2abb5-e2b4-4224-8345-5aac1dc68a5d,78.58,Systemic Anti-Cancer Treatment (SACT) data for CPRD GOLD,014e7973-b43e-4a4a-91b4-de3f353b71b9,ALLIANCE > CPRD,75.38,33.33,1.1.7
76.19,84.13,25.58,Bronze,Silver,81c54c5a-ceb1-487c-820a-437b4dd002ca,79.36,Risk and outcomes of coagulopathies in acutely unwell adults,bf3fe16c-5377-4571-b5a5-7aa7e796594c,HUB > PIONEER,75.31,25.4,1.1.7
83.33,88.89,30.23,Silver,Silver,81f3bdfe-de6b-4831-ba9a-4e28a34a6ab4,78.57,HES Outpatient data for CPRD GOLD,21dc2345-3983-4a46-960c-f17974bc7b71,ALLIANCE > CPRD,76.55,31.75,1.1.7
64.29,77.78,44.19,Not Rated,Not Rated,8226b6fa-d815-4f15-9064-b56beb0fddb1,64.28,Mental Health & Learning Disabilities Dataset v 1 (Sensitive) Episodes,a27400b0-0efb-4af8-a7bc-e2c7e59796e3,ALLIANCE > NHS DIGITAL,60.05,49.21,1.1.7
76.19,66.67,20.93,Silver,Bronze,826114ca-2563-4c0c-b023-3417ead32956,73.81,Research Donors Ltd,fcb62cb3-c876-47a3-961e-fb27c6f718fa,ALLIANCE > TISSUE DIRECTORY,77.63,19.05,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,8286eef9-0533-488e-bf19-8fc0fa1dd00b,38.88,NHS Tayside and Fife Immunology (Extractable),39055449-c074-4b58-adb2-b1c0d2441c4d,,32.78,55.56,1.1.7
4.76,4.76,46.51,Not Rated,Not Rated,828bc515-6b42-4492-a77e-cf20226ba041,29.36,Reasons for delay in seeking care for pneumonia in children under five,46f50b9b-b8e2-4ff1-a1b3-779174c3d032,,29.12,46.03,1.1.7
71.43,79.37,25.58,Bronze,Bronze,82b0be0d-3bd3-4a4e-a37d-be4c3b8a42f7,75.4,Labour Force Survey (Person),8c60a308-1e47-4a0c-8b69-9259f05338cb,NCS > OFFICE FOR NATIONAL STATISTICS,72.93,28.57,1.1.7
71.43,63.49,16.28,Silver,Bronze,82f4cf19-9e6a-4c31-8cc3-085f3d44ba44,73.81,Northern Ireland Biobank (NIB),c6e1ea88-f5bf-4a57-953f-688f313fcb04,ALLIANCE > TISSUE DIRECTORY,77.58,15.87,1.1.7
28.57,23.81,32.56,Not Rated,Not Rated,83099c35-3152-4e7e-accf-ca4c7ed922b6,45.24,National Clinical Audit of Anxiety and Depression - Core audit of practice,4a96b9bf-beb0-41b1-9211-e6ce39a21c1a,ALLIANCE > HQIP,48.0,33.33,1.1.7
4.76,4.76,46.51,Not Rated,Not Rated,830c22bb-4321-4fa3-ba04-be9b30518877,29.36,Hypertonic saline nasal irrigation and gargling for suspected COVID-19,574cf7bc-dd70-4508-a66d-ac59d8d06639,,29.12,46.03,1.1.7
4.76,4.76,46.51,Not Rated,Not Rated,83e177bb-5a05-4ec1-be22-272a0f985957,29.36,Trusted Research Environments for CVD-COVID-UK / COVID-IMPACT,7e5f0247-f033-4f98-aed3-3d7422b9dc6d,,29.12,46.03,1.1.7
61.9,55.56,27.91,Bronze,Not Rated,842e8c5c-a298-4942-9ac4-f95d1a5f87b3,64.29,Deriving and validating a clinical prediction rule for the diagnosis of asthma in primary care,b0a68ee7-742d-45dc-aae9-4be4e1655fc0,HUB > BREATHE,67.0,26.98,1.1.7
95.24,100.0,32.56,Silver,Silver,844f3be0-f50d-4a88-9783-0928ad1c2aad,82.54,HIC Acute Coronary Syndromes,869a9b4e-3537-449f-9a59-a0eac523c4e4,NIHR Health Informatics Collaborative Cardiovascular Theme,81.34,34.92,1.1.7
69.05,60.32,16.28,Silver,Bronze,8466ec6f-8a4c-4286-8138-04c35e12b1f8,72.22,"Oncology Clinical Trials Office, University of Oxford",4a65f6d6-f2e4-4d98-a3a4-94a32206836d,ALLIANCE > TISSUE DIRECTORY,76.38,15.87,1.1.7
28.57,23.81,34.88,Not Rated,Not Rated,849d46e6-49a6-4456-a5ae-990c02012bf2,44.45,National Audit of Psychosis - Audit on Early Intervention in Psychosis services -  patient experience survey,c3e63860-bd61-4154-ab5f-ca927fb029c4,ALLIANCE > HQIP,46.84,34.92,1.1.7
45.24,39.68,23.26,Not Rated,Not Rated,84b6d047-2a05-4fc0-8537-809dbb3d18ed,58.73,COMPARE,8cbb73e2-a2c4-4caf-8dcd-6ac3795bb996,OTHER > The University of Cambridge,60.99,22.22,1.1.7
16.67,14.29,37.21,Not Rated,Not Rated,84de0d13-f5bd-4c22-83d3-e1adb00d5a72,38.89,CRIS,67cea834-33f5-4ed7-9dc2-072ad077de07,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,39.73,36.51,1.1.7
92.86,96.83,18.6,Gold,Gold,850f99cb-f091-4f10-86ee-06a3eaa7df53,87.31,North West London Coordinate My Care (NWL CMC),c853b41b-fbd1-4896-b0fb-85303109fec4,HUB > DISCOVER NOW,87.13,22.22,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,859c37b7-3c37-4423-ad85-190b210f5627,38.88,Intensive Care National Audit and Research Centre - Covid19 (ICNC),add6226b-0f21-439a-84a6-51dc26cdc425,,32.78,55.56,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,85aae5d4-c0da-43f7-bd37-703dd61f8501,38.88,Tayside & Fife Radiology,af10ec29-1866-4726-b33f-3948afe182f2,,32.78,55.56,1.1.7
95.24,100.0,20.93,Gold,Silver,8638e095-a609-463f-b36e-c4cac4519660,84.92,Cystic Fibrosis Patient Tendon Rupture,4fcc8b11-2b9b-4f68-b51a-978749d89acc,ALLIANCE > CYSTIC FIBROSIS TRUST,87.16,30.16,1.1.7
69.05,60.32,18.6,Bronze,Bronze,865f0e79-f862-493b-b863-b39b777d60ca,71.43,Oxford Musculoskeletal Biobank,ccd6e59d-3582-4f47-a4cd-f5845192d75c,ALLIANCE > TISSUE DIRECTORY,75.22,17.46,1.1.7
78.57,68.25,11.63,Silver,Silver,8665b36e-f9a5-4062-ba56-d33fecfe3376,77.78,Its Not JUST Idiopathic pulmonary fibrosis Study (INJUSTIS),cc6f926a-90cf-4083-84e7-131d1e63813b,HUB > BREATHE,83.47,12.7,1.1.7
85.71,93.65,20.93,Silver,Silver,8697d105-4b32-4e7f-9998-8df4250cb3e5,84.92,Scottish Stillbirth and Infant Death Survey,e54d35a6-2e7c-422d-a4a5-a7da930b08f2,ALLIANCE > PUBLIC HEALTH SCOTLAND,82.39,23.81,1.1.7
64.29,76.19,37.21,Not Rated,Bronze,86d7088b-7a15-4e9a-b2b0-857a67e04650,67.46,HES:Civil Registration (Deaths) bridge,21aec912-444f-447d-b3c4-6791a6c82667,ALLIANCE > NHS DIGITAL,63.54,41.27,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,87860b0b-fa39-4158-9a80-177703f4b0df,41.27,Maternity Indicators Dataset (MIDS),a0c27454-8cbe-418f-bdae-a85d5e92e9d4,,33.95,50.79,1.1.7
83.33,90.48,32.56,Bronze,Silver,88155e0d-a88f-4a72-ba3f-45d4e352439a,78.58,Cancer registration data for CPRD GOLD,e2f5d637-94b3-447b-b7eb-ea957ce449b6,ALLIANCE > CPRD,75.38,33.33,1.1.7
47.62,41.27,23.26,Not Rated,Not Rated,8821748d-9d8b-4787-91cc-0a58c5ab890d,58.73,EMEP4UK Pollution,eb76598f-e228-413c-82f3-231809062611,HUB > BREATHE,62.18,23.81,1.1.7
69.05,60.32,16.28,Silver,Bronze,88576066-fb5f-43e2-8af4-0904630b2f1b,72.22,University of Southampton Faculty of Medicine Tissue Bank,786563e9-5377-4d18-8d32-65ff14d53987,ALLIANCE > TISSUE DIRECTORY,76.38,15.87,1.1.7
83.33,90.48,30.23,Silver,Silver,8895d3d9-78bd-4216-986a-3bb7f864c382,79.37,HES Accident and Emergency data for CPRD GOLD,733b1060-f958-4c3e-ab6a-2b87901d9a9a,ALLIANCE > CPRD,76.55,31.75,1.1.7
64.29,77.78,44.19,Not Rated,Not Rated,895e5c2f-e484-4d08-91c6-35ac2f85c231,64.28,Mental Health Minimum Dataset v2.6 (Non-Sensitive),702201ff-e729-4e29-a428-32953c9a0332,ALLIANCE > NHS DIGITAL,60.05,49.21,1.1.7
69.05,60.32,16.28,Silver,Bronze,89aac17d-f8a1-4ddc-9495-4adc278234a9,72.22,Human Biomaterials Resource Centre,2f085ac6-d33d-4b9b-8a99-624cc51c3f17,ALLIANCE > TISSUE DIRECTORY,76.38,15.87,1.1.7
78.57,85.71,27.91,Bronze,Silver,89f76cff-03dd-47a1-b6fc-29e42b78e7a5,78.57,Hospital Episode Statistics Admitted Patient Care,2b6409db-a669-4bef-9fd5-39c2b6f8d5e9,ALLIANCE > NHS DIGITAL,75.33,28.57,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,8a0d67e2-6daa-4ebe-913b-eb5ede8801ba,41.27,"Studies Supported by NIHR CRN, ICD10 Coded, with Summary Site Recruitment Data",02397c83-62e6-4ec2-8366-89d211739564,,33.95,50.79,1.1.7
21.43,17.46,37.21,Not Rated,Not Rated,8a128e75-0188-40a3-94d4-5f1967fcffb2,40.48,Fife Radiology,d020302b-a691-49fb-9d10-1274af2f3110,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,42.11,36.51,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,8a68c731-fdc4-4497-b457-2b0f5151edf9,38.88,Tayside & Fife Diabetes – Summary and a range of diabetes related datasets.,49e63323-e564-48ac-9f11-cf77bf0fe20b,,32.78,55.56,1.1.7
19.05,15.87,41.86,Not Rated,Not Rated,8a91286f-3d29-40fc-ae5b-196c46a50426,38.09,CDE Documentation,f866b225-10b8-4df4-9c32-072411f816d8,ALLIANCE > BARTS HEALTH,38.59,39.68,1.1.7
95.24,100.0,16.28,Gold,Gold,8bbcf9f4-a3c4-4f26-aa0e-c5c46457afa3,89.69,COVID-19 Consolidated Deaths,70e37f44-5c3e-4c83-a42a-89b3476d1d45,ALLIANCE > SAIL,89.48,20.63,1.1.7
78.57,85.71,27.91,Bronze,Silver,8c573599-30cf-4708-bcbd-e2e37c795664,77.78,NIHR BioResource: Demographic,d2c486bb-b95b-4093-bb58-b196cfc08c7b,ALLIANCE > NIHR BIORESOURCE,75.33,30.16,1.1.7
19.05,15.87,39.53,Not Rated,Not Rated,8c7abca7-4292-4d1f-b311-c132a7adf109,38.88,Sectra PACS,10bf4c08-6702-44fe-8faa-1280dea6b0c9,ALLIANCE > BARTS HEALTH,39.76,38.1,1.1.7
28.57,23.81,34.88,Not Rated,Not Rated,8c8cf129-e87c-46b3-8812-19e07578ee89,44.45,Falls and Fragility Fracture Audit Programme Fracture Liaison Service Database clinical dataset,d94a604c-5733-4f07-93bb-e77b6ea2313f,ALLIANCE > HQIP,46.84,34.92,1.1.7
76.19,82.54,16.28,Silver,Silver,8cfbaeec-98ce-4e09-b49c-d7c5968f1e85,82.54,Child Health Systems Programme - 6-8week review,f9cf4be7-fbc9-4601-8beb-5d3c3596bf04,ALLIANCE > PUBLIC HEALTH SCOTLAND,79.95,17.46,1.1.7
80.95,88.89,25.58,Silver,Silver,8d06cb09-640c-40db-8387-adf7fab54c3b,81.75,Quality of Life of Cancer Survivors: Pilot Patient Reported Outcomes (Gold),83059be4-071b-4a36-8ab1-9fde1e32e75e,ALLIANCE > CPRD,77.69,25.4,1.1.7
80.95,88.89,25.58,Silver,Silver,8d24889c-ac3c-4b9d-a8bd-cf9effd64370,81.75,Quality of Life of Cancer Survivors: Pilot Patient Reported Outcomes (Aurum),3bc43876-507b-4dff-bd2b-7df147322e15,ALLIANCE > CPRD,77.69,25.4,1.1.7
64.29,77.78,39.53,Not Rated,Bronze,8d3f80d4-aeae-46f0-809b-cd6c51e24f75,67.46,Bridge file: Hospital Episode Statistics to Mental Health Minimum Data Set,31bb8022-f8b1-405a-a22f-140f7c4b4fa6,ALLIANCE > NHS DIGITAL,62.38,42.86,1.1.7
4.76,4.76,46.51,Not Rated,Not Rated,8da6766c-df44-4414-a858-4415e473ea76,29.36,Developing and evaluating interventions to improve asthma care: HEAL ASTHMA,216924f0-585e-4842-a165-78cf9e0af0aa,,29.12,46.03,1.1.7
28.57,23.81,34.88,Not Rated,Not Rated,8dc64dc2-91e0-4a43-9524-1658df371301,44.45,National Clinical Audit of Anxiety and Depression - spotlight audit on psychological therapies (patient experience survey),d94eb31c-04c4-41b6-ad38-45f6aef30132,ALLIANCE > HQIP,46.84,34.92,1.1.7
61.9,69.84,32.56,Not Rated,Not Rated,8e5e3ebe-c0ae-458f-bc75-a5a3368d4c2d,65.87,REal-time Assessment of Community Transmission (REACT-2),25003f25-384c-4264-9c8f-dd8734ee5595,ALLIANCE > IMPERIAL COLLEGE LONDON,64.67,38.1,1.1.7
47.62,46.03,32.56,Not Rated,Not Rated,8eace3c2-1dc8-4708-9350-ad129b7d2bc9,57.94,Mental Health Services Data Set - Inpatients,275ac6a4-798b-4f49-a25e-008245050bbc,ALLIANCE > NHS DIGITAL,57.53,30.16,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,8f54b1ad-b8cd-44a3-94d7-c98133ca913d,41.27,Unscheduled Care Data Mart,a265af2e-40fc-4759-af61-eab293cdad5a,,33.95,50.79,1.1.7
76.19,84.13,25.58,Bronze,Silver,8fac682b-96be-4e21-a2a9-5fe66c3b35ff,79.36,The impact of hospitalised patients with COPD: from admission to outcome,780bf7d0-9ee1-4641-a74f-dc148e361970,HUB > PIONEER,75.31,25.4,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,8fc6bf25-df25-429f-be41-b7d5ffd4ff15,41.27,Eye images and retinopathy grades in diabetic eye screening,3b1bb176-e22f-402a-b863-730d05b22021,,33.95,50.79,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,90ace555-da01-4940-a3ef-78bb83976ff0,38.88,COVID-19 COG-UK Viral Genome (variant strain data),9a36f3f8-3b7e-4e61-8993-b9cc2734fcb8,,32.78,55.56,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,90f44ae7-8394-4fe5-8c1e-c9aa5bf0edf1,41.27,Prescribing Information System (PIS),22e3943e-edb5-44a1-9e4e-22b0f7a31767,,33.95,50.79,1.1.7
71.43,63.49,16.28,Silver,Bronze,914321d0-1d86-4974-a38d-97469f9ff2cd,73.81,Bloodwise Childhood Leukaemia Cell Bank,93baeb13-cc4b-47fd-9dae-5ae5277cba54,ALLIANCE > TISSUE DIRECTORY,77.58,15.87,1.1.7
28.57,23.81,34.88,Not Rated,Not Rated,91b2fdab-1d0e-41a1-a9cc-1ebb536c7ee5,44.45,National Asthma and COPD Audit Programme (NACAP): Pulmonary rehabilitation - clinical audit,3afbb83d-d47b-43b3-a202-0d3081e5d294,ALLIANCE > HQIP,46.84,34.92,1.1.7
59.52,52.38,23.26,Bronze,Not Rated,91f1aef1-7dfe-4cb3-86ab-15e09f91e969,64.28,Seasonal Influenza Vaccine Effectiveness II,50b47298-d935-4990-a002-e26b6bb26d30,HUB > BREATHE,68.13,23.81,1.1.7
4.76,4.76,46.51,Not Rated,Not Rated,922f72c0-e3cb-4d89-a56f-50d938a87630,29.36,"Estimate the cost of care, quality of life and wider societal burden due to COPD",ee6013d6-5584-4275-b124-3113ee5ad37d,,29.12,46.03,1.1.7
4.76,4.76,46.51,Not Rated,Not Rated,927beb63-f650-4972-a3ad-af8e29dc26a5,29.36,Omega 3 Cohort,a1bcea4c-89dd-4cdb-978c-43db676ed73c,,29.12,46.03,1.1.7
92.86,96.83,20.93,Silver,Silver,931efe47-04eb-4ff3-aa62-97e2e4007aed,84.92,Yorkshire Specialist Register of Cancer in Children and Young People,93582beb-e45a-47b6-aeab-d26f583e4c3b,HUB > DATA-CAN,85.97,26.98,1.1.7
95.24,100.0,18.6,Gold,Gold,9360bc6c-2a7d-4415-869d-3e853c558f4d,88.89,National Survey for Wales,bcca421a-9077-4c47-9daa-b1bc030d3dee,ALLIANCE > SAIL,88.32,22.22,1.1.7
35.71,46.03,46.51,Not Rated,Not Rated,93ad5a26-65f5-438f-b4e3-9f7078cc2f92,47.62,Demography,b88c2b24-b75d-4d28-9391-2dbac1605a17,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,44.6,50.79,1.1.7
80.95,87.3,25.58,Silver,Silver,93aeac00-2e6d-44d7-8643-092c587c241a,79.37,South West Primary Care Dataset,a47a8c77-3ced-43a0-acf0-3997c4eb5a29,HUB > DATA-CAN,77.69,28.57,1.1.7
38.1,34.92,25.58,Not Rated,Not Rated,93d26255-7199-4ea7-997d-f74890d12b87,55.55,Imaging,32a2dcb1-1e18-44ba-ad49-b3da312ca447,UK Biobank,56.26,23.81,1.1.7
4.76,4.76,46.51,Not Rated,Not Rated,94188672-a44d-4ae3-8bb3-f249891a5af7,29.36,Exploring psychological issues of primary care teams in Malaysia amidst COVID-19,64f78a5f-268f-4951-9c91-f7e7130baffa,,29.12,46.03,1.1.7
69.05,60.32,18.6,Bronze,Bronze,9445e723-655a-43d0-a4e5-50313d98eac0,71.43,National Unified Renal Translational Research Enterprise (NURTuRE),15f07cef-f4cc-4a50-90bc-9fd40f8b6327,ALLIANCE > TISSUE DIRECTORY,75.22,17.46,1.1.7
69.05,60.32,16.28,Silver,Bronze,94e28efd-a976-4748-81fd-956a598c26cb,72.22,BioDock,ecb82441-286f-408d-880c-9239a25fb5cd,ALLIANCE > TISSUE DIRECTORY,76.38,15.87,1.1.7
80.95,87.3,20.93,Silver,Silver,94f983ec-af41-451a-af5d-657ac58207c6,83.34,Unscheduled Care Datamart,a265af2e-40fc-4759-af61-eab293cdad5a,ALLIANCE > PUBLIC HEALTH SCOTLAND,80.01,20.63,1.1.7
71.43,63.49,16.28,Silver,Bronze,94fab6d3-9753-4ffd-ade2-02d199d93f94,73.81,RAPPER,76d26f0f-0136-4ae5-8be9-37782a70bac5,ALLIANCE > TISSUE DIRECTORY,77.58,15.87,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,953f6cc1-bd69-4fbc-a91b-d33f6c7aa6ca,41.27,GP dataset - Welsh Primary Care,33fc3ffd-aa4c-4a16-a32f-0c900aaea3d2,,33.95,50.79,1.1.7
80.95,88.89,32.56,Bronze,Silver,9552365b-7b9a-4d04-a857-358d0e171424,76.98,Pregnancy Register for CPRD GOLD,14aaf184-5922-4459-affb-6c9e55c12176,ALLIANCE > CPRD,74.19,34.92,1.1.7
4.76,4.76,46.51,Not Rated,Not Rated,95b26238-3379-4188-ad6c-a09657b77648,29.36,"4 Country ChrOnic Respiratory Disease study: PILOT PHASE, Islamabad",a6ea6185-2e2e-4738-b7f1-dc052eae902e,,29.12,46.03,1.1.7
59.52,69.84,30.23,Not Rated,Bronze,96c73136-da1b-43de-9fd1-9d5e63631b14,68.25,VIVALDI 2,12f1ffbc-0ddd-4d6e-b126-2cccf6738658,OTHER > UNIVERSITY COLLEGE LONDON,64.64,33.33,1.1.7
83.33,90.48,23.26,Silver,Silver,9709ee81-c5f1-4c01-a1ac-51ae2a0a60f3,83.34,SAIL Dementia e-Cohort,f48b7c05-6a44-480c-84c6-4f7a684f29f8,ALLIANCE > SAIL,80.03,23.81,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,977ca75e-32da-4e60-a2e5-2bdf534a5986,38.88,CPRD COVID-19 Symptoms and Risk Factors Synthetic Dataset,a48c65e2-a4e0-4d05-9e9c-fc84e050dea0,,32.78,55.56,1.1.7
85.71,92.06,30.23,Silver,Silver,97ae3443-b60b-4b33-b861-83663caea1dc,80.16,HES Admitted Patient Care data for CPRD GOLD,4bcf64a6-f404-4ef4-ae6e-172512ab5f43,ALLIANCE > CPRD,77.74,31.75,1.1.7
28.57,23.81,32.56,Not Rated,Not Rated,97edcc7e-ac9c-4ff6-8634-f19ccc18a44d,45.24,National Audit of Dementia Round 4 - staff questionnaire,ef6e68d6-dcba-410c-943c-26ca21376a3a,ALLIANCE > HQIP,48.0,33.33,1.1.7
64.29,77.78,44.19,Not Rated,Not Rated,97fa09e6-5ea5-41cd-baf8-20366db13a3f,64.28,Mental Health Minimum Dataset v4 (Sensitive) Records,eab996ed-b268-439a-bff4-19925698336a,ALLIANCE > NHS DIGITAL,60.05,49.21,1.1.7
73.81,63.49,18.6,Silver,Bronze,99812cec-ea1c-4979-8e00-32df5bad000b,73.02,RATHL Trial,e5ec63dd-4da5-4119-99c8-5cc79045618c,ALLIANCE > TISSUE DIRECTORY,77.61,17.46,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,99b505ee-44c6-497d-b30b-3ce80eba4047,38.88,Sars-CoV-2 Immunity & REinfection EvaluatioN (SIREN),8e0221d4-dcfa-4580-834b-f44421fca3b5,,32.78,55.56,1.1.7
80.95,88.89,27.91,Silver,Silver,9a5fdb85-7bd6-4073-9058-e45667d497a8,79.37,Quality of Life of Colorectal Cancer Survivors: Patient Reported Outcomes (Gold),61a607a9-b404-41e0-a52e-0c6d0ce8c2be,ALLIANCE > CPRD,76.52,30.16,1.1.7
4.76,4.76,46.51,Not Rated,Not Rated,9a836aa8-60c7-4911-943e-477b0ae8bbb8,29.36,Blended learning for primary care physicians on COPD in Bangladesh,3907a55f-104b-4533-ba21-69bd5f08ce8f,,29.12,46.03,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,9abb8804-de89-4aba-8877-0e9a405870fe,38.88,Systemic Anti-Cancer Therapy Dataset [SACT],6c4ed998-0f05-415c-a3e4-42430bb62d24,,32.78,55.56,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,9b356432-2650-4ded-aa75-657871b38fe3,41.27,Neovascular age related macular degeneration at University Hospitals Birmingham,89c2c798-2e0f-4235-9cd9-e2347f2dfc50,,33.95,50.79,1.1.7
28.57,23.81,34.88,Not Rated,Not Rated,9b7d2306-35e2-44a3-a97d-0b0e03a15336,44.45,National Cardiac Audit Programme - National Congenital Heart Disease Audit (NCHDA),2b640175-725a-465f-9aec-6794e6d27791,ALLIANCE > HQIP,46.84,34.92,1.1.7
47.62,46.03,32.56,Not Rated,Not Rated,9b7f7994-0b9c-4809-b67d-45ae1f04ec5c,57.94,Mental Health Services Data Set - Currencies,add485fa-4c54-4a3e-8676-abe2ff4725a5,ALLIANCE > NHS DIGITAL,57.53,30.16,1.1.7
78.57,85.71,27.91,Bronze,Silver,9bfba8a4-43c3-4356-93a5-3eb3b7bc247a,77.78,PHM and Cancer Outcomes in the WYH Cancer Alliance,bc839e9c-e303-4c3c-9c2c-9975602376e2,HUB > DATA-CAN,75.33,30.16,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,9c2356fe-409f-4a34-9fbf-663d2add3902,41.27,Domiciliary Social Care Worker (DSCW),0e38bbf4-c788-4a1a-9af8-a24821250154,,33.95,50.79,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,9c31bd50-e999-4d4d-bb9d-545c00fcf23e,41.27,Optimum Patient Care Research Database (OPCRD),ac755244-4143-4629-9170-a9e8fc98bb1e,,33.95,50.79,1.1.7
95.24,100.0,18.6,Gold,Gold,9ca6e8d2-98d2-4757-84e1-287585400e55,88.89,"Extended Cohort for E-health, Environment and DNA (EXCEED)",e22ddf52-7f9e-4072-ae61-cb722461b37d,HUB > BREATHE,88.32,22.22,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,9cb83fb7-e8d7-436b-b847-e4759b9589c5,38.88,National Survey for Wales Dataset (NSWD),bcca421a-9077-4c47-9daa-b1bc030d3dee,,32.78,55.56,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,9cc82b97-d508-4cb9-98ca-0105aa897bb6,38.88,UK Renal Registry - Kidney PREM dataset,ea068fd4-1a96-4ed5-a010-8930afb968bb,,32.78,55.56,1.1.7
90.48,95.24,20.93,Silver,Silver,9d4f445e-f81e-45d7-bd83-7e9f68199b4f,85.72,IBD NIHR BioResource: Sample holding,f2af20f9-af84-40ce-8a07-7d095948653e,HUB > GUT REACTION,84.78,23.81,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,9da5acec-1749-46a6-bf93-51457bbaa52c,38.88,National Vascular Registry -  Abdominal Aortic Aneurysm Repair clinical dataset,fbe1ae63-0c12-48e5-be16-87d6bc7bd179,,32.78,55.56,1.1.7
52.38,44.44,25.58,Not Rated,Not Rated,9de20d42-8e9b-45c8-8574-52a49fba826c,59.52,Respiratory social media database,43fc768a-9d2c-4c6d-952f-d8570c487b4a,HUB > BREATHE,63.4,25.4,1.1.7
95.24,100.0,16.28,Gold,Gold,9e67001e-7c77-4bc0-9af2-5138b5d638e4,89.69,Annual District Death Daily,584bf8c8-d58f-44c6-9b65-e1611144fd54,ALLIANCE > SAIL,89.48,20.63,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,9ea7a624-ce4c-460e-b68f-0655dac36765,41.27,Radiotherapy Dataset (RTDS),f102ca50-d1e4-44ec-924e-be89446652af,,33.95,50.79,1.1.7
78.57,87.3,27.91,Bronze,Silver,9f7608a0-2424-457d-ba50-f51a4444403b,80.16,Patient postcode linked deprivation measures for CPRD GOLD,f5c9ba01-a9cb-4a85-9850-d9466b2ff4fb,ALLIANCE > CPRD,75.33,26.98,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,a0292641-9e1a-495d-a7f2-d9ce87ff0b88,38.88,Outpatient Referral (OPRD),7465c65e-c321-42e9-a2f4-6bc664caf1fc,,32.78,55.56,1.1.7
69.05,60.32,16.28,Silver,Bronze,a06afa88-caba-4354-ac70-d05c67b34dfc,72.22,UK CLL Trials Biobank,636e216a-072b-4c8b-b867-23b7666d2cb2,ALLIANCE > TISSUE DIRECTORY,76.38,15.87,1.1.7
71.43,63.49,18.6,Silver,Bronze,a0c4719e-871b-450a-b977-689df35131dd,72.22,National Joint Registry - Primary Hip Replacement dataset,03280e87-6975-4a2a-967d-b332cb788e44,ALLIANCE > HQIP,76.42,19.05,1.1.7
92.86,98.41,37.21,Silver,Silver,a0e0c0c2-072a-47ac-9252-e27b37ac024f,78.57,HIC Transplantation,359a322e-3781-4796-b6b2-81962fa19b7a,NIHR Health Informatics Collaborative Renal Transplantation Theme,77.83,41.27,1.1.7
80.95,87.3,27.91,Silver,Silver,a1164dbd-4057-45a2-9860-cbb69696bd7c,78.57,HES Patient Reported Outcomes Measures (PROMs) data for CPRD GOLD,2439a88e-d961-4152-a7b5-042097946209,ALLIANCE > CPRD,76.52,30.16,1.1.7
38.1,34.92,25.58,Not Rated,Not Rated,a11a234b-8b59-41e8-920a-f8f1799d3c77,55.55,Biological sample assays,14c697a5-2d41-4d86-bf17-2e596d07418b,UK Biobank,56.26,23.81,1.1.7
78.57,85.71,30.23,Bronze,Bronze,a182b27f-5000-40f0-8afd-f2f193a31b7d,75.39,NIHR BioResource: Case report form,4b8675d3-dd87-4cca-804c-aaf0e4ff8140,ALLIANCE > NIHR BIORESOURCE,74.17,34.92,1.1.7
64.29,77.78,44.19,Not Rated,Not Rated,a1a67182-e81b-4144-ac51-92a86f277eb2,64.28,Mental Health Minimum Dataset v4.1 (Non-Sensitive) Events,7b31b427-b447-432e-9a6c-ad2099343491,ALLIANCE > NHS DIGITAL,60.05,49.21,1.1.7
28.57,23.81,34.88,Not Rated,Not Rated,a1d41f64-76e1-4576-a906-f64a7fe664c4,44.45,National Paediatric Diabetes Audit - Spotlight survey of diabetes-related technologies,eecbdd8d-92a0-4dfd-a216-1cf7f1f8c98f,ALLIANCE > HQIP,46.84,34.92,1.1.7
95.24,100.0,13.95,Gold,Gold,a1e1ec62-d78c-40ac-9f90-66ef1dd865b2,92.06,Brecon dataset,9c6e891f-6449-48d2-a1c3-8dd236e34bbd,ALLIANCE > SAIL,90.64,15.87,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,a2226588-3fce-4103-8960-6bb0b22631fb,41.27,Cafcass England (CAFE),8ee61578-e298-423a-be22-cb0438023e5c,,33.95,50.79,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,a239d453-7f49-4e80-a0ea-87a12d445df2,38.88,Death Registration Data - Finalised Extracts,fdfa5116-4f44-457d-99ef-e8c1852aa858,,32.78,55.56,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,a2a324f8-ccd3-405b-a146-34bbb85cc34a,41.27,Enhanced Prescribing Database,2843087f-23a4-4cfe-8e72-53f2b9562cc3,,33.95,50.79,1.1.7
95.24,100.0,20.93,Gold,Gold,a337845e-1dde-445b-90cf-91d8b825e3a5,86.51,Comprehensive Patient Records for Cancer Outcomes,ce4582a8-0985-46c6-b95f-29a5de862d4a,HUB > DATA-CAN,87.16,26.98,1.1.7
95.24,100.0,13.95,Gold,Gold,a45acd02-82d7-4bfe-9845-6b4df683bba8,92.06,Care Home Dataset,aae02f9e-1bad-415d-9730-c46a07a990aa,ALLIANCE > SAIL,90.64,15.87,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,a4936ec2-002e-4927-9a46-29ae9b5d695f,38.88,NIHR IBD BioResource: Demographic,b4121feb-f91b-4e20-a19b-fa49c7a5c1c1,,32.78,55.56,1.1.7
76.19,80.95,23.26,Silver,Silver,a4eb97a6-6a61-415b-9dfb-65503675ed00,77.78,Health & Attainment of Pupils in a Primary Education Network [HAPN],464d8653-4e69-406b-93fd-d68c29d5dfdc,ALLIANCE > SAIL,76.47,25.4,1.1.7
28.57,23.81,32.56,Not Rated,Not Rated,a513dd3b-7e58-4d7f-8164-0a4dbe0a96c0,45.24,Paediatric Intensive Care Audit Network - core dataset (referral),79ae4881-6223-471a-a278-6b2d3b84f971,ALLIANCE > HQIP,48.0,33.33,1.1.7
71.43,63.49,16.28,Silver,Bronze,a5163bce-7c03-4e61-8ebc-024939c047a8,73.81,UK ME/CFS Biobank,d0694e15-b6ba-4a95-962a-dbf627ca207c,ALLIANCE > TISSUE DIRECTORY,77.58,15.87,1.1.7
76.19,85.71,30.23,Bronze,Silver,a53b2f7a-c4a6-4914-9adb-17946c58afad,78.57,Rural-Urban classification for CPRD GOLD,a7d8c6a8-0825-4e73-8f29-3d76194d7114,ALLIANCE > CPRD,72.98,28.57,1.1.7
4.76,4.76,46.51,Not Rated,Not Rated,a5b41636-a112-4631-aaee-215bc4cf200e,29.36,Air Quality Study: An ecological analysis of asthma health outcomes in Malaysia,95f385b1-4f5c-4a88-8e79-9613acc66938,,29.12,46.03,1.1.7
28.57,23.81,34.88,Not Rated,Not Rated,a5c088cd-dae6-4c58-b381-a0d273585f4d,44.45,The Primary-Secondary Care Partnership to Improve Outcomes in Chronic Kidney Disease,d472a895-8587-4503-956e-3bd66d990979,ALLIANCE > UNIVERSITY HOSPITALS OF LEICESTER,46.84,34.92,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,a5d1a44f-9e9d-4c6d-9ce0-53889d579781,41.27,Patient Medical Card Registration (NI),4e5ba567-c452-4979-8e2e-865f7df20252,,33.95,50.79,1.1.7
69.05,60.32,18.6,Bronze,Bronze,a6472a29-17db-477c-bb6e-264686c8fc26,71.43,plasmaMATCH,5618f65d-23fc-4bd5-9a4c-73e4b330c3a6,ALLIANCE > TISSUE DIRECTORY,75.22,17.46,1.1.7
16.67,14.29,37.21,Not Rated,Not Rated,a74f72ad-bf70-42e4-8933-069c7b53c7f9,38.89,LIMS,df70b490-3c00-458e-a6dd-ea3242a3ebac,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,39.73,36.51,1.1.7
80.95,87.3,27.91,Silver,Silver,a79944dc-2696-4326-b378-dbd9224635f1,78.57,HES Patient Reported Outcomes Measures (PROMs) data for CPRD Aurum,7958450d-bd25-42c4-b79e-0e3d0806ac21,ALLIANCE > CPRD,76.52,30.16,1.1.7
92.86,98.41,16.28,Gold,Gold,a8bb670a-b45b-48a6-8e4d-9e8f61de4f5b,90.47,Healthcare Workers Risk Assessment,ed131fee-0635-4613-a453-a383d5dd7cec,ALLIANCE > SAIL,88.29,17.46,1.1.7
28.57,23.81,32.56,Not Rated,Not Rated,a8bfd0c4-1aec-47cc-9e45-00a713482fa2,45.24,Paediatric Intensive Care Audit Network - core dataset (transport),45310176-6331-4bdd-bc53-d9194e212a35,ALLIANCE > HQIP,48.0,33.33,1.1.7
61.9,55.56,18.6,Bronze,Bronze,a8f5117e-7523-452f-abf3-ced72f03cb2e,68.25,Salford Lung Study,86838cad-d5d3-4b65-9c37-29b0c8c36309,HUB > BREATHE,71.65,19.05,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,a933d1f3-374c-4205-b3f2-67def97780e2,41.27,Moorfields DMO Dataset 003,120106fb-49b4-4bc0-b30c-50a59c5c6253,,33.95,50.79,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,a95be055-c758-45e7-9010-80337239c5e8,38.88,COVID-19 Wastewater data,fa9c25eb-1ce0-4f44-b6a6-46ec8caeef40,,32.78,55.56,1.1.7
83.33,90.48,20.93,Silver,Silver,a971ac7b-04e5-4bd5-8bfa-b456d5ed4dbf,84.93,Scottish Cancer Registry (SMR06),ad36dc03-1856-44de-99b0-1af6f312d86b,ALLIANCE > PUBLIC HEALTH SCOTLAND,81.2,20.63,1.1.7
73.81,82.54,25.58,Bronze,Silver,a9b50e33-9974-4635-8e52-9c9b3cb87eb2,78.57,"Demography, interventions & outcomes of patients with Cerebrovascular Disease",ddf7f82f-b453-442d-b562-bb0157593831,HUB > PIONEER,74.12,25.4,1.1.7
92.86,96.83,18.6,Gold,Gold,a9f4a852-a1f2-4041-bb33-3a50e6c43f8d,87.31,North West London Primary Care Events Data (NWL PCE),0f930154-0a0e-4bef-9464-59e657b904d6,HUB > DISCOVER NOW,87.13,22.22,1.1.7
64.29,77.78,44.19,Not Rated,Not Rated,aa019da2-0f2f-493c-95e8-7263ee735f46,64.28,Mental Health Minimum Dataset v3_3.5 (Non-Sensitive),348b12fb-7718-477e-a572-4fc3c716152d,ALLIANCE > NHS DIGITAL,60.05,49.21,1.1.7
80.95,88.89,25.58,Silver,Silver,aa1fe6a9-79cc-4afc-bd38-ec0d5e4fc195,78.57,ONS 2011 Census Wales (CENW),fc24482c-0f9b-445f-af7a-8598627c3b15,ALLIANCE > SAIL,77.69,31.75,1.1.7
28.57,23.81,34.88,Not Rated,Not Rated,aa3ba46a-9494-45f9-987d-fae9c5e9f759,44.45,National Joint Registry - Revision Elbow Replacement dataset,12babf2b-42e8-4b1e-9143-3475a07bb343,ALLIANCE > HQIP,46.84,34.92,1.1.7
4.76,4.76,46.51,Not Rated,Not Rated,aad2340a-ab87-40ee-bfbe-c56adb01fd47,29.36,Assessing the eDPSEEA model in seasonal pollen induced asthma in Islamabad,bfa012ad-e609-4d15-a824-6d143758ca4d,,29.12,46.03,1.1.7
4.76,4.76,46.51,Not Rated,Not Rated,ab2dafd8-b513-4b33-9365-5eb74f32f9d1,29.36,Developing Patient and Public Involvement in Research in Malaysia,153c0ba6-f2ec-4fb4-b5a7-33e11cbdf7fc,,29.12,46.03,1.1.7
4.76,4.76,46.51,Not Rated,Not Rated,ab7f482c-42ea-4ddb-8c92-5ecc1be868ce,29.36,GOAL,563c0bfc-437e-4c10-b144-b392d983017c,,29.12,46.03,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,ac39847d-21d1-457d-9e07-343c0afc85a3,41.27,Walker Study Data,245bffa9-07c3-40b6-916b-161062cdf674,,33.95,50.79,1.1.7
61.9,74.6,39.53,Not Rated,Bronze,acafb160-b18a-436e-90f1-dc4530a90267,67.46,Mental Health Minimum Data Set,285ae0ae-196b-4a75-b1f1-78b07162acfa,ALLIANCE > NHS DIGITAL,61.19,39.68,1.1.7
76.19,84.13,25.58,Bronze,Silver,ad376d74-4f12-4fb4-8d34-a9e7d0b45b3b,77.78,COVID-19 SARI-Watch (formerly CHESS),f61f116d-f732-450e-9d34-c6ae00e3fd1e,ALLIANCE > NHS DIGITAL,75.31,28.57,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,ad5dd22c-f6e1-4338-9d4e-80e4b9ec8f26,41.27,2019 UK Parkinson's Audit - Elderly care and neurology,0cac3870-dd13-44fc-97c2-4bdb67550b39,,33.95,50.79,1.1.7
88.1,92.06,20.93,Silver,Silver,ad638da8-366b-481f-995e-fc326301eb16,84.12,IBD NIHR BioResource: Contact detail,02ddc5c9-03d4-40e4-9934-e60817ec8f3e,HUB > GUT REACTION,83.58,23.81,1.1.7
69.05,60.32,16.28,Silver,Bronze,adbee090-9634-455e-9be1-62843158fb08,72.22,Cardiff School of Dentistry Tooth Bank,0d4f0103-82d8-43f4-8058-4aec80ea562f,ALLIANCE > TISSUE DIRECTORY,76.38,15.87,1.1.7
92.86,96.83,18.6,Gold,Gold,adce90ad-d576-4c98-9de9-dca19f7f4d41,87.31,North West London Admitted Patient Care Data (NWL APC),788857b5-6a5b-4ec2-825e-d965e291cf45,HUB > DISCOVER NOW,87.13,22.22,1.1.7
69.05,60.32,16.28,Silver,Bronze,ae2022bc-2083-4e57-b825-1fb610d910ee,72.22,Biobank for patients with retinal degenerations & dystrophies,cee932f8-151c-4834-ac6d-61d842f9d170,ALLIANCE > TISSUE DIRECTORY,76.38,15.87,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,ae68c3c8-7930-40bd-86e8-7ca1aa6ce57d,38.88,COVID antigen testing - Pillar 2,c8f2ee14-2831-445d-a207-2f7f932f4735,,32.78,55.56,1.1.7
95.24,100.0,20.93,Gold,Silver,ae788191-69e5-4a03-b11b-bd25574b0e4f,84.92,Cystic Fibrosis Patient NTM culture,69bdac5f-bb70-4ca5-a5ce-51a6106ad00b,ALLIANCE > CYSTIC FIBROSIS TRUST,87.16,30.16,1.1.7
19.05,15.87,39.53,Not Rated,Not Rated,ae9e8a9f-533f-4823-8e00-84e39ad2c266,38.88,Community Services Dataset,cae0a9a5-1bf2-49c3-b8d1-c315d3239074,ALLIANCE > BARTS HEALTH,39.76,38.1,1.1.7
57.14,50.79,20.93,Bronze,Not Rated,aecc1328-3c30-4eff-9f56-ae1278846ef9,65.08,Accelerometer,ceab57e8-1e13-499b-a8f4-6ad60dad3721,ALLIANCE > UK BIOBANK,68.1,20.63,1.1.7
71.43,63.49,16.28,Silver,Bronze,af2b3e6d-718e-464a-8c0d-5882fa1d869f,73.81,Manchester Cancer Research Centre (MCRC) Biobank,095d805c-4b62-4726-b968-bb2f1c463701,ALLIANCE > TISSUE DIRECTORY,77.58,15.87,1.1.7
71.43,63.49,16.28,Silver,Bronze,af2ecff2-398c-437f-8c45-adef2406ce43,73.81,Cardiff University Biobank,097540aa-a0ed-492e-853b-9ebcfd061dea,ALLIANCE > TISSUE DIRECTORY,77.58,15.87,1.1.7
80.95,87.3,20.93,Silver,Silver,af434b05-52a7-4ff1-92f5-e2dd38a574aa,81.75,Scottish Birth Record (SBR),81c53293-ef64-4507-8fcf-2a254dc19936,ALLIANCE > PUBLIC HEALTH SCOTLAND,80.01,23.81,1.1.7
69.05,60.32,16.28,Silver,Bronze,af4af5cc-a9eb-4e0e-b50a-3cab4ac2daf9,72.22,NIHR Exeter Clinical Research Facility,df9b7bb1-1b26-4e67-b885-df2dcb8e3450,ALLIANCE > TISSUE DIRECTORY,76.38,15.87,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,af829238-feb6-4fc4-933a-b06812a6c1b8,38.88,Education Daily Attendance Dataset (EDAD),17056e83-ee5a-4fe7-86e1-f09563256be1,,32.78,55.56,1.1.7
90.48,95.24,16.28,Gold,Gold,afc8af43-d6cd-4faa-b204-8fc471119b98,87.31,National Neonatal Research Database,67020745-9def-4c6e-b5ac-bb273bd0a20e,ALLIANCE > NEONATAL DATA ANALYSIS UNIT - IMPERIAL COLLEGE LONDON,87.1,20.63,1.1.7
4.76,4.76,46.51,Not Rated,Not Rated,b009b68f-730a-4d72-9a3c-c917b1ff715d,29.36,Childhood Pneumonia Governance in Bangladesh,5df03d24-ad95-4d64-96df-0684a4f26e58,,29.12,46.03,1.1.7
80.95,87.3,27.91,Silver,Silver,b02e2091-f48a-4d50-91a0-de8c76f76c18,78.57,HES Diagnostic Imaging Dataset for CPRD GOLD,a1bef3a6-9700-43a5-8f3e-dad44ce1fe10,ALLIANCE > CPRD,76.52,30.16,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,b0319b9b-14ba-4e23-86ff-89363d4d69a7,41.27,COVID antigen testing - Pillar 1,3abc20ce-3dc6-4715-9de0-56aa97a6f5ec,,33.95,50.79,1.1.7
61.9,53.97,11.63,Bronze,Bronze,b05a0353-81ac-4e24-b7f6-ecee71272981,70.63,Scottish Immunisation Recall System (SIRS),c027d0ca-7c7d-4864-b4dd-8040f4020fbb,ALLIANCE > PUBLIC HEALTH SCOTLAND,75.14,12.7,1.1.7
38.1,34.92,25.58,Not Rated,Not Rated,b27afede-a51d-4aae-8bf7-ce94888fe898,55.55,Primary-care data,439e71c7-33b5-4e85-98ce-4b068f2523ad,UK Biobank,56.26,23.81,1.1.7
95.24,100.0,20.93,Gold,Silver,b2fb79c5-26db-484b-8e93-1c56d7654f57,84.92,Cystic Fibrosis Patient Transplants,bea354e8-c552-41ef-80c2-a76ca5767e4b,ALLIANCE > CYSTIC FIBROSIS TRUST,87.16,30.16,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,b3004f9b-11a0-482b-9cec-791b28fd492e,38.88,Fife Microbiology: Tests,0c43c0b6-de3a-478b-8190-4da37fbe5ff5,,32.78,55.56,1.1.7
95.24,100.0,34.88,Silver,Silver,b40777a2-468b-4b45-8b7d-2f62f912e950,80.16,HIC ICU 8.3.2,4f546f1e-433c-4884-a090-2a4520c878ac,NIHR Health Informatics Collaborative Critical Care Theme,80.18,39.68,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,b41215cd-afe1-4463-9786-ed86812143e2,38.88,CPRD GOLD,a29feafa-7bdd-44e9-b977-c9d26425e67f,,32.78,55.56,1.1.7
80.95,88.89,25.58,Silver,Silver,b43309eb-7860-49b7-9f11-1a7a0fd5532e,78.57,UK Cystic Fibrosis Registry (CYFI),0628fb77-057d-4838-b80e-18245a8f535d,ALLIANCE > SAIL,77.69,31.75,1.1.7
95.24,100.0,20.93,Gold,Silver,b5033be2-0744-49c5-a398-a4d3ed4e1deb,84.92,Cystic Fibrosis Patient Chronic Medication,0ad31772-0893-4cf7-bab0-683e80302201,ALLIANCE > CYSTIC FIBROSIS TRUST,87.16,30.16,1.1.7
61.9,74.6,44.19,Not Rated,Not Rated,b53f716d-a5c3-4ad8-a2aa-cae09c12ac18,62.69,Mental Health Minimum Dataset v4.1 (Non-Sensitive) Episodes,ef22c16c-c294-46e1-abf9-5204212e9053,ALLIANCE > NHS DIGITAL,58.86,49.21,1.1.7
83.33,90.48,25.58,Silver,Silver,b589b19b-b43f-4344-affb-5d7ea328c909,82.54,Radiotherapy Dataset,f102ca50-d1e4-44ec-924e-be89446652af,ALLIANCE > SAIL,78.88,25.4,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,b63aadf4-da85-478e-a171-05714ef9057e,38.88,National Vascular Registry - Lower Limb Angioplasty clinical dataset,c8b6c319-239b-4792-9898-644a63d07ab5,,32.78,55.56,1.1.7
69.05,58.73,18.6,Bronze,Bronze,b6a60be1-5d94-41f9-a426-5f9523a98d50,69.84,Development of spirometry predictive values for Indian population,59521b01-6adb-4dd3-8b40-dbeb51171e4f,HUB > BREATHE,75.22,19.05,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,b6f26b11-da8d-402a-91c7-3b7122be274c,41.27,Welsh Demographic Service (WDSD),8a8a5e90-b0c6-4839-bcd2-c69e6e8dca6d,,33.95,50.79,1.1.7
73.81,82.54,27.91,Bronze,Bronze,b6fbcdaf-6732-4b76-b8ca-3388f67bce47,74.61,SICSAG Daily (Scottish Intensive Care Audit Group),811a54fb-8b79-442f-8e28-a725a0561a15,ALLIANCE > PUBLIC HEALTH SCOTLAND,72.95,33.33,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,b6fe3b50-aff3-435d-9c57-8b46eaa34671,41.27,Welsh Longitudinal GP Dataset - Welsh Primary Care (WLGP),33fc3ffd-aa4c-4a16-a32f-0c900aaea3d2,,33.95,50.79,1.1.7
95.24,100.0,13.95,Gold,Gold,b70900e9-85e9-4dd2-ae4b-02523be4219d,92.06,Cafcass England,8ee61578-e298-423a-be22-cb0438023e5c,ALLIANCE > SAIL,90.64,15.87,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,b789c975-7042-445c-bfa6-c24e5ca8a983,38.88,UHB 100K Genomics patient clinical data including their acute care contacts,ceae4fe0-4e98-4e3c-85db-e86539aade81,,32.78,55.56,1.1.7
69.05,60.32,16.28,Silver,Bronze,b7a352ee-6306-4bd8-b9bc-f2a69fe17d70,72.22,Public Health England Seroepidemiology Unit,89497432-17e0-49f4-96a4-65ef57d07701,ALLIANCE > TISSUE DIRECTORY,76.38,15.87,1.1.7
71.43,80.95,30.23,Bronze,Bronze,b87dda75-59ac-4b33-97c0-439b4771babe,71.42,NHS Scotland General Practice (GP) Contact Data - Subset,8f486c3d-9504-4a0e-8e24-ab96f057fc9e,ALLIANCE > PUBLIC HEALTH SCOTLAND,70.6,38.1,1.1.7
4.76,4.76,46.51,Not Rated,Not Rated,b95a3ebd-f1f2-4f5f-a598-1eaa60dd1790,29.36,COVID-19 Detection from Chest X-Rays using Deep Learning,57526718-0a9a-42ad-8b7a-582d9ef96d13,,29.12,46.03,1.1.7
69.05,60.32,18.6,Bronze,Bronze,b9642fb3-3bee-491b-8d83-22f9de0fd77f,71.43,ESPAC-TPlus,47f979bc-da9d-4e9e-9f2b-15e09366db04,ALLIANCE > TISSUE DIRECTORY,75.22,17.46,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,b97ff350-f84d-4739-a4d6-f3a607063799,38.88,2019 UK Parkinson's Audit - Patient Reported Experience Measure (PREM),6a6c4568-59e9-4760-89d6-07558a24944c,,32.78,55.56,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,b988b8bc-fbc5-40a7-8123-76ea5286b8c7,41.27,Hospitalised patients with diabetic emergencies & acute diabetic health concerns,0d556d7e-be27-4979-a09e-d419b2e838f3,,33.95,50.79,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,b9a739c2-8601-4518-bd1a-e976ed9172c8,41.27,SAIL Dementia e-Cohort (SDEC),f48b7c05-6a44-480c-84c6-4f7a684f29f8,,33.95,50.79,1.1.7
28.57,23.81,32.56,Not Rated,Not Rated,b9b4ee9a-3ffa-483d-8e46-16f862c83740,45.24,Paediatric Intensive Care Audit Network - customised data collection,6c78af2c-3898-435e-b1f4-e6a44682dc71,ALLIANCE > HQIP,48.0,33.33,1.1.7
80.95,87.3,20.93,Silver,Silver,b9f460e1-cee9-4f52-b464-26b421886939,83.34,Mental Health Inpatient and Day Case - Scottish Morbidity Record (SMR04),24de9d1a-1f48-4c10-b8fc-a3bd7449e191,ALLIANCE > PUBLIC HEALTH SCOTLAND,80.01,20.63,1.1.7
4.76,4.76,46.51,Not Rated,Not Rated,b9ffcd6b-cabd-4875-ac5c-5cb878f7290f,29.36,Pneumonia case management practices in selected communities in Pakistan,cf190350-74c6-45f2-8ede-69ace62eb88d,,29.12,46.03,1.1.7
64.29,77.78,44.19,Not Rated,Not Rated,ba071b0b-5ef4-457b-b194-3a69c2c71a06,64.28,Mental Health Minimum Dataset v4 (Non-Sensitive) Events,3adeb2f4-a924-49cb-9537-84a9a4242a62,ALLIANCE > NHS DIGITAL,60.05,49.21,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,ba30a8b6-bfc7-4105-b094-11f187c7b293,38.88,Emergency Department (Symphony),8002b4d7-ff3b-4402-b805-a6a0022836fd,,32.78,55.56,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,bac86432-1ad7-4ff9-903d-26e28bf4ef97,41.27,CPRD Aurum,1d574c14-1af0-490d-9c4e-be88cfd0e345,,33.95,50.79,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,bb61567b-431f-4e30-b906-654490ea14c7,38.88,IBD NIHR BioResource: Case report form,877a7275-b99d-4ed4-9691-de577e0ab49e,,32.78,55.56,1.1.7
28.57,23.81,34.88,Not Rated,Not Rated,bc236fba-2935-4406-aaa9-0006cbbf693d,44.45,National Cardiac Audit Programme - National Audit of Percutaneous Coronary Interventions (PCI),ac7016ce-f7a9-4c71-bebb-6af6efa27844,ALLIANCE > HQIP,46.84,34.92,1.1.7
40.48,36.51,23.26,Not Rated,Not Rated,bcb224fe-592f-4aaf-abd1-ad3e3caa61ff,57.14,UK Biobank Assessment Centre,2775b97f-1606-490e-81ef-35bad050434a,UK Biobank,58.61,22.22,1.1.7
28.57,23.81,34.88,Not Rated,Not Rated,bcb7804e-e852-423b-a3e7-343242098d70,44.45,National Clinical Audit of Anxiety and Depression - spotlight audit on psychological therapies (therapist survey),bf2d780d-936b-4f4c-88f9-a280b849b652,ALLIANCE > HQIP,46.84,34.92,1.1.7
83.33,90.48,23.26,Silver,Silver,bd87cdf4-ec39-41f6-bb07-c19f10372840,81.75,Education Daily Attendance Dataset,17056e83-ee5a-4fe7-86e1-f09563256be1,ALLIANCE > SAIL,80.03,26.98,1.1.7
80.95,88.89,25.58,Silver,Silver,bd90290d-d60b-499f-b30d-88332274cc46,81.75,Cancer Patient Experience Survey (CPES) for CPRD GOLD,a4ecb8df-c72f-4018-8f23-e180c28dfdb6,ALLIANCE > CPRD,77.69,25.4,1.1.7
64.29,77.78,44.19,Not Rated,Not Rated,bdc17b2c-8b0f-4959-ab9b-e2de32d8a5f9,64.28,Mental Health & Learning Disabilities Dataset v 1 (Sensitive) Events,3d348613-2d66-4814-a294-7e0c365f43f8,ALLIANCE > NHS DIGITAL,60.05,49.21,1.1.7
23.81,22.22,39.53,Not Rated,Not Rated,be0e737d-37a2-4af0-ac28-0bb7d3b49a52,42.06,Outpatient Appointment Dataset,1c27bfbf-c659-42ff-8afe-d58250b49c07,ALLIANCE > BARTS HEALTH,42.14,38.1,1.1.7
59.52,68.25,27.91,Not Rated,Bronze,be1368c6-c97f-4ce0-8322-f97ccb28b9c3,68.25,Oxford Healthcare Workers,9de2f365-4c5d-4252-acee-6270b113aa93,ALLIANCE > OXFORD UNIVERSITY HOSPITALS,65.81,31.75,1.1.7
69.05,60.32,18.6,Bronze,Bronze,be77a483-2eff-4c05-8091-035fe79b3c8a,70.64,Barts CTU,22aa219f-f3c8-4a25-822e-aa2504f6f29a,ALLIANCE > TISSUE DIRECTORY,75.22,19.05,1.1.7
59.52,49.21,20.93,Bronze,Not Rated,bf083b35-da74-4b82-87d3-203ba60325c6,63.5,NIHR BioResource: Metabolite data,dec09f2e-a93f-41e2-8217-72431ea4a19e,ALLIANCE > NIHR BIORESOURCE,69.3,22.22,1.1.7
38.1,34.92,23.26,Not Rated,Not Rated,bf625cfe-c4b2-4ea8-bbe8-1a8873ca4cb9,56.35,Online questionnaires,8ef26f38-d1b3-4b24-b80a-717f216c6aea,UK Biobank,57.42,22.22,1.1.7
16.67,14.29,39.53,Not Rated,Not Rated,bf83ada4-b72e-4789-b177-12a53aa763ea,38.09,TheatreEvents,2c6adf80-f30b-46c9-b9d4-fe3e68622469,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,38.57,38.1,1.1.7
28.57,23.81,32.56,Not Rated,Not Rated,c0025712-8bde-4cbb-93a6-c9a52b99d035,45.24,National Diabetes Inpatient Audit Hospital Characteristics Survey dataset,a9098b51-f8ec-432e-a52f-f4c1f2c1e4f6,ALLIANCE > HQIP,48.0,33.33,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,c01fbdae-33e3-4839-b842-3b61a722a925,38.88,"Ventilatory strategies, medications and outcomes for patients with COVID",55a744c4-a2d4-4ea0-b0eb-1af6e1465383,,32.78,55.56,1.1.7
71.43,63.49,18.6,Silver,Bronze,c03468f4-ba51-4d9f-a785-f041adb84724,73.02,Daisy Tumour Bank,b3ec5c18-e339-4bd8-8a59-5a3445a81f16,ALLIANCE > TISSUE DIRECTORY,76.42,17.46,1.1.7
95.24,100.0,18.6,Gold,Gold,c1682cb7-8f43-49fa-b66a-0a4a205885d3,87.3,Cystic Fibrosis Patient Demographics,19bc55c2-13d7-4488-a52c-35287483ea4e,ALLIANCE > CYSTIC FIBROSIS TRUST,88.32,25.4,1.1.7
28.57,23.81,32.56,Not Rated,Not Rated,c1b8c893-bda6-42f8-8f0e-05a3cba5d5a9,45.24,National Audit of Dementia Round 4 - carer experience survey,3b5907da-256d-49a3-b24b-00893afe8bdd,ALLIANCE > HQIP,48.0,33.33,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,c230a8d8-bf78-4713-8f2f-312162e92e55,38.88,COVID-19 Vaccination Status,98372a87-f3e6-475d-be12-46c0f9587413,,32.78,55.56,1.1.7
69.05,60.32,18.6,Bronze,Bronze,c2c77d1a-d4d8-40cd-95f3-31912d4bd561,71.43,NICAM: Nilotinib treatment for c-KIT mutated advanced AMM,ba0edcaf-854d-4907-851a-280b56128b3b,ALLIANCE > TISSUE DIRECTORY,75.22,17.46,1.1.7
95.24,100.0,16.28,Gold,Gold,c2ddca9f-f144-437b-ac7a-0a628a50ba1a,89.69,Outpatient Referral,7465c65e-c321-42e9-a2f4-6bc664caf1fc,ALLIANCE > SAIL,89.48,20.63,1.1.7
80.95,87.3,25.58,Silver,Silver,c2e112a0-a198-46b0-9a0c-ec91edfb6839,80.16,National Diabetes Audit,9a434a5c-563b-4da1-9133-9994960ade54,ALLIANCE > NHS DIGITAL,77.69,26.98,1.1.7
76.19,82.54,16.28,Silver,Silver,c2ebe992-e9e8-4316-a565-20d312aa9ef7,82.54,Child Health Systems Programme - 4-5 year review,5844bde6-628d-4e76-bb56-3534e2728eb6,ALLIANCE > PUBLIC HEALTH SCOTLAND,79.95,17.46,1.1.7
71.43,63.49,18.6,Silver,Bronze,c3b4f4f2-953e-4470-bedd-9d09fd30a508,73.02,TRICON8,85113a93-89ed-40e3-a479-33b461b91858,ALLIANCE > TISSUE DIRECTORY,76.42,17.46,1.1.7
78.57,87.3,27.91,Bronze,Silver,c4426ec2-fbf0-45b2-9f68-0477527257a0,76.98,2011 Census variables (and variable breakdowns),a05aef07-c3fa-4331-905a-6b6f58eac3d5,ALLIANCE > PUBLIC HEALTH SCOTLAND,75.33,33.33,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,c47f463f-6e7e-4abb-b9bc-010ae68156b7,38.88,National Waiting List Open Pathways,c7b1e328-f2d7-4d11-b38f-ce9930b95ca0,,32.78,55.56,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,c4985b2b-c972-4b7a-a0b0-2d841a63bad6,38.88,Fife Microbiology: Isolations,79086e92-cbbf-4615-b642-bc65d8a3bc6d,,32.78,55.56,1.1.7
57.14,66.67,30.23,Not Rated,Not Rated,c66f943f-4307-4486-817c-49f6d8b9fd6b,65.08,PANTHER study,596077a9-298b-44cc-aa7a-81f04cf5dcb3,ALLIANCE > UNIVERSITY OF NOTTINGHAM,63.45,36.51,1.1.7
54.76,47.62,25.58,Not Rated,Not Rated,c6e2fffb-4817-462e-ba7e-ff546728f3d1,61.11,Exogenous sex steroid hormones and asthma in females of reproductive age,bc5d6d69-ec03-42fe-a63b-638c25c5258c,HUB > BREATHE,64.59,25.4,1.1.7
64.29,77.78,44.19,Not Rated,Not Rated,c713773c-e961-400e-b44a-947002deb073,64.28,Mental Health & Learning Disabilities Dataset v 1 (Non-Sensitive) Episodes,334afc50-a05a-43b9-aa1e-a012a22733e0,ALLIANCE > NHS DIGITAL,60.05,49.21,1.1.7
28.57,23.81,34.88,Not Rated,Not Rated,c72b9078-4d9a-4bfd-95b3-98d96e235e2a,44.45,National Bowel Cancer Audit - clinical dataset,c8a28f0b-a5f8-4dbb-8d71-5b89c7cb3111,ALLIANCE > HQIP,46.84,34.92,1.1.7
76.19,66.67,20.93,Silver,Bronze,c78122ae-8be1-40d7-8567-b83059941c16,73.81,SCOT translational sample collection,b3b790a7-a455-4efb-9c68-60e7131cb836,ALLIANCE > TISSUE DIRECTORY,77.63,19.05,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,c8654ef8-585c-4ac4-ac0e-33a875d407a1,41.27,UHB Linked Diabetic Eye Disease in Acute Diabetic Hospital Admissions,865c99c4-bbe9-45de-83b9-290fb54d5470,,33.95,50.79,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,c885e039-1c1b-45f7-8acf-79a54fa3ab02,38.88,Tayside Bowel Screening Dataset,00201dde-1faf-41d3-b282-5c24c0ca3697,,32.78,55.56,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,c8db5528-7ba5-40fe-8c5f-2c86a9637c73,38.88,CPRD Cardiovascular Disease Synthetic Dataset,780c0a71-0264-4843-939d-1336eee60d40,,32.78,55.56,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,c8edcbd8-40e6-4c34-b138-307a94c19cc0,41.27,Admissions and Discharges,1d5b9205-dae4-4b0e-a3d3-04707875edf8,,33.95,50.79,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,c94f3f11-1bc5-4b0e-9343-3fdd5763d8d6,41.27,Brecon Dataset (BREC),9c6e891f-6449-48d2-a1c3-8dd236e34bbd,,33.95,50.79,1.1.7
69.05,60.32,16.28,Silver,Bronze,c960ffab-a94c-45e3-96a0-598719acfbf5,72.22,National Diet and Nutrition Survey (NDNS),f86400cb-7cab-4e34-aab6-57138b6a96c2,ALLIANCE > TISSUE DIRECTORY,76.38,15.87,1.1.7
64.29,77.78,44.19,Not Rated,Not Rated,c97b8058-a6a4-4c8d-92e1-6e9f4cddd301,64.28,Mental Health Minimum Dataset v4.1 (Non-Sensitive) Records,01c88a30-b14d-401e-82bb-165cbde81942,ALLIANCE > NHS DIGITAL,60.05,49.21,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,c9809e56-5b29-4ab4-a5f3-f72a2d6419fc,41.27,COVID-19 Test Results (PATD),f5f6d882-163d-4ef1-a53e-000fba409480,,33.95,50.79,1.1.7
73.81,80.95,27.91,Bronze,Silver,ca05a688-c305-4ebd-967f-facb010c29bf,76.98,Secondary Uses Services Payment By Results,2004c512-f7c9-4995-b820-55f36aa3fad2,ALLIANCE > NHS DIGITAL,72.95,26.98,1.1.7
95.24,100.0,18.6,Gold,Gold,ca2c6ec0-00ce-42fc-a077-88911259576c,87.3,Cystic Fibrosis Patient Annual Review Encounters,11360490-8da3-4a25-bb87-4fcc249b9af5,ALLIANCE > CYSTIC FIBROSIS TRUST,88.32,25.4,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,ca8c912d-82c4-481e-b17a-b567e3bf3c72,38.88,NHS Tayside and Fife Haematology (Lab Data Restructured),c294bb01-062b-494e-942b-1efe8cbac3dc,,32.78,55.56,1.1.7
95.24,100.0,20.93,Gold,Silver,caa644b6-a50d-455b-bee1-96232443e2b9,84.92,Cystic Fibrosis Patient Liver Enzyme,f72e80fc-dcd3-4457-ae91-dd14449002dd,ALLIANCE > CYSTIC FIBROSIS TRUST,87.16,30.16,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,cace4854-a8de-4487-9c43-fe580b341d26,41.27,Northern Ireland Regional Maternity system (NIMATS),be7efa4f-e500-4a54-8157-6c4442a7e8a8,,33.95,50.79,1.1.7
19.05,15.87,39.53,Not Rated,Not Rated,cb020c3c-f738-4741-bf6b-3df16611b02e,38.88,Critical Care Minimum Dataset,c71fbdc3-0311-4b3f-a9ff-7d2f2c0ba993,ALLIANCE > BARTS HEALTH,39.76,38.1,1.1.7
71.43,63.49,18.6,Silver,Bronze,cb7370a6-a1b0-4473-a32f-ec85ec0155a5,72.22,UKCTOCS Longitudinal Women's Cohort (UKLWC),e0b951ba-0f7d-4743-9374-b965042accdd,ALLIANCE > TISSUE DIRECTORY,76.42,19.05,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,cbab40e4-9e61-4466-b706-db47771d2512,41.27,Congenital Anomaly Register and Information Service (CARIS),6fe7e004-eb51-4c7b-9905-1ec9a4827dca,,33.95,50.79,1.1.7
64.29,77.78,44.19,Not Rated,Not Rated,cc383a3f-1c47-4b7d-99cf-be8ee0afe401,64.28,Mental Health Minimum Dataset v4.1 (Sensitive) Records,c00d5ad2-d5d2-4318-8849-4c2fe52aabd0,ALLIANCE > NHS DIGITAL,60.05,49.21,1.1.7
19.05,33.33,55.81,Not Rated,Not Rated,cc9b9e79-e4b0-421e-a59e-f62ee56918a3,36.5,Business Insights and Conditions Survey (BICS),8e739a01-bcfa-4b75-b7f8-e694ee185f8d,,31.62,60.32,1.1.7
73.81,80.95,32.56,Bronze,Bronze,cca8ff71-fc4e-4544-9345-e87f6c0b3f2d,70.64,RAPID (Hospital Stay Level Data),1fc57971-5af5-499e-a500-4ffbb087f0c4,ALLIANCE > PUBLIC HEALTH SCOTLAND,70.62,39.68,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,ccd9bea4-55d4-4666-90d9-bf407a24009b,38.88,Tayside Pathology,419e5a82-2d82-48a7-a8f3-a83e64a54e92,,32.78,55.56,1.1.7
73.81,63.49,20.93,Silver,Bronze,cde234d0-748b-4df6-a59d-3268cc7e8c1d,72.22,RIO,18bc81e3-7d99-4152-bd7a-3c90ee7e489d,ALLIANCE > TISSUE DIRECTORY,76.44,19.05,1.1.7
92.86,98.41,16.28,Gold,Gold,ce192e2e-4f31-4bb0-9c1f-5c4173c03011,88.89,Postponed Admitted Procedures,bff94600-a254-4111-82f7-6167084d81ca,ALLIANCE > SAIL,88.29,20.63,1.1.7
19.05,15.87,39.53,Not Rated,Not Rated,ce1bcddb-a6af-4511-84c6-2a252d3eb202,38.88,Maternity Services Dataset,173d07ab-5930-4d19-b3de-dcca193e62fd,ALLIANCE > BARTS HEALTH,39.76,38.1,1.1.7
92.86,96.83,20.93,Silver,Silver,ce896b89-5f4a-407c-bb10-7eec51089458,84.92,North West London Community Data (NWL COM),65dad445-ed81-4005-9f5a-4f8a7164043e,HUB > DISCOVER NOW,85.97,26.98,1.1.7
95.24,100.0,13.95,Gold,Gold,cea328df-abe5-48fb-8bcb-c0a5b6377446,92.06,Welsh Demographic Service (WDS),8a8a5e90-b0c6-4839-bcd2-c69e6e8dca6d,ALLIANCE > SAIL,90.64,15.87,1.1.7
85.71,92.06,27.91,Silver,Silver,cf1feb84-837e-4f51-8320-6171f4970a5f,80.95,Death Registration data for CPRD GOLD,1d35e229-13eb-4be1-9dae-4752b6c27c4a,ALLIANCE > CPRD,78.9,30.16,1.1.7
71.43,60.32,16.28,Silver,Bronze,cf64602c-7703-4f29-bd90-e0d511e2b24e,71.43,4 LMIC Asian Country ChrOnic: estimating respiratory disease burden in adults,490747bf-b268-41f3-8f35-f6bc4a4bdbfa,HUB > BREATHE,77.58,17.46,1.1.7
64.29,55.56,18.6,Bronze,Bronze,cf8a9d13-0ee9-494d-b50d-cef39e7823c8,68.25,NIHR BioResource: Full Blood Counts,c20c2d81-c2d3-47cc-be38-93074467544c,ALLIANCE > NIHR BIORESOURCE,72.84,19.05,1.1.7
92.86,98.41,16.28,Gold,Gold,cfdb9fbd-9f67-435c-b257-6b51430451bb,88.89,Referral to Treatment Times,0bf54842-c1db-4bdb-9f55-c5be490bf758,ALLIANCE > SAIL,88.29,20.63,1.1.7
69.05,60.32,16.28,Silver,Bronze,d006821e-a507-4699-b560-b5d023e09d4b,72.22,Cancer Group CTR Cardiff trials,cd833805-f0a8-4ddb-a50d-b12695c92120,ALLIANCE > TISSUE DIRECTORY,76.38,15.87,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,d094b10a-b1b4-4805-9424-33547e9c46ba,38.88,National Vascular Registry Audit - Carotid Endarterectomy Clinical Dataset,f857055b-c29e-4c7f-99ce-65f4ed59648e,,32.78,55.56,1.1.7
83.33,90.48,27.91,Silver,Silver,d0f5761c-66af-4a1c-81c3-eae0f87724b1,80.16,Death Registration data for CPRD Aurum,ad8f07ef-a984-449b-8a60-d1dd564cc36d,ALLIANCE > CPRD,77.71,30.16,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,d11422cc-8865-46bd-b514-c3daafd8f221,38.88,NHS Tayside and Fife Virology,855a84b2-9d58-4b2b-a450-b6c6d534e403,,32.78,55.56,1.1.7
28.57,23.81,34.88,Not Rated,Not Rated,d15b6d4a-a5de-4df4-8f29-4a8926af8024,44.45,National Audit of Psychosis - Early Intervention Psychosis Audit patient experience survey,a464c126-8591-4af6-a10f-99c020f59527,ALLIANCE > HQIP,46.84,34.92,1.1.7
92.86,98.41,16.28,Gold,Gold,d27f265d-8931-4f76-83a2-cb47189a53f0,90.47,Welsh Dispensing Dataset,50ef6443-ed4b-40f9-97fb-1cfd53be6579,ALLIANCE > SAIL,88.29,17.46,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,d2981964-3ff7-47e2-91e1-ac5812227a80,38.88,NIHR IBD BioResource: Case report form,877a7275-b99d-4ed4-9691-de577e0ab49e,,32.78,55.56,1.1.7
33.33,46.03,51.16,Not Rated,Not Rated,d2af6a29-291b-4444-a17c-40f4208f1e1b,46.03,Patient Reported Outcome Measures,55614ed3-2484-4408-a4e9-e5fffed9e8e4,ALLIANCE > NHS DIGITAL,41.09,53.97,1.1.7
95.24,100.0,18.6,Gold,Gold,d2da2750-7482-4ce9-ae5c-2ab393408a67,87.3,Education - Wales,204fa806-071d-4410-9c2c-143017d32d24,ALLIANCE > SAIL,88.32,25.4,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,d3010e1b-09ea-49e5-a5fb-3cf5a030fda6,38.88,Cancer Network Information System - CNIS / CANISC,da91f0eb-1761-485b-8b7f-9121b6a1d004,,32.78,55.56,1.1.7
28.57,23.81,32.56,Not Rated,Not Rated,d3523bb1-c129-4574-ba26-839ba1d3a320,45.24,National Diabetes Audit - National Diabetes in Pregnancy clinical Audit dataset,7c789df2-46f0-4e0e-b6ff-b04dce801445,ALLIANCE > HQIP,48.0,33.33,1.1.7
16.67,14.29,37.21,Not Rated,Not Rated,d3fd4dac-2d15-401c-8185-905ee108d9ce,38.89,JANUS,6590f79d-cfea-4695-9fe0-dc5f85e6d273,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,39.73,36.51,1.1.7
85.71,92.06,23.26,Silver,Silver,d441348a-6121-4e77-b4fb-d14966dc7a3e,80.16,National Records of Scotland (NRS) - Deaths Data,e600dae2-a83c-4b7a-8d23-af4ac31ca374,ALLIANCE > PUBLIC HEALTH SCOTLAND,81.22,31.75,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,d524cd6b-14be-44a5-868c-f3e187d4e5d8,38.88,Follow-COVID,e50d2b20-ef95-43fe-bbf0-83224d88e480,,32.78,55.56,1.1.7
16.67,14.29,37.21,Not Rated,Not Rated,d57a096a-4fa3-4529-b508-0b9df0f1893c,38.89,OUH Patient Master Index,5d7465f6-ced8-434b-9907-d357ad125024,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,39.73,36.51,1.1.7
47.62,42.86,23.26,Not Rated,Not Rated,d58d02f1-47c2-44fc-b16e-4f6cbbb46e62,60.32,INTERVAL,c1fa9b47-a954-4587-a0c2-bae0f3ec2b9b,OTHER > The University of Cambridge,62.18,22.22,1.1.7
4.76,4.76,46.51,Not Rated,Not Rated,d5af13e0-cbcc-47f9-8d85-21867f198051,29.36,Use of digital auscultation to improve diagnosis of paediatric pneumonia,198bd2cc-ca40-4dff-992c-a9480703fc37,,29.12,46.03,1.1.7
52.38,61.9,30.23,Not Rated,Not Rated,d614f4fc-fae9-4775-86d9-4d4710017cf4,63.49,TRACK-COVID,9e89af6b-bfa8-43dc-a2d4-5540c899a670,OTHER > UNIVERSITY OF CAMBRIDGE,61.08,34.92,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,d62892f9-539e-48be-b77e-d3f903d3d118,38.88,Annual District Birth Extract (ADBE),12a77014-4a77-4eb1-8b26-f49689352d1b,,32.78,55.56,1.1.7
69.05,60.32,18.6,Bronze,Bronze,d6296f3e-ccd9-46a5-acc9-50eb5aa41c56,71.43,UNIRAD UK Sample collection,a1d16f3f-c7e7-41c5-a071-07889bf49ab1,ALLIANCE > TISSUE DIRECTORY,75.22,17.46,1.1.7
4.76,4.76,46.51,Not Rated,Not Rated,d7f1b4ab-ae3c-4318-afc9-1b561d46d442,29.36,Research on use of an online learning platform on under-five pneumonia,a3d85fd2-9df3-4f6e-9035-0830a3488ddb,,29.12,46.03,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,d89732fc-1bc3-4bd6-a634-9e9d03f3fea4,38.88,HIV PiNS,1abc859e-4ac6-431a-b550-af1afb36df1b,,32.78,55.56,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,d977abd8-a966-4b4c-99f0-7a4c368f9934,38.88,National Vascular Regsitry - Oragnisational Audit dataset,3c661240-e4d2-456c-a809-133c23f9c469,,32.78,55.56,1.1.7
28.57,23.81,32.56,Not Rated,Not Rated,d9ac0117-f4ba-4939-983d-86406580c5e2,45.24,National Early Inflammatory Arthritis Audit - patient survey,e87410ec-a819-43db-99d1-f887c977e525,ALLIANCE > HQIP,48.0,33.33,1.1.7
95.24,100.0,13.95,Gold,Gold,da5098df-414f-48e0-aaa7-7e2277f80eb7,92.06,Looked After Children Wales,cfdafacb-48f0-4ad8-9f20-193a5eec2da4,ALLIANCE > SAIL,90.64,15.87,1.1.7
69.05,60.32,16.28,Silver,Bronze,da9cdc4c-2790-47f4-b4b5-76e87ce450ae,72.22,King's Health Partners Cancer Biobank,a218d0b4-0273-4a04-ba17-c01dae6dcf33,ALLIANCE > TISSUE DIRECTORY,76.38,15.87,1.1.7
78.57,85.71,25.58,Silver,Silver,dad781b9-43c2-4e8b-a377-e6c0f76d1c04,78.57,NIHR BioResource: Sample holding,56993820-96e4-4a1f-9de1-bad53108c201,ALLIANCE > NIHR BIORESOURCE,76.5,28.57,1.1.7
83.33,90.48,20.93,Silver,Silver,dada485d-2dbd-4e17-ade6-94512210e909,84.93,Outpatient Appointments and Attendances - Scottish Morbidity Record (SMR00),04cb9964-54fb-4529-b09b-735c3daa1c7b,ALLIANCE > PUBLIC HEALTH SCOTLAND,81.2,20.63,1.1.7
64.29,77.78,44.19,Not Rated,Not Rated,db113fcd-69a0-4357-9c6d-250085deb3f5,64.28,Mental Health Minimum Dataset v4.1 (Sensitive) Events,a1154967-a80e-41da-a9ae-6183584ecf6b,ALLIANCE > NHS DIGITAL,60.05,49.21,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,db53c086-db48-4f7e-9264-ed44a9154753,38.88,National Vascular Registry Audit  - Lower Limb Amputation clinical dataset,03e77b9d-57b8-44d5-8d64-9b1325958b22,,32.78,55.56,1.1.7
80.95,71.43,9.3,Silver,Silver,db89a123-0402-4962-8a8f-78557ba4d84f,80.16,UK Lung Volume Reduction Surgery,9f98a674-12f6-42f4-b1a5-322b3b75eef1,HUB > BREATHE,85.83,11.11,1.1.7
21.43,17.46,37.21,Not Rated,Not Rated,dba474a3-90c4-423d-beb0-5ef79c490d24,40.48,"NHS Tayside, A&E Drugs given during an A&E visit",acfbef89-344c-49a5-8079-7344f4316e0f,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,42.11,36.51,1.1.7
4.76,4.76,46.51,Not Rated,Not Rated,dbcf49c1-f23c-4bb8-8c4f-6fc4e996ff97,29.36,The Consequence of Respiratory Syncytial Virus (RSV) Infection in Young Infants,51d41006-727e-43d4-bdb6-f8b427c295c6,,29.12,46.03,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,dc5507d0-807e-4981-906b-731690a5e085,41.27,Outpatient Dataset (OPDW),d331159b-b286-4ab9-8b36-db39123ec229,,33.95,50.79,1.1.7
71.43,63.49,16.28,Silver,Bronze,dcb4c87b-5884-41c0-b9af-d7d094dd0922,73.81,NHS Greater Glasgow & Clyde Bio-Repository,762976cc-83d0-4b31-a879-37f87f947406,ALLIANCE > TISSUE DIRECTORY,77.58,15.87,1.1.7
71.43,63.49,18.6,Silver,Bronze,dd2b5b8c-a2b5-48f2-a2b2-0432d54a0486,72.22,National Joint Registry - Primary Knee Replacement dataset,d517e6fc-9a88-4647-b787-dcbed3635885,ALLIANCE > HQIP,76.42,19.05,1.1.7
69.05,60.32,16.28,Silver,Bronze,ddbc149a-db56-41de-bd2c-3624149f6e7e,72.22,MesobanK,b03835b7-7408-49a0-a9aa-ea405f9855c9,ALLIANCE > TISSUE DIRECTORY,76.38,15.87,1.1.7
69.05,60.32,16.28,Silver,Bronze,ddd49721-ff49-4f68-b3f5-e95a417fb0ac,72.22,NIMRAD-TRANS,039b55f7-d416-49ab-9bdb-4ff7dbc733df,ALLIANCE > TISSUE DIRECTORY,76.38,15.87,1.1.7
73.81,65.08,13.95,Silver,Bronze,de4b46f5-1591-442d-a896-6e0d91657c01,75.4,Children's Health in London and Luton (CHILL),722be723-04bd-48b4-923b-e7d393f0c22b,HUB > BREATHE,79.93,14.29,1.1.7
42.86,38.1,23.26,Not Rated,Not Rated,de794427-edf8-4c9e-b089-9d7b56d01373,57.14,VIKING GENES,43636f80-27fd-43d0-8556-d0a2de0cd819,OTHER > VIKING GENES,59.8,23.81,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,de8d0b95-b968-45f2-8cd4-2c87d72ff729,38.88,UK Renal Registry - COVID-19 dataset,2a3dba77-34ff-4781-b273-1b3d54d11f32,,32.78,55.56,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,df0b5ce6-3c11-4e79-9e69-7836e8639ccd,38.88,NHS Tayside - A&E drugs given during an A&E visit,acfbef89-344c-49a5-8079-7344f4316e0f,,32.78,55.56,1.1.7
95.24,100.0,23.26,Silver,Gold,df23aabd-3e5f-4fc2-aad6-af990cff6f19,86.51,Children’s Kidney Cancers - Great Ormond Street Hospital,3f71bef5-c5a2-400c-a482-2ad30b29a240,HUB > DATA-CAN,85.99,26.98,1.1.7
90.48,95.24,23.26,Silver,Silver,df3cc57d-08ae-4e81-ae79-283d71cf8d95,83.34,IBD NIHR BioResource: SNP chip data,3c749cfc-4008-4916-b64f-969d6a754c0f,HUB > GUT REACTION,83.61,28.57,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,df55c56f-b081-45f4-b265-ed1b2c6d94cd,38.88,Welsh Health Survey Dataset (WHSD),e4d8edb3-6e8e-435d-9732-60c83027d8f9,,32.78,55.56,1.1.7
64.29,55.56,13.95,Bronze,Bronze,df63e893-f688-4bb4-956c-cc4354bb4001,69.84,Klang Asthma Cohort,a2eddb27-c8bd-42ae-94f8-2a3026220da3,HUB > BREATHE,75.17,15.87,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,df6aee16-b3ba-4653-b750-0f046528caf4,41.27,Moorfields AMD Dataset 002,bf392537-82b4-4d71-ace0-e7bea3b167fb,,33.95,50.79,1.1.7
61.9,57.14,25.58,Bronze,Bronze,dfba178f-ce67-4c2d-8693-b23110aeecae,66.66,National Paediatric Diabetes Audit - core clinical dataset (care processes and outcomes),e355c9b9-44f0-4ba3-a872-645aa88f4f2b,ALLIANCE > HQIP,68.16,23.81,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,dfc16033-7620-4002-aa3b-e5bbc400bbfd,38.88,MATCH,5429fc2a-3d72-414d-9393-4079c4c6c0fa,,32.78,55.56,1.1.7
69.05,60.32,16.28,Silver,Bronze,dfc3205c-3079-4e95-93e2-8a3a3beeea5a,72.22,Generation Scotland,019fad36-65ea-4d47-8d6d-a47240eeb801,ALLIANCE > TISSUE DIRECTORY,76.38,15.87,1.1.7
28.57,23.81,34.88,Not Rated,Not Rated,dfedefac-c389-4d07-a8a3-eb2e4ff34587,44.45,National Asthma and COPD Audit Programme (NACAP): secondary care workstream – children and young people asthma (organisational),3efd9b30-1f84-48c0-a3e0-402ecb5c7724,ALLIANCE > HQIP,46.84,34.92,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,e096053e-b028-4487-a6d0-6958cbb5f388,38.88,UK Renal Registry - Your Health Survey dataset,14ed4ab3-470b-45c8-b48f-27fd382a912e,,32.78,55.56,1.1.7
76.19,85.71,30.23,Bronze,Silver,e149e0c4-7edd-4e9c-af9d-2b3b2baef9bd,78.57,Rural-Urban classification for CPRD Aurum,b7d24b82-f8a4-4838-844c-ecd86ddf5db2,ALLIANCE > CPRD,72.98,28.57,1.1.7
78.57,69.84,9.3,Silver,Silver,e172870f-37c4-4103-afae-8a60cae43ccb,79.37,SpiroMeta Consortium Dataset,fb6d98c5-e41d-4804-bb28-839556e0f657,HUB > BREATHE,84.63,11.11,1.1.7
78.57,85.71,25.58,Silver,Silver,e22f93fb-bc08-44eb-b292-dc2baf0ad343,80.16,Coagulopathies & arterial/venous thrombosis in COVID patients: an OMOP dataset,dd4629c0-14b6-4cba-8dcf-31ec5fea68bb,HUB > PIONEER,76.5,25.4,1.1.7
76.19,82.54,25.58,Bronze,Silver,e2f18151-1bce-4a54-ab32-af6296abdfda,76.99,NIHR BioResource: Consent records,1fb479b1-98d4-4d7b-91a2-8368ce3dc77c,ALLIANCE > NIHR BIORESOURCE,75.31,28.57,1.1.7
69.05,60.32,18.6,Bronze,Bronze,e3373d01-48c6-49bc-8c9b-827831e525b3,71.43,"Leeds Dental Institute/School of Dentistry Leeds, Skeletal Tissues Bank",f94168a1-cab8-4211-90e0-38a241609697,ALLIANCE > TISSUE DIRECTORY,75.22,17.46,1.1.7
71.43,63.49,16.28,Silver,Bronze,e443bc67-bc8a-430b-88a9-d3380cd2ae38,73.81,eLIXIR - Early Life Data Cross-Linkage in Research,c8cd0645-b728-4c62-84b8-036c1d8763be,ALLIANCE > TISSUE DIRECTORY,77.58,15.87,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,e4a745d6-f44c-481a-b337-aae4cfe72594,41.27,Care Home Dataset (CARE),aae02f9e-1bad-415d-9730-c46a07a990aa,,33.95,50.79,1.1.7
28.57,23.81,34.88,Not Rated,Not Rated,e6433c92-8439-4e2e-a3e7-016e7812dcfb,44.45,National Asthma and COPD Audit Programme (NACAP): COPD secondary care clinical dataset,85b4dc84-88f4-4740-80fa-fa1eb04a0ae6,ALLIANCE > HQIP,46.84,34.92,1.1.7
83.33,90.48,20.93,Silver,Silver,e6a61d31-d13f-4804-b24c-9966cc40dcc6,84.93,Maternity Inpatient and Day Case - Scottish Morbidity Record (SMR02),d47c809f-3da8-4f8a-b1ee-258d21aad530,ALLIANCE > PUBLIC HEALTH SCOTLAND,81.2,20.63,1.1.7
71.43,63.49,16.28,Silver,Bronze,e7979d81-708d-4657-857c-4ca95d05cda2,73.81,IDRIS Trial,8437b207-c925-4dd1-9478-5af329cd736e,ALLIANCE > TISSUE DIRECTORY,77.58,15.87,1.1.7
61.9,69.84,25.58,Bronze,Bronze,e79c5f26-deb0-4531-834d-58912c9fe663,69.84,COVID-19 Staff Testing of Antibody Responses Study (Co-STARS),435bfcda-f378-44f6-9387-042d959eb945,ALLIANCE > GREAT ORMOND STREET HOSPITAL,68.16,30.16,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,e8932b23-ed21-40f4-8fb1-00ef186e6ee1,38.88,Air Pollution Exposure Estimates,584cbecc-43ef-4015-adf7-ff70178d7abe,,32.78,55.56,1.1.7
61.9,53.97,20.93,Bronze,Bronze,e8c3b66d-f06b-4e3f-944d-f65235133f00,66.67,Strategy introducing Pulmonary Rehabilitation for COPD management in rural India,e8afaf39-86fa-4085-a075-6118cc25fae0,HUB > BREATHE,70.48,20.63,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,e9820518-54e3-46d1-a63f-c5da867dcd82,38.88,IBD NIHR BioResource: Health and Lifestyle Questionnaire,18bfe765-5733-41f3-8114-0a1ec2524b5b,,32.78,55.56,1.1.7
95.24,100.0,16.28,Gold,Gold,ea9fa5fb-928d-4736-8fbf-e3b58a49c6d6,89.69,Children Receiving Care and Support Census,fb3fac03-a428-4b3f-8058-5622e1fd57d8,ALLIANCE > SAIL,89.48,20.63,1.1.7
16.67,14.29,37.21,Not Rated,Not Rated,eaca9ed1-30b6-4157-8894-8e53efc84849,38.89,Sunquest,a80b2567-4755-46f1-bd2a-f3817ce4f10c,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,39.73,36.51,1.1.7
76.19,82.54,27.91,Bronze,Silver,eaf84760-348c-4a78-bd9f-489a5813276a,76.19,NIHR BioResource: Contact detail,fc2fcaec-bd5b-4d43-9e0c-2fed36eff0e4,ALLIANCE > NIHR BIORESOURCE,74.14,30.16,1.1.7
4.76,4.76,46.51,Not Rated,Not Rated,eb376dc5-1abb-4d06-a39a-e479078bcf9d,29.36,ICT-based intervention for adult asthma with limited health literacy,1d6b02f1-47b8-42ad-919d-f738b545cff7,,29.12,46.03,1.1.7
28.57,23.81,32.56,Not Rated,Not Rated,eb50327d-03d1-4672-94b1-67116d95b2d0,45.24,National Joint Registry - Primary Shoulder Replacement dataset,0e903b9e-a329-478a-937c-480eecee4996,ALLIANCE > HQIP,48.0,33.33,1.1.7
95.24,100.0,16.28,Gold,Gold,eba50bb1-e971-4062-8ece-81be39ceca5b,89.69,Annual District Death Extract,15cf4241-abad-4dcc-95b0-8cd7c02be999,ALLIANCE > SAIL,89.48,20.63,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,ec121652-b3ab-4f90-8b93-ab5f6b1bc64c,38.88,Community Services Data Set,5616e0a6-22f1-43a5-a2bd-dcecfa2f3b70,,32.78,55.56,1.1.7
71.43,63.49,16.28,Silver,Bronze,ece82228-9af1-4699-a763-b4608908b645,73.81,NHS Grampian Biorepository,10d0def8-dc03-473f-b60b-4c0dc3642a25,ALLIANCE > TISSUE DIRECTORY,77.58,15.87,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,edac1d8a-af24-43a6-82a7-e15028d5a5db,41.27,National Exercise Referral Scheme (NERS),131784c0-769d-4f7b-b7d0-b5f4b89886d4,,33.95,50.79,1.1.7
28.57,23.81,34.88,Not Rated,Not Rated,ee099373-8a72-4ec7-818f-3cbb9c8a793d,44.45,Falls and Fragility Fracture Audit Programme National Hip Database Facilities Survey 2019,025c9e8a-938b-4886-9e03-fcad90fe7157,ALLIANCE > HQIP,46.84,34.92,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,ee2350f2-c619-446e-9785-fce8e0ac9f44,38.88,Hospital Episode Statistics Accident and Emergency,3ddfccc3-ba32-4653-a999-966b8d6c412f,,32.78,55.56,1.1.7
69.05,60.32,18.6,Bronze,Bronze,ee4a73ef-fb4e-4926-9fcc-db6b44b1447e,70.64,The PEACE Study,33b1a989-5f61-412e-bdae-b551c92d1ed6,ALLIANCE > TISSUE DIRECTORY,75.22,19.05,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,eee15509-f23a-441e-b5be-ee76bd2ba649,38.88,Scottish Covid-19 Vaccination Data,bcfd3b49-f7f0-489e-bc1b-bcce0bd261f2,,32.78,55.56,1.1.7
80.95,88.89,16.28,Silver,Silver,ef3fbf5f-a87c-4f63-8d87-4a5f18fb4301,85.72,GP Out of Hours,731dc868-3e79-4722-9b79-6bb8dec9435b,ALLIANCE > PUBLIC HEALTH SCOTLAND,82.34,17.46,1.1.7
19.05,15.87,39.53,Not Rated,Not Rated,ef727724-6c38-483b-b28d-8e94b5a9d7ac,38.88,Freetext Dataset,0f07f939-1265-4e8b-aaa6-d897d254c2f3,ALLIANCE > BARTS HEALTH,39.76,38.1,1.1.7
28.57,23.81,32.56,Not Rated,Not Rated,f0e2688e-d36e-403e-9faa-bd9912a8f7bc,45.24,National Audit of Care at the End of Life - case note review,d8c67899-2d81-48c2-8482-31cd33973a36,ALLIANCE > HQIP,48.0,33.33,1.1.7
83.33,90.48,25.58,Silver,Silver,f0fc13b4-f801-4647-82f3-07ed07f26ea0,80.96,Welsh Health Survey Dataset,e4d8edb3-6e8e-435d-9732-60c83027d8f9,ALLIANCE > SAIL,78.88,28.57,1.1.7
78.57,85.71,27.91,Bronze,Silver,f1f17da0-0249-45a8-8491-ba52b43fbf33,76.19,Linked Census and death occurrences,54095c0e-6faa-4de4-ac26-e2c7ef3cba5c,NCS > OFFICE FOR NATIONAL STATISTICS,75.33,33.33,1.1.7
80.95,87.3,25.58,Silver,Silver,f2268d4e-0149-4913-9832-0399960eecd4,77.78,North West London Acute Patient level Data (NWL Acute PLD),0d5a40e6-52c0-43c4-bd9f-f2a803cc8ff6,HUB > DISCOVER NOW,77.69,31.75,1.1.7
71.43,79.37,23.26,Bronze,Silver,f25c8ba2-aa2f-4644-b017-b0a2aa76af65,77.78,Labour Force Survey (Household),0b630200-1e7c-4b19-ad53-bcc8863f7ade,NCS > OFFICE FOR NATIONAL STATISTICS,74.09,23.81,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,f298cb2a-20bb-4607-933e-6951942ae6d7,41.27,Welsh Results Reports Service (WRRS),71d37610-ac55-432d-82a3-bdb04407acd8,,33.95,50.79,1.1.7
21.43,19.05,39.53,Not Rated,Not Rated,f29c2012-132d-4994-b5f4-7992d79a0a08,40.48,Admitted Patient Care Dataset,b67f0edd-fed2-4d68-a25f-d225759aa3b0,ALLIANCE > BARTS HEALTH,40.95,38.1,1.1.7
19.05,15.87,39.53,Not Rated,Not Rated,f2b4211b-1af7-46ff-82a3-35b29d1d478e,38.88,"Problems, Diagnosis and Procedures",51b41359-1558-48df-9950-88f75ca6ac4c,ALLIANCE > BARTS HEALTH,39.76,38.1,1.1.7
28.57,23.81,32.56,Not Rated,Not Rated,f34ac736-a1ef-4666-b295-dcbc8831503a,45.24,National Neonatal Audit Programme - 2 year outcomes audit,3bb02d77-9678-4e6e-832d-c2ed3ede412c,ALLIANCE > HQIP,48.0,33.33,1.1.7
28.57,23.81,32.56,Not Rated,Not Rated,f499041f-197e-4cd5-9295-952d60110e48,45.24,National Audit of Care at the End of Life - Quality Survey,51a8dfba-5c94-48bd-9c68-3707f0ebc2a2,ALLIANCE > HQIP,48.0,33.33,1.1.7
28.57,23.81,32.56,Not Rated,Not Rated,f4f5647e-e1bc-4813-8cdc-5c1d6b16d1f9,45.24,National Diabetes Inpatient Audit - Harms clinical dataset,f1471a45-a6f4-4ed7-96b0-56a1af21086e,ALLIANCE > HQIP,48.0,33.33,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,f58a3c47-44aa-4815-aeab-e19a4a330926,38.88,UHB Linked Diabetic Eye Disease and Cardiac Outcomes,4385ed4c-1c42-4ba5-b57f-9ab18e5ffbe1,,32.78,55.56,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,f5d0e254-1005-43a9-88d3-5180c015b7f0,41.27,CAFCASS Wales (CAFW),29a714e1-5289-4362-be24-2848c954344e,,33.95,50.79,1.1.7
95.24,100.0,16.28,Gold,Gold,f6aa8836-b437-40b6-bd1e-ae20010048dd,89.69,Substance Misuse Dataset,291c0dd4-0988-42d2-8e0b-878a892add57,ALLIANCE > SAIL,89.48,20.63,1.1.7
92.86,96.83,20.93,Silver,Gold,f6e25ba4-4f7a-436e-a5f9-f0257d45a612,86.51,North West London Integrated Care Record (NWL ICR),602d8093-6a1e-42cf-a89c-8bf0d47ecc8c,HUB > DISCOVER NOW,85.97,23.81,1.1.7
71.43,63.49,16.28,Silver,Bronze,f71e0f89-edf6-4070-9045-6024b00f79ca,73.81,PHOTO Translational bladder cancer biorepository,07d1b768-78f6-41e8-995a-66afd2549b34,ALLIANCE > TISSUE DIRECTORY,77.58,15.87,1.1.7
28.57,23.81,32.56,Not Rated,Not Rated,f786ff92-f6bb-489e-bf27-c27d1a1a0ab1,45.24,National Maternity and Perinatal Audit clinical audit,1419533e-3d46-4d8a-992b-b5311e6bd27b,ALLIANCE > HQIP,48.0,33.33,1.1.7
76.19,82.54,25.58,Bronze,Silver,f80940e8-0ee1-46be-876b-46fb4bbbc4d2,78.57,Medicines dispensed in Primary Care (NHSBSA data),f201b68f-d995-4a70-a9ee-aa3510232777,ALLIANCE > NHS DIGITAL,75.31,25.4,1.1.7
78.57,85.71,16.28,Silver,Silver,f87064b0-cb12-4e6e-a709-52e776a0f6b7,84.12,Child Health Systems Programme - 13-15 Month Review,e77af7a3-32fa-4a08-8455-4fb489e5b64a,ALLIANCE > PUBLIC HEALTH SCOTLAND,81.14,17.46,1.1.7
28.57,23.81,32.56,Not Rated,Not Rated,f8866aa4-67cc-4655-b315-0c4e7b3406ae,45.24,National Audit of Dementia Round 4 - casenote audit,587a94e6-48a4-4e5e-8230-4018897bc7c7,ALLIANCE > HQIP,48.0,33.33,1.1.7
76.19,84.13,25.58,Bronze,Silver,f8a268c1-831c-4c80-b62c-e254a572b9a0,79.36,Ventilation strategies for patients on intensive care,1a66dbc1-4f06-455c-85fc-68b372575cad,HUB > PIONEER,75.31,25.4,1.1.7
19.05,17.46,34.88,Not Rated,Not Rated,f93aea28-7592-42c0-a5e7-5802f0d6051f,41.27,UK Longitudinal Linkage Collaboration (UK LLC),d858cd90-9a2f-4330-9bbe-46e047a5d0a2,OTHER > UK Longitudinal Linkage Collaboration (UK LLC),42.09,34.92,1.1.7
69.05,61.9,11.63,Silver,Bronze,f9505b84-2794-491f-aff2-05fefd16cad5,74.6,National Records of Scotland (NRS) - Births Data,3b87eef0-bfb6-4bf4-84b9-29880197fec9,ALLIANCE > PUBLIC HEALTH SCOTLAND,78.71,12.7,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,f98d83ec-ad27-46d7-9786-7a0f2749aa11,41.27,2019 UK Parkinson's Audit - Speech and language therapy,c7f7541b-5030-40b9-962a-4aba44af7e1a,,33.95,50.79,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,f98f9578-a4a3-4d93-b32e-f30ff75888b7,41.27,Bowel Screening Wales (SBSW),9f29d47e-4e9a-41b8-b7bc-5ef3570294ef,,33.95,50.79,1.1.7
40.48,36.51,23.26,Not Rated,Not Rated,f9959c00-c063-4fbf-933d-755e3b6ecedc,57.14,Real-time Assessment of Community Transmission (REACT) Study 2: COVID antibody,70656016-c1c9-4bc2-93d1-c66341fcdf36,ALLIANCE > IMPERIAL COLLEGE LONDON,58.61,22.22,1.1.7
71.43,63.49,16.28,Silver,Bronze,f99d82da-13eb-42db-ad0d-348be2173535,73.81,Tommy's National Reproductive Health Biobank,20639743-9a28-43dd-a8af-7571ece2a7f8,ALLIANCE > TISSUE DIRECTORY,77.58,15.87,1.1.7
71.43,63.49,18.6,Silver,Bronze,f9c40294-92d8-45cd-b11a-70eb0fc09004,73.02,PHOENIX DDR-Anti-PD-L1 Trial,df94730b-374b-4d91-8116-1c10a7c77c4e,ALLIANCE > TISSUE DIRECTORY,76.42,17.46,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,fa07a8df-4584-4dc1-87f9-f03ff8d31861,38.88,National Vascular Registry Audit - Lower Limb Bypass clinical dataset,d357be1e-27fe-4b2f-9174-3a2a03ecc12b,,32.78,55.56,1.1.7
30.95,25.4,34.88,Not Rated,Not Rated,fa179e24-2068-4c34-b73c-230003010e9f,45.24,Genvasc Primary Care Data,f397acff-a7af-4062-8e8b-c85889cc41df,ALLIANCE > UNIVERSITY HOSPITALS OF LEICESTER,48.04,34.92,1.1.7
19.05,33.33,55.81,Not Rated,Not Rated,fa1eb6da-697c-48dc-9a6f-e82033db04ba,36.5,HDR UK Papers & Preprints,fd8d0743-344a-4758-bb97-f8ad84a37357,,31.62,60.32,1.1.7
57.14,47.62,23.26,Bronze,Not Rated,fb274dd9-27ab-4eac-9432-90373a9837e6,61.91,NIHR BioResource: Returned datasets,261bcf76-8621-4f0d-b2e6-310993d73daa,ALLIANCE > NIHR BIORESOURCE,66.94,23.81,1.1.7
42.86,38.1,27.91,Not Rated,Not Rated,fb2a851b-3f1c-4665-bbdb-5461f1f36bca,56.35,Hospital Inpatient data,97c68424-dc80-4faa-b777-67c42f92a9b6,UK Biobank,57.48,25.4,1.1.7
95.24,100.0,13.95,Gold,Gold,fb4a069b-fd74-47b2-bbb1-9cde6b590d66,92.06,Breast Test Wales,8b9efd45-f56d-4aa3-b2b8-c66ff3813a2b,ALLIANCE > SAIL,90.64,15.87,1.1.7
80.95,71.43,9.3,Silver,Silver,fb50af29-4aa6-4071-9300-bd2d57c850b0,80.16,Idiopathic Pulmonary Fibrosis (IPF) Genome-wide Association Study,b850e56c-5c5b-413e-b829-743772053978,HUB > BREATHE,85.83,11.11,1.1.7
4.76,4.76,46.51,Not Rated,Not Rated,fba3b66d-8d3a-473f-bb3d-537a6ab1fa7a,29.36,Asymptomatic COVID-19 in Education (ACE) Cohort,48adf432-9b66-4d03-a25e-008fbbb24f56,,29.12,46.03,1.1.7
61.9,52.38,20.93,Bronze,Not Rated,fbad23e8-5079-4f11-b8b7-aaa01c0fbc4b,65.08,NIHR BioResource: Whole Genome Sequencing,ecb90b4a-6f4f-4398-a4f6-d64891c4a137,ALLIANCE > NIHR BIORESOURCE,70.48,22.22,1.1.7
28.57,23.81,34.88,Not Rated,Not Rated,fbb5d74c-802a-4888-9452-3e0faf257f82,44.45,National Asthma and COPD Audit Programme (NACAP): secondary care workstream – children and young people asthma (clinical),33b36393-3760-40d8-bb98-61806fea5398,ALLIANCE > HQIP,46.84,34.92,1.1.7
28.57,23.81,32.56,Not Rated,Not Rated,fc08ad6a-3e94-44db-a122-945c4c875616,45.24,National Vascular Registry Audit Carotid Endarterectomy Clinical Dataset,f857055b-c29e-4c7f-99ce-65f4ed59648e,ALLIANCE > HQIP,48.0,33.33,1.1.7
92.86,96.83,18.6,Gold,Silver,fc704af0-368b-4dd0-866f-753b6d1dccf8,85.72,North West London High Cost Drugs Data (NWL HCD),75638d2c-556a-46b6-afcc-7ab425b34679,HUB > DISCOVER NOW,87.13,25.4,1.1.7
16.67,14.29,37.21,Not Rated,Not Rated,fc7b44f0-eb69-4257-8c07-7516c1210c46,38.89,CellPath,c4538af4-505f-45df-aeae-788ddfd7cb54,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,39.73,36.51,1.1.7
64.29,57.14,13.95,Bronze,Bronze,fcd366e3-b814-4a4a-873f-0ac7cfc75eb7,71.43,Child Health Systems Programme - School,2c31cb1c-2b3d-40c5-b8d4-bf0b81f089b4,ALLIANCE > PUBLIC HEALTH SCOTLAND,75.17,14.29,1.1.7
69.05,60.32,16.28,Silver,Bronze,fd2317ea-c729-433b-b578-309118118b78,72.22,Infectious Diseases BioBank at King's College London,47b544f4-301c-43e0-b347-fc623ea1a8b3,ALLIANCE > TISSUE DIRECTORY,76.38,15.87,1.1.7
80.95,87.3,27.91,Silver,Silver,fd296ed6-6e12-49ab-9e5f-f40428a47b02,79.37,MSDS (Maternity Services Data Set),11d3cf0f-ae5d-42f4-a756-b98c3eff46bc,ALLIANCE > NHS DIGITAL,76.52,28.57,1.1.7
28.57,23.81,32.56,Not Rated,Not Rated,fd7030c8-d5a6-4935-a7fa-dd6037dc29cd,45.24,National Cardiac Audit Programme - National Heart Failure Audit,834618f3-0c6d-4ed2-abae-39208c6b3080,ALLIANCE > HQIP,48.0,33.33,1.1.7
45.24,36.51,25.58,Not Rated,Not Rated,fdb053d7-375a-4422-aa16-c899661d72b1,54.77,"Projections of global, regional and national prevalence of asthma from 2018-2040",0911f991-6c0f-4412-b805-1ee0ded93a12,HUB > BREATHE,59.83,26.98,1.1.7
19.05,33.33,53.49,Not Rated,Not Rated,fdd5864f-c777-4e6c-a5a7-6c85968edc60,38.88,COVID-19 Test Trace and Protect (CTTP),c0fc84af-aeab-4c7e-aa0b-8264baff55d9,,32.78,55.56,1.1.7
19.05,33.33,55.81,Not Rated,Not Rated,fddd0686-1742-45ce-85d8-684a66aa7b30,36.5,Covid Vaccination Dataset (CVVD),471f101c-a45e-4620-8710-be3036a46fba,,31.62,60.32,1.1.7
69.05,60.32,16.28,Silver,Bronze,fe3f2246-aec4-4be4-8f51-3e5bde80931d,72.22,Bristol Biobank,9d56ae46-5955-4f03-a93c-a4a6d9f641ab,ALLIANCE > TISSUE DIRECTORY,76.38,15.87,1.1.7
28.57,23.81,34.88,Not Rated,Not Rated,fed22efe-8a84-4b1e-a642-2412a1420ce8,44.45,Falls and Fragility Fracture Audit Programme National Hip Database clinical dataset,e06b951b-e9d8-4a2c-a51f-1d819f669205,ALLIANCE > HQIP,46.84,34.92,1.1.7
69.05,60.32,16.28,Silver,Bronze,fede80e2-aea9-4229-8024-39b09110be7b,72.22,REQUITE,b5217dcb-582f-4914-ae45-9eb3899add30,ALLIANCE > TISSUE DIRECTORY,76.38,15.87,1.1.7
19.05,33.33,55.81,Not Rated,Not Rated,fee7f039-99d6-4eab-951d-b35e0ae71a75,36.5,UK SARS-CoV-2 viral sequencing data (COG-UK data)-Lineage/Variant Data-Scotland,69a356d6-599e-4d02-8241-066ce3c297bd,,31.62,60.32,1.1.7
4.76,4.76,46.51,Not Rated,Not Rated,ff0ee5d5-aeb4-4dc0-bddf-79336e0ab004,29.36,Enhancing access to pulmonary rehabilitation through implementation research,6265a41f-9444-457b-b401-1d0978f5c58a,,29.12,46.03,1.1.7
19.05,33.33,51.16,Not Rated,Not Rated,ff10d5c4-42a2-4a06-b6af-a2f7393c62e0,41.27,Mortality (Death registration),59fb436a-f8c3-4d4a-bc76-d4a02904b078,,33.95,50.79,1.1.7
64.29,77.78,44.19,Not Rated,Not Rated,ff2c6982-00f3-4483-9fc2-19b3a7211d8d,64.28,Mental Health Minimum Dataset v4 (Non-Sensitive) Records,b9f24f81-bcf2-4e47-8909-0d5414e2d7a4,ALLIANCE > NHS DIGITAL,60.05,49.21,1.1.7
4.76,4.76,46.51,Not Rated,Not Rated,ff727b8e-4805-424a-ba34-acc9b90225fe,29.36,Oxford Carpal Tunnel Syndrome (CTS) Cohort,cd3555b0-514a-4693-8f68-c8267a8e9939,,29.12,46.03,1.1.7
71.43,63.49,16.28,Silver,Bronze,ff8231e5-3ede-4844-a21b-b1d05120e07e,73.81,IMPORT HIGH trial blood samples,edafebac-9479-4d2c-b44e-349091d5b35b,ALLIANCE > TISSUE DIRECTORY,77.58,15.87,1.1.7
